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In South Africa, the incidence of urolithiasis in the white population occurs to the 
same extent as in other western societies.  However, in the black population, this 
disease is extremely rare.  Differences in the gastrointestinal and renal handling of 
several lithogenic and antilithogenic agents in the two ethnic groups have been 
reported, but the rarity of kidney stone disease in the black group remains a riddle.  
The studies described in this thesis were undertaken to address aspects of this 
phenomenon. 
 
Carbohydrate and oxalate-containing dietary agents were identified as being of 
interest since surveys have paradoxically demonstrated that the consumption of 
these potentially lithogenic substances is significantly higher in the black group.  The 
carbohydrates selected for study were glucose, sorbitol and xylitol, while the oxalate-
containing agents were rhubarb, spinach and an aqueous solution of sodium oxalate 
itself.  Finally, taurine, which has been shown to reduce urinary glycolate and oxalate 
in animal models, was also selected for investigation in the two population groups. 
 
In all studies, similar protocols were adopted.  These were approved by the Research 
and Ethics Committee of the University of Cape Town.  Subjects were recruited from 
the black and white student cohorts of the university.  All gave their informed 
consent.  In general, 24 h urine samples were collected before and after ingestion of 
the particular test substance while following a standardized diet.  In some protocols, 
urine samples were also collected at various time intervals during the 24 h period.  
Urines were analysed by routine biochemical techniques.  In addition, some 
specialized analytes were determined in certain studies.  Urinary sorbitol was 
analysed by high performance anion exchange chromatography (HPAEC) and by 
fluorescent assay.  In the studies involving the oxalate-rich challenges, N-acetyl-β-
glucosaminidase (NAG), a urinary marker enzyme of renal injury was measured by a 
colorimetric assay.  Cellular oxidative stress was also evaluated in these particular 
studies by measuring 8-hydroxydeoxyguanosine (8-OHdG), a biomarker of oxidative 
damage to DNA, using an enzyme-linked immunosorbent assay (ELISA).  In the 
study involving taurine, urinary glycolate was measured using gas chromatography 
tandem mass spectrometry (GC/MS).  Several crystallization experiments were 
performed on the urine samples.  These included determination of the calcium 












using a scintillation counter, calcium oxalate aggregation inhibition by a 
spectrophotometric technique, particle volume-size distributions using a Coulter 
Counter and the Bonn Risk Index (BRI) by an automated titration method.  In 
addition, crystals formed in these experiments were examined by scanning electron 
microscopy. 
 
In the carbohydrate studies, glucose caused a decrease in urinary phosphate 
excretion in black subjects.  Sorbitol induced an increase in urinary oxalate and a 
decrease in urinary phosphate excretion in white subjects.  The latter observation 
was also noted in black subjects.  Finally, xylitol provoked an increase in the urinary 
excretion of oxalate in black subjects.  The decreases in phosphaturia are attributed 
to reduced renal filtered load of phosphate consequent to entry of phosphate into 
cells after glucose or sorbitol ingestion.  On the other hand, it is proposed that the 
elevation of oxaluria following sorbitol and xylitol occurs via metabolic pathways 
which are governed by certain enzymes that convert the two sugars into oxalate.  
The observed difference in the urinary excretion of this parameter is ascribed to the 
difference in the activity of the enzyme aldolase which was determined in the two 
groups. 
 
In the studies involving dietary oxalate challenges, rhubarb did not alter significantly 
the urinary excretion of oxalate in both groups.  However, spinach and sodium 
oxalate provoked an increase in oxaluria in black subjects but did not concomitantly 
change either NAG or 8-OHdG excretion.  The implication of these results is that the 
increases in oxaluria were not injurious suggesting resistance in this group to calcium 
oxalate stone formation. 
 
In the study involving the taurine challenge, there were no changes in either group 
with respect to urinary oxalate and glycolate excretion.  Interferences by other 
ingredients in the source of taurine, Red Bull Energy Drink, used in this study, may 
have limited the inhibitory effect previously observed in animal models. 
 
The studies described in this thesis have demonstrated that subjects from South 
Africa’s black and white population groups respond differently to some lithogenic and 
antilithogenic dietary challenges.  The different handling mechanisms that are likely 
to be involved in these different responses may contribute towards understanding 
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1.1   Urolithiasis  
 
Urolithiasis is a common clinical disorder which occurs in both industrialized and 
developing countries.  Increased incidence of kidney stones in the industrialized 
world is associated with affluent standards of living and is strongly associated with 
race or ethnicity and region of residence (Parmar 2004).  In general, a range of risk 
factors have been identified for kidney stone formation.  These include life style, 
positive family history of stones, nutrition and nutrition deficiencies and associated 
diseases and these will be discussed. 
 
Approximately 80% of kidney stones contain calcium, and the majority of them are 
composed primarily of calcium oxalate (60%) (Heilberg et  al. 2006).  The other 
common constituents of kidney stones are calcium phosphate (10%), magnesium 
ammonium phosphate (struvite) (5-10%), uric acid (5-10%) and cystine (1%) (Morton 
et al. 2002).  Kidney stones occur in different shapes and sizes and are formed in the 
kidneys or anywhere along the urinary tract. 
 
1.2   Renal Function and Stone Formation 
 
1.2.1   Overview of the Kidney  
 
The kidney is one of the vital organs in the body which plays a twofold pivotal role, 
namely in the elimination of waste products which are either ingested or produced by 
metabolism (e.g. urea, cr atinine, uric acid, drugs) and in the maintenance of body 
homeostasis.  The kidneys are located on the posterior wall of the abdomen and 
each is made up of about 1 million nephrons, which control and regulate the 
processes involved in urine formation in the kidney (Guyton and Hall 1996).  The 
number of nephrons is fixed and therefore new nephrons cannot be regenerated by 
the kidney once damaged.  Figure 1 depicts a schematic overview of the nephron 
and the parts which are involved in urine formation. 
 
Each nephron is composed of various segments which effectively and exclusively 
function in the production of urine.  The glomerulus is the initial segment where urine 
formation begins. A large amount of fluid (from blood) is filtered in this component 
into the Bowman’s capsule and then into the proximal tubule.  Partial- and complete- 
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and nutritional substances such as amino acids and glucose, respectively, occurs in 
this region (Guyton and Hall 1996). From the proximal tubule, the fluid flows into the 
Loop of Henle and then enters the distal tubule.  The final urine is processed in the 
collecting duct and is passed into the ureter which in turn propels the urine toward 
























1.2.2   Mechanisms of stone formation 
 
Crystal formation in the kidneys can result in the formation of a kidney stone.  The 
precipitation of these crystals in the urinary tract when the urine is supersaturated, 
i.e. when the concentration of salts is higher than what can be retained in solution, 
ultimately results in the formation of a stone.  An imbalance between factors that 
promote crystallization and those that inhibit crystal formation and growth usually 
precedes stone formation (Coe et  al. 2005).  The interaction of Ca and/or Ox with 
other urinary ions and macromolecules that are present in different quantities, may 
give rise to the crystallization process.  It is believed that urine from healthy controls 
and stone formers is always supersaturated with CaOx and that everyone forms 
CaOx crystals in urine from time to time (Ryall 1997).  In the kidney, the 
supersaturation of calcium oxalate (CaOx) usually occurs in the collecting ducts of 
the nephron, whereas calcium phosphate (CaP) precipitation occurs rather in the 
earlier parts, such as the Loop of Henle or distal tubules.  As the precipitated CaP is 
propelled through the tubules, it dissolves as the pH is lower in the collecting ducts 
and it can then act as a nucleation site for CaOx crystals at this region (Mandel 1996, 
Højgaard and Tiselius 1999a).  A brief description of the crystallization steps involved 




Nucleation is defined as the formation of new crystal nuclei in a supersaturated 
solution capable of spontaneous growth into large crystals of a more stable solid 
phase (Finlayson 1978, Brown and Purich 1992).  This transformation is influenced 
by supersaturatio .  Supersaturation is essential, although not a prerequisite, for 
stone formation as it lays the foundation for crystal nucleation to begin.  The 
crystallization process is dependent on the supersaturation and as the 
supersaturation ratio increases, the nucleation rate also increases (El-Shall et  al. 
2004).  Crystals can form if the relative supersaturation is greater than 1 but they 
dissolve if it is less than 1 (Finlayson 1978).   
 
The increase in the concentration of calcium and oxalate ions in an aqueous CaOx 
solution can occur to such an extent that the relative supersaturation escalates to 
values greater than 10, in which the solution becomes unstable and crystals form 
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complexes of stone salt ions in a solution combine to form tiny clusters, which 
gradually increase in size over time and with a concomitant addition of new clusters 
(Boskey 1981).  Finlayson (1978) posited that the conversion of these clusters further 
into stable nuclei depends on changes in free energy.  There are two types of 
nucleation, namely homogeneous and heterogeneous nucleation.  Homogeneous 
nucleation is the process whereby nucleation occurs in a pure urine solution and the 
formation of crystals is spontaneous (Finlayson 1978).   
 
In a case whereby the concentration of calcium and oxalate ions is augmented 
beyond the relative supersaturation value in a solution containing calcium, oxalate 
and CaOx crystals, secondary nucleation occurs on the on the surface of pre-existing 
CaOx crystals (Hess and Kok 1996).  This mechanism, however, is very rare as urine 
in most cases is not concentrated enough.   Nucleation can therefore occur via 
another process called heterogenous nucleation, i.e. nucleation in an impure urine 
solution resulting in facilitated crystal formation (Lonsdale 1968).   In this process 
crystalline particles of foreign substances which act as nucleating substrates could 




Subsequent to nucleation, crystal growth process occurs, a prerequisite for the 
formation of particles in renal tubules and thus stone formation.  Crystals can either 
grow or aggregate individually to form stones or they can concomitantly grow and 
aggregate to produce larger particles which ultimately lead to stone formation 
(Fleisch 1978).   New crystal components are incorporated into a crystal nucleus 
thereby reducing the overall free energy of atoms or molecules as they bond to each 
other (Hess and Kok 1996).  The process whereby the newly formed crystal in the 
urine travels through the solution and ultimately sticks to the crystal to facilitate the 
growth of the crystal is termed bulk diffusion (Hess and Kok 1996).  The rate at which 
crystal components are directly incorporated into the solid crystal lattice is believed to 
be dependent on supersaturation, which must be above 1 (Kavanagh 2006).  The 
crystal growth process is also governed by other crucial factors like pH, size and 



















The most determinant process in the formation kidney stones is called crystal 
aggregation which can be defined in simple terms as the sticking together of crystals 
in solution thereby forming larger particles (Hess and Kok 1996).  This process is 
controlled by aggregating forces that promote crystal aggregation (i.e. van der Waals, 
viscous binding, solid bridges), disaggregating forces that disrupt crystal aggregation 
(i.e. electrostatic repulsion/Zeta potential), as well as shear forces which play a dual 
role (Finlayson 1978, Robertson et al. 1981, Hess 1991).  Two types of mechanisms 
which govern the crystal aggregation process are primary and secondary 
aggregation (Sohnel and Grases 1995).  On the one hand, primary aggregation 
occurs through the attachment of crystals into another pre-existing crystal to form an 
aggregate.  Secondary aggregation, on the other hand proceeds via the collision of 
free particles which are suspended in solution.  However, the structure of the 
aggregate which is formed as a result is usually irregular and of poor order compared 
to that of the aggregate formed via primary aggregation (Hess and Kok 1996).  The 
crystal aggregation process is very fast compared to crystal growth as it produces 
larger particles within seconds.  In contrast, the latter produces particles of 
insignificant size at a much slower rate (Robertson and Nordin 1982, Kok and 
Papapoulos 1993).  However, crystal aggregation is also dependent on 
supersaturation, as it is the case with crystal growth (Hounslow et al. 2001). 
 
Clinical studies have shown that recurrent CaOx stone formers excrete urine with 
larger crystal aggregates than their healthy controls (Robertson et al. 1969, Hallson 
and Rose 1976).  This is believed to be due to the reduced ability of the urine of 
stone formers to i hibit crystal aggregation.  Evidence suggests that citrate plays a 
major role in the inhibition of crystal aggregation and the correlation between 
hypocitraturia and renal stone formation has been reported (Kok et  al. 1990a).  In 
addition, it has been reported that crystal growth and aggregation can be affected by 
urinary macromolecules such as Tamm Horsfall protein, albumin, bikunin, 
osteopontin, inter-α-trypsin and prothrombin fragment 1, which may promote or inhibit 
these two crystallization processes (Worcester and Beshensky 1995, Marengo et al. 
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Crystal Retention 
 
The retention of crystals in the kidney is required prior to their conversion into a 
stone.  It is conceded that crystals mechanistically adhere to renal epithelial cells of 
the kidney through crystal-cell interactions (Kok and Khan 1994, Mandel 1996).  The 
composition of the renal tubular epithelial cell surface, which makes the surface 
either adherent or non-adherent, is regarded as an important determining factor for 
crystal retention.  Evidence suggests that CaOx urolithiasis is initiated by 
hyperoxaluria (i.e. high urinary oxalate levels) which induces crystal formation and 
then deposition in the epithelial cells of the kidney (Khan 1996).  It is postulated that 
the bound crystals on the renal epithelial cells induce injury, partly by reactive oxygen 
species (Aihara et  al. 2003).  An increased urinary excretion of γ-glutamyl 
transpidase, N-acetyl-β-glucosaminidase  and β-galactosidase, has been observed in 
hyperoxaluric patients, indicating damage to the epithelial cells (Baggio et al. 1983, 
Khan et al. 1989).  It is therefore hypothesized that crystal binding to the epithelium 
lining of the renal tubules may be triggered by renal injury.  In some cases, with 
individual variability, the primary constituent of crystal aggregates is COM and these 
are often found adhered to the papillary tip of the epithelial cells. Calcium oxalate 
dihydrate (COD) crystals are less common and are in most cases found in 
hypercalciuric patients. Hyperoxaluric patients on the other hand often have 
predominantly COM crystals in their urines.   
 
Another factor which facilitates crystal retention is the inability of larger crystals to 
pass through the tubular lumen, which then get trapped as result. The morphologies 
of COM and COD crystals are different and thus are dragged with urine at a different 
pace.  When crystals flow at a slower rate and close to the tubule wall they tend to 
form crystal-cell interactions, which promote crystal attachment (Khan 2006).  Figure 




























Figure 2:   Schematic outline of the processes of kidney stone 
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1.3   Epidemiological factors 
 




The prevalence of urolithiasis has been persistently and progressively increasing in 
the last century in both developing and industrialized countries thereby inducing a 
concomitant elevation of costs of diagnosis and treatment of kidney stones.  A direct 
proportionality between affluence and stone formation has emerged over the years.  
It has been observed that the higher the socio-economic class, the higher the 
prevalence of idiopathic nephrolithiasis (Robertson et  al. 1980a).  In 1993, it was 
estimated in the United States that the annual urolithiasis treatment cost is $1.83 
billion (Clark et  al. 1995).  This is primarily due to the fact that the rate of stone 
incidence is rising. 
 
Kidney stones usually recur and a recurrence rate of as high as 50% in 10 years has 
been documented (Trinchieri et  al. 1999).  Not much has been done to evaluate 
protection against stone recurrence.  This impacts the economy unfavourably hence 
dietary measures have been taken in order to combat the formation of stones and 




Research has repeatedly indicated that people who have sedentary occupations are 
at a much higher risk of forming stones (Lonsdale 1968, Blacklock 1969, Ferrie and 
Scott 1984, Borghi et al. 1993).  A study by Sutor and colleagues (1974) confirmed a 
higher incidence of stone formation amongst the professional and managerial groups 
compared to manual workers.  Astronauts have also been studied as they spend 
more time in the microgravity environment and have been noted to have a higher 
incidence of calcium oxalate and uric acid stone formation (Whitson et al. 1993).  This 
is primarily due to the increase in the urinary excretion of calcium, a decrease in 


















Climate and Season 
 
Seasonal and climatic variations have been implicated in the incidence and 
recurrence of kidney stone disease.  Research has indicated a prevalence of stone 
disease in warm and hot climates particularly during spring and summer (Robertson 
et  al. 1975).  Pierce and Bloom (1945) observed a high stone incidence amongst 
troops located in desert areas during war.  It is postulated that more concentrated 
urine, as a result of dehydration, and increased production of vitamin D, subsequent 
to prolonged exposure to sunlight, are important risk factors governing the formation 
of stones in hot regions.  It is hypothesized that skin exposure to excessive sunlight 
triggers the production of 25-hydroxycholecalciferol which is then converted in the 
kidneys to 1,25 dihydroxy-vitamin D.  Subsequently, an increased intestinal 
absorption of calcium occurs, which then stimulates a high urinary excretion of 
calcium and thereby leading to stone propensity (Berlin et al. 1986). 
 
1.3.2 Intrinsic Risk Factors 
 
Race / Ethnicity 
 
One of the important factors which influence the risk of stone incidence has been 
associated with race.   Research has shown that idiopathic stone disease occurs 
more frequently in white Caucasians than in blacks (Ramello et al. 2000).  Similary, 
results of a survey conducted in the United States revealed a high and Iow 
prevalence of kidney stones in whites and blacks, respectively and an intermediate 
prevalence was found in people of Asian and Hispanic ethnic origin (Soucie et  al. 
1994, Hiatt et  al. 1982).  Moreover, Maloney (2005) reported a higher incidence of 
hypercalciuria in white stone formers in the United States.  In South Africa 
approximately 15% of the white population has a high incidence of calcium oxalate 
stone formation compared to less than 1% of the black population which has shown 
immunity towards this disease (Wise and Kark 1961, Modlin 1967, Whalley et  al. 
1998).  These intriguing findings have resulted in further investigations of the two 
population groups and a study by Rodgers et al. (2002) showed that the difference in 
the renal handling of calcium could be one of the factors governing the difference in 
stone incidence between the two groups.  More studies on this aspect will be 
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Age and Gender 
 
A positive correlation between age and urolithiasis has been reported in various 
studies (Robertson et al. 1980b, Daudon et al. 2004).  It has been postulated that the 
peak age for the development of CaOx stones is between 50 and 60 years whilst UA 
stones tend to occur in an older population over the age of 60 years (Baker et  al. 
1993).  The rate of kidney stone formation in women is about half that in men, with 
two peaks, the first among women aged 35 years and the second among those aged 
55 years (Morton et al. 2002). 
 
The prevalence of kidney stone disease has been rising over the years in both males 
and females with the incidence in the former being two to three times higher than in 
the latter.  The reason for this male predominance is obscure.  Presently, CaOx and 
uric acid (UA) stones are more frequent in males than in females, whereas calcium 
phosphate (CaP) and struvite stones are more prevalent in females (Daudon et  al. 
2004, Gault and Chafe 2000, Robertson et  al. 1980b).  A study by Fan and co-
workers (1999) has shown that the higher prevalence of nephrolithiasis in males can 
be ascribed to the effect of sex hormones on some lithogenic risk factors wherein 
androgens appeared to increase, and estrogens to decrease, urinary oxalate 
excretion and kidney calcium oxalate deposition.   It has been suggested that the 
female sex hormone oestrogen may play an important role in protection against 
stone formation by affecting calcium metabolism.  An increased risk of stone 
formation has been observed to increase after menopause (Heller et al. 2002). 
 
Genetics / Family History 
 
Studies on genetics have postulated that kidney stone disease is a polygenic defect 
(Mc Geown 1960; Resnick et al. 1968; Goodman et al. 1995). It has been reported 
that in most cases a family history of kidney stones is more common and frequent in 
patients with kidney stones than in non-stone formers (Lavan et  al. 1971).   In 
addition, in a previous study, Curhan and co-workers (1997a) observed that the 
likelihood of a family history of kidney stones was three times more in men who had 




















1.4   Pathophysiological Aspects 
 
The development of renal calculi usually involves urine composition factors.  It has 
long been documented that the 24 hour urine studies have revealed that urinary 
volume and urinary pH as well as the excretion of oxalate, calcium, uric acid, 
magnesium and citrate, in no particular order, are risk factors which influence crystal 
generation (Robertson et  al. 1978, Hess et  al. 1996).  The ease of crystallization 
depends on the degree of supersaturation, the presence of preformed particles 
(promoters) and the level of crystallization inhibitor, with the latter hindering crystal 
nucleation and/or growth (Grases et al. 2006).  The following section discusses the 
urinary risk factors and their effects on stone formation. 
 
Urine Volume  
 
It is widely known that a suitable fluid intake is the key inhibitor of kidney stone 
formation as it can reduce supersaturation (Curhan et  al. 1993, Borghi et  al. 1996, 
Curhan 1998a).  Recommendations for urinary out ut vary, but there is a broad 
consensus that it should exceed two liters per day, while some even encourage 
urinary outputs in excess of three liters per day (Sakhaee et  al.1980, Menon and 
Resnick, 2002).  To confirm this, Borghi et al. (1996) found, in a retrospective study 
lasting 5 years that the recurrence of stones was evident in patients who maintained 
a urine volume of about 2.6 liters per day compared to those who maintained about 




The pH of the urine plays an important role in the process of kidney stone formation.  
The influence of urinary pH on the crystallization of CaOx and CaP, in particular, has 
been studied.  On the one hand, it has been shown that CaP stone formation occurs 
at higher pH (above 7.0).  This is caused by the dissociation of phosphate ions at the 
higher pH which, in the presence of high urinary calcium excretion promotes 
complexation of phosphate with calcium (Tiselius 1978, Pak 1994, Højgaard et  al. 
1999).  However, the converse of this is the concomitant favourable reduction of 
CaOx stone formation, as there will be less calcium ions to bind with oxalate.  CaOx 
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On the other hand, at lower pH (below 5.5-5.7), the risk of uric acid stone formation 
may be enhanced (Sperling 1964, Tiselius 2003).  A low urinary pH alone is not 
entirely responsible for uric acid lithiasis, since it has been shown that healthy 
subjects have relatively low urinary pH values and thus other factors need to be 
considered (Frank et al. 1963). 
 
Urinary Calcium  
 
Calcium is the most abundant element present in most stones with CaOx being the 
most common compound (Holmes et  al. 2001, Hall 2002, Moyad 2003).  It is 
generally perceived that the supersaturation of urine with calcium, termed 
hypercalciuria, is one of the most common and important risk factors for kidney 
stones (Asplin et al. 2000).  Parmar (2004) defines hypercalciuria as the excretion of 
urinary calcium exceeding 200 mg in a 24 hour collection or an excess of 4 mg 
calcium/kg/24 h.  There are different types of hypercalciuria (Bhandari and Menon 
2003, Parmar 2004), namely: 
 
o Idiopathic hypercalciuria: Increased urinary calcium excretion in the absence of 
elevated serum calcium levels. 
o Absorptive hypercalciuria: Enhanced renal filtered load of calcium as a 
consequence of its elevated absorption from the intestine. 
o Renal hypercalciuria: Primary leak of calcium due to impaired renal tubular 
absorption. 
o Resorptive hypercalciuria: Increased bone demineralization and enhanced 
intestinal absorption of calcium. 
 
It is estimated that about 30 to 50 % of patients with kidney stones have idiopathic 
hypercalciuria (Bushinsky 2002). Studies have linked idiopathic hypercalciuria (IH) 
with intestinal hyperabsorption of calcium (Hennemann et al. 1958) and there is also 
supporting evidence that most patients with IH present abnormally high serum levels 
of 1,25-dihydroxyvitamin D3 (Hess and Jaeger 1992).  Recommendations of 
restricting dietary calcium intake in the case of absorptive hypercalciuria as a 
therapeutic measure against CaOx stone formation have been implemented (Breslau 
1994), even though no clinical data has been reported in support of this hypothesis.  
More recently, this practise has been shown to increase the risk of CaOx stone 
















It has been demonstrated that the saturation of urine with CaOx rises significantly 
with small increases in oxalate concentration and this has led to the hypothesis that 
calcium binds with oxalate in the intestinal lumen, which results in its excretion in the 
stool and thereby abating oxalate absorption, subsequently increasing the risk of 
CaOx crystallization (Coe et al. 1992, Curhan and Curhan 1994, Krishnamurthy et al. 
2003, Hatch and Freel 2003).  The amount of oxalate available for absorption in the 
intestine and its excretion via the urinary tract can be limited by its complexation with 
calcium (Sutton et al. 1994, Nishiura et al. 2002, Seiner et al. 2003, Hatch and Freel 
2003).  
 
In CaOx stone formers the molar ratio of urinary calcium to oxalate is 5 : 1, therefore 
based on this fact,  it is recommended that oxalate intake must be restricted as small 
changes in oxalate concentration have much  larger effects on calcium oxalate 
crystallization than calcium concentration (Heilberg 2000). Theoretically, the 
excessive excretion of oxalate in the urine could result from firstly, increased 
absorption from the gut, secondly, increased renal clearance or thirdly, increased 
rate of synthesis (Williams and Smith 1968).  Research has shown that healthy 
individuals excrete less urinary oxalate compared to stone formers (Goldfarb 1988, 
Schwille et  al. 1989, Wilson et  al. 1989).  On one hand, most patients with urinary 
calculi appear to excrete normal quantities of oxalate, but a small proportion excretes 
moderately increased amounts i.e. 50-100 mg per day.  On the other hand, patients 
with the rare genetic disorder of primary hyperoxaluria excrete more than 100 mg per 
day.  By contrast, only 10-40 mg per day of oxalate is excreted by healthy adults on a 
normal diet (Zarembski and Hodgkinson 1969).  
 
Another equally important factor which influences the absorption and subsequently 
the urinary excretion of oxalate is the deficiency of Oxalobacter formigenes (O. 
formigenes), an intestinal bacterium which plays a crucial role in degrading dietary 
oxalate (Allison et  al. 1986, Troxel et  al. 2003).  Research has shown that O. 
formigenes is acquired in early childhood by children and is present in faeces of 70-
80% of adults (Sidhu et  al. 1997, Sidhu et  al. 1999, Kwak et  al. 2001, Kumar et  al. 
2002, Kwak et al. 2003).  However, patients with enteric hyperoxaluria and calcium 
oxalate stone formers have been reported to have a lower colonization rate of O. 
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et al. 2003, Kumar et al. 2004).   In order to find further evidence for the role of O. 
formigenes in oxalate homeostasis in humans, a decrease in oxalate excretion has 
been observed in two adult human subjects after co-administration of O. formigenes 
with an oxalate supplement (Duncan et al. 2002).   
 
Urinary Uric Acid 
 
High urinary uric acid is well-known as one of the primary risk factors of kidney stone 
formation.  The main dietary source of uric acid is animal protein (purines).   It is 
believed that an excessive dietary intake of purines and an excessive production of 
uric acid result in a condition known as hyperuricosuria (i.e. increased urinary 
excretion of uric acid).  The risk factors deemed to be crucial in uric acid 
nephrolithiasis are acidic urine pH, low urine volume and hyperuricosuria (of genetic 
or environmental origin) (Riese and Sakhaee 1992).  Excessive sweating and 
dehydration result in a low urinary volume which is usually accompanied by an 
unduly low urine pH which speeds up the uric acid stone formation (Sakhaee 2007).  
It has been postulated that a low urinary pH (below 5.5), rather than high urinary 
excretion of uric acid is the principal determinant of uric acid supersaturation (Coe et 
al. 1980).  The association of hyperuricosuria with calcium oxalate stone formation 
has been well documented (Gutman and Yu 1968, Coe 1978).   
 
It has been indicated that the development of acidic urine in patients with idiopathic 
uric acid nephrolithiasis may be a result of overproduction of endogenous acid and 
defective urinary excretion of ammonium (Sakhaee et al. 2002, Cameron et al. 2006).  
The latter results in decreased urinary citrate excretion in these uric acid stone 
formers.  Recent findings have also noted a positive correlation between uric acid 
nephrolithiasis and insulin resistance, with the former being the result of low urinary 
pH in patients who experience the latter condition (Abate et al. 2004, Maalouf et al. 
2004).  
 
The recommendations for preventing uric acid stone disease involve alkalinization of 
urine using citrate or bicarbonate to maintain a pH of 6.0-6.5 and a higher daily intake 
of large quantities of fluids (Morton et  al. 2002).  It has also been suggested that 
treatment with Allopurinol may be beneficial in patients with hyperuricosuria as it 
blocks uric acid production thereby causing a reduction in the heterogeneous 
















One of the most crucial inhibitors of stone formation is citrate. In the urine, citrate 
binds with free calcium ion thereby forming a soluble complex and inhibiting the 
precipitation of calcium oxalate and calcium phosphate (Meyer and Smith 1975, Kok 
et al. 1987). Nucleation, growth and aggregation of pre-formed calcium oxalate and 
calcium phosphate crystals are also retarded by citrate to hinder the development of 
stones (Ryall et al. 1981, Nicar et al. 1987, Kok et al. 1987, Tiselius et al. 1993, Parks 
et al. 1996, Schwille et al. 1999).  Hypocitraturia (i.e. low urinary citrate excretion) has 
been found to differ in male and female controls.  It is defined as urinary excretion of 
citrate less than 200 mg/day in men and less than 400 mg/day in women 
(Hodgkinson 1962).  In both stone formers and non-stone formers hypocitraturia 
results from increased reabsorption of citrate in the renal proximal tubules of the 
kidney (Pajor 1999, Hering-Smith et al. 2000).  It has been reported that about 19-
63% of patients with CaOx nephrolithiasis have hypocitraturia (Pak 1991).  
  
Hypocitraturia is correctable and alkali therapy has been prescribed for the treatment 
of this defect. However, the efficacy of alkali therapy on its own in treating 
hypercalciuria related hypocitraturia has been deemed insufficient hence the addition 




Hypomagnesuria (decreased urinary magnesium excretion) is one of the primary 
causes of calcium oxalate crystallization and crystal growth.  It has been reported 
that addition of magnesium to a sodium oxalate load or to meals containing oxalate 
reduces the urinary excretion of oxalate (Barilla et al. 1978, Berg et al. 1990a).  This 
has often been attributed to the complexation of magnesium with oxalate ions thus 
forming a soluble magnesium oxalate salt and thereby reducing the uncomplexed 
oxalate ions in the urine.  A correlation between the two inhibitors of crystallization, 
magnesium and citrate has been observed as most patients with hypomagnesuria 
also have hypocitraturia (Preminger et al. 1989). 
 
Studies have noted a difference in urinary magnesium excretion between adults and 
children in western regions.  It was found that the former excrete lower urinary 
magnesium than the latter, which explains the low incidence of stone formation in 
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1999).  Similarly, it has generally been conceded that stone formers exhibit lower 
levels of urinary magnesium than controls (Trinchieri et  al. 1991, Deshmukh and 
Khan 2006).  However, contrary to this observation, some studies found the levels to 
be equal if not higher (Johansson et al. 1980, Drach 1988). 
 
1.5   Diet  
 




Contrary to popular belief, the high incidence of CaOx nephrolithiasis is not a 
consequence of increased dietary calcium consumption (Curhan 1993, Curhan 
1997b, Bushinsky 2002).  Studies have shown that calcium restriction is no longer 
advisable for stone formers, with or without hypercalciuria, as a low-calcium diet 
leads to a greater oxalate absorption in the gastrointestinal (GI) tract, and thereby 
results in enhanced urinary oxalate absorption and excretion (Ettinger 1976, Hesse et 
al. 1981, Bastille et al. 1983, Martini et al. 1993, Heilberg et al. 1996).  In fact, Curhan 
and colleagues (1993, 1997b) also investigated the effect of dietary calcium on 
kidney stone formation in both men and women and they observed that high calcium 
intake does lower intestinal binding of oxalate by calcium and prevents urinary 
crystallization.  A study on male smokers showed no increase in risk of stone 
formation after dietary calcium intake (Hirvonen et  al. 1999).  Additionally, to find 
further proof on these findings, a study of normal men showed that simultaneous 
ingestion of a sufficient amount of calcium with oxalate-containing foods can help to 
prevent a marked hyperoxaluria (Hess et al. 1998).   
       
There have been contradicting findings with regard to the association of calcium 
supplements with the risk of stone formation.  Two studies by Curhan and colleagues 
have shown supplementation with calcium induced a nonsignificant risk of stone 
formation in men (Curhan et  al. 1993) and a significant increase in risk in women 
(20%) (Curhan et al. 1997b).  Their explanation for the conflicting observations was 
the fact that the calcium supplement was taken with breakfast or without meals by 
most subjects, further from the time of their intake of dietary oxalate.  The 
consequence of this is the elevation of absorption and urinary excretion of calcium, 














highlights, therefore, the importance of the timing of ingestion of supplemental 
calcium for optimum results.  Another study has reported an inverse correlation 
between the urinary oxalate-to-creatinine ratio and calcium intake in healthy men and 
women subjects subsequent to the elimination of calcium supplements after frequent 
consumption (Lemann et al. 1996). 
 
However, by contrast, supplementation with calcium citrate in normal women 
revealed a nonsignificant increase in calcium oxalate saturation after three months 
(Sakhaee et al. 1994).  Likewise, Levine et al. (1994) observed no significant changes 
in calcium oxalate saturation in female stone formers after six months of calcium 
citrate supplementation.  More studies are therefore required to elucidate the 




It is well known that an increased intake of dietary oxalate leads to hyperoxaluria, a 
key risk factor for calcium oxalate kidney stone formation.  Urinary oxalate is derived 
not only from diet but also from endogenous synthesis.  There seems to be 
uncertainty as to how much urinary oxalate comes from the diet.  Some researchers 
have reported that diet contributes about 10 to 20 % (Williams and Smith 1983) while 
others have recently argued that it contributes 40-50 % (Holmes et al. 2001).  The 
remainder and more substantial part of urinary oxalate is derived endogenously.   
 
It has been estimated that a Western diet contains an oxalate content of 50 to 100 
mg/day, whereas vegetarian diets have more than 150 mg/day (Hesse and Siener 
1997, Holmes and Kennedy 2000).  High oxalate levels are found in foodstuffs such 
as spinach, rhubarb, beets, nuts, tea, wheatbran, cocoa and strawberries.  Ingested 
dietary oxalate is believed to be absorbed both actively and passively anywhere 
along the gastrointestinal tract (Prenen et  al. 1984) and most researches have 
posited that 3-8 % of oxalate is absorbed from food (Finch et al. 1981, Brinkley et al. 
1990).  Furthermore, studies have revealed that stone formers possess a metabolic 
disorder in relation to gastrointestinal absorption of oxalate.  It has been shown that 
stone formers absorb approximately 50 % more oxalate than non-stone formers 
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Berg et al. (1990b) studied the response to an oral load of 14C-labeled oxalic acid in 
recurrent idiopathic calcium stone patients and normal subjects.  Their results 
showed an increased calcium absorption (>15 %) in 40 % of the patients compared 
to <10 % in 68 % and ≤15 % in 32 % of normal subjects.  A few plausible 
mechanisms have been proposed and they include, less available unbound calcium 
to bind to oxalate due to increased calcium binding to free fatty acids and a 
deficiency of oxalate-degrading bacteria in the gut or increased gut permeability 
consequential to augmented delivery of bile salts (Sutton and Walker 1994). This 
clearly indicates that an elevated consumption of oxalate-rich foods is not always a 
predisposing factor to hyperoxaluria in some CaOx stone formers.  As mentioned 
earlier, it is imperative to avoid calcium restriction as it may result in increased 
intestinal absorption of oxalate and thus an elevated urinary oxalate excretion.   
 
Evidence for the toxicity of oxalate to renal epithelial cells has been provided (Khan 
and Thamilselvan 2000, Koul et al. 2003, Jonassen et al. 2005).  It is hypothesized 
that an increased urinary excretion of oxalate induces renal tubular injury, which is 
manifested by an elevated excretion of marker enzymes including N-acetyl-β-
glucosaminidase in the urine (Huang et al. 2003).  This topic will be dealt with later in 




The relation between the intake of animal protein and the high incidence of calcium 
oxalate kidney stone formation in industrialized countries has been examined.  
Curhan et al. (1993) found a 33 % risk increase in men who consumed ≥77 g/day of 
animal protein compared to those who consumed ≤50 g/day.  Studies have indicated 
that increased dietary protein consumption triggers an unfavourable increase in the 
urinary excretion of calcium, oxalate and uric acid and lowers citrate excretion (Coe 
et al 1976, Robertson et al. 1979, Urivetzky 1987, Trinchieri et al. 1991, Holmes et al. 
1993, Giannini et al. 1999, Nguyen et al. 2001).  Hypercalciuria has been ascribed to 
an increase in the production of endogenous acids during metabolism.  
Consequently, bone resorption increases followed by the increase in the filtered load 
of calcium, hyperoxaluria (due to the high oxalate synthesis), hyperuricosuria (due to 
purine overconsumption) and hypocitraturia (due to high tubular resorption of citrate) 















Kok and co-workers (1990b), in a quest to examine the chemical composition of urine 
of healthy subjects after consumption of four different diets, with a high protein diet 
being one of the diets, found a significant increase in calcium and uric acid excretions 
and a decrease in the excretion of citrate.  These results are in agreement with the 
findings of the aforementioned studies.  In addition, COM crystallization kinetics, 
which these authors also measured, showed that the high protein diet resulted in the 
decreased inhibition of COM crystal aggregation.  They attributed this effect to the 
reduced levels of urinary citrate, a well known inhibitor of CaOx stone formation.  In 
light of these and other findings, the efficacy of a diet containing normal calcium, low 
animal protein and low sodium in the prevention and treatment of kidney stones has 
therefore been established and thus such a diet is highly recommended by Borghi et 
al. (2002). 
   
Sodium 
 
Many investigators have emphasized the importance of limiting the intake of sodium 
chloride (NaCl) as high amounts overtly elevate excretion of calcium (Muldowney et 
al. 1982, Kok et al. 1990b, Massey and Whitting 1996, Blackwood et al. 1999). This 
effect has been ascribed to the inhibition of sodium and calcium resorption.  
 
Lemann et al. (1979) showed that every increase of 100mmol of sodium in the diet 
significantly increases urinary calcium by 25 mg.  Yamakawa et  al. (1996) 
investigated the effect of a simultaneous intake of NaCl and sodium oxalate (Na2Ox) 
and of NaCl alone. Their results showed a significant decrease in the oxalate-to-
creatinine ratio after a simultaneous intake of NaCl and Na2Ox compared to the 
intake of Na2Ox alone.  On the other hand, both the simultaneous intake of NaCl and 
Na2Ox and Na2Ox alone induced no increase in the urinary calcium-to-creatinine 
ratio.  However, intake of NaCl alone induced a remarkable increase in the calcium-
to-creatinine ratio and a decrease in the oxalate-to-creatinine ratio.  They deduced 
from their results that sodium chloride detemines oxalate absorption and increases 
the risk of stone formation. 
 
A positive correlation between a high NaCl intake and bone loss has also been 
established.  In fact, a previous study revealed that an intake of ≥16 g per day in 
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Refined Carbohydrate 
 
It is conceded that an excessive consumption of high carbohydrate diets, especially 
those containing refined carbohydrates, induces unfavourable changes in urine 
composition which may increase the risk of stone development (Hodgkinson and 
Heaton 1965, Lemann et  al. 1969, Thom et  al. 1978, Rao et  al. 1982).   Evidence 
suggests that consumption of refined carbohydrates brings about more pronounced 
and rapid changes in the urinary excretion of calcium and its absorption (MacLeod 
and Blacklock 1979).  Sucrose, for instance, when consumed in large quantities is 
considerably lithogenic as it induces an elevation of the urinary calcium excretion 
which may increase the risk of renal stone formation (Lemann et  al. 1969).  The 
magnitude of this effect is more prominent in stone formers than in controls.  Rao and 
co-workers (1982) postulated that insulin and glucagon, the hormones involved in 
carbohydrate metabolism, may be responsible for the differences in the response to 
a carbohydrate load in the two groups.  The effect of plasma insulin has been 
elucidated by its role in the renal tubular electrolyte transport.  It brings about 
changes in the urinary electrolyte composition as calcium reabsorption is reduced 
predominantly in the proximal tubules (DeFronzo et al. 1976).   
 
Nguyen et  al. (1986) administered a 75 g glucose load to healthy subjects, which 
provoked an increase not only in urinary calcium but also in oxalate excretion.  
Similarly, in a different study where stone formers and healthy controls ingested a 
100 g glucose load, an increase in the excretion of the aforementioned urinary 
parameters was observed in both groups and the rise in the relative supersaturation 
with respect to calcium oxalate and uric acid was noted in the patient group (Gluszek 
1988). In addition, a comparative study to investigate the effect of a glucose or 
fructose challenge in normal subjects was undertaken.  On one hand, a concomitant 
augmentation of calcium and oxalate excretion in the urine was observed after the 
glucose challenge.  On the other hand, fructose caused an increase in the urinary 
excretion of calcium and in contrast, a decrease in the urinary excretion of oxalate 
(Nguyen et  al. 1989).  However, a recent study examined the association between 
fructose intake and stone risk in three distinct cohorts comprising 93 730 older 
women, 101 824 younger women and 45 984 men and revealed a positive 
correlation (Taylor and Curhan 2008).   Moreover, compelling evidence suggests that 
fructose augments the production of uric acid and thus leads to uric acid stone 














Of interest in the context of the present thesis is that consumption of carbohydrates 
has been shown to be higher in the South African black population than in the white 
population (Vorster and Nell 2001).  This aspect will be fully explored in Chapter Two. 
 




The protective effect of potassium citrate (Pak and Fuller 1986, Abdulhadi et al. 1993, 
Barcelo et  al. 1993) and sodium potassium citrate (Schwille et  al. 1985, Berg et  al. 
1990, Hofbauer et  al. 1994) supplementation in the management and treatment of 
urolithiasis has been of wide interest.  The two citrate-containing products are 
associated with the formation of complexes with calcium thereby reducing the 
concentration of free Ca2+ and hence decreasing supersaturation of CaOx and CaP 
(Pak et al. 1982). They also increase the urinary pH, which concomitantly induces an 
increase in the dissociation of uric acid and reduces undissociated uric acid levels 
(Heilberg and Schor 2006).   Calcium citrate (Sakhaee et al. 1994), calcium sodium 
citrate (Schwille et al. 1997) and potassium-magnesium citrate (Ettinger et al. 1997) 




The efficacy of dietary magnesium in the inhibition of crystallization with respect to 
CaOx and CaP has been reported.  It does so by complexing oxalate to form 
magnesium oxalate, thereby reducing urinary oxalate excretion (Barilla et  al. 1978, 
Berg et al. 1986).  A study conducted in healthy men whose diet was assessed every 
four years using a food frequency questionnaire over 14 years showed a reduced risk 
of stone formation after a dietary intake of magnesium (Taylor et al. 2004). 
 
Controversy over the effect of magnesium supplementation on the treatment of 
kidney stones has been of interest.  The administration of magnesium hydroxide in a 
randomized trial did not have a beneficial effect in preventing the recurrence of 
calcium oxalate urolithiasis (Ettinger et al. 1988).  This is likely due to the fact that the 
magnesium supplement was not taken with meals and participants were on a low 
oxalate diet which may have resulted in reduced intestinal binding of oxalate by 
magnesium.  Similarly, magnesium oxide has been proven ineffective in the 
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supplements have been endorsed in recent years as they have shown their 
effectiveness in increasing urinary magnesium excretion thus inhibiting oxalate 
absorption and excretion (Zimmerman et  al. 2005).  General therapeutic measures 
which have proved effective for a low urinary excretion of magnesium include 
magnesium citrate (Lindberg et al. 1990, Pak 1990) and intake of magnesium- and 
bicarbonate-rich mineral water (Karagülle et al. 2007). 
 
1.5.3   Beverages  
 
A question that is frequently asked is which fluids are recommended and which ones 
are prohibited.  Water seems to the best beverage as it contains insignificant 
amounts of solutes and no caffeine.  A previous study undertaken by Curhan and 
associates (1998b) in non-stone forming women demonstrated that of the 17 
beverages that were studied, women who drank one daily 8 ounce glass of grapefruit 
had a 44% increased risk of forming stones.  In contrast, women who consumed a 
similar amount of wine, coffee or tea had an 8% to 10% decreased stone risk.  
 
The protective effect of coffee against stone formation has been supported by 
Goldfarb et  al. (2005).  However, notwithstanding this observation, a positive 
relationship between caffeine intake and urinary calcium excretion has been 
observed (Massey and Sutton 2004).  Therefore moderate consumption of 
caffeinated beverages is highly recommended.  In addition, apple juice has been 
found to have an adverse effect in stone formation (Curhan et  al. 1996) and it is 
advised that excess consumption must be avoided.  Consumption of lemonade, 
however, has a beneficial effect as it contains citrate, a well-known inhibitor of stone 
formation (Seltzer et al. 1996, Kang et al. 2007, Penniston et al. 2007).  Studies have 
shown that taurine, which is one of the major ingredients in the well-known Red Bull 
energy drink, reduces the urinary excretion of both glycolate and oxalate in rats 
(Talwar et al. 1985).  A study investigating the efficacy of taurine in lowering glycolate 
urinary excretion is described in Chapter Five of this thesis. 
 
1. 6   Urolithiasis in South Africa  
 
In South Africa, 12-15% of the white population is susceptible to CaOx stone 
formation but this disorder is virtually non-existent in the black population, affecting 














al. 1998).  Studies have shown that South African blacks have lower urinary calcium 
(Muskat et al. 1951, Modlin 1967, Whalley et  al. 1998) and relatively higher urinary 
oxalate levels than whites (in women only) (Whalley et al. 1998).  In addition, studies 
on urine composition of these two ethnic groups have also shown that blacks have a 
lower urinary citrate compared to whites (Modlin 1967, Whalley et al. 1998).  Some of 
these results are surprising and counterintuitive; none of them provides a compelling 
explanation for the rarity of urolithiasis in this population group.   
 
In an attempt to elucidate the differences in stone frequency in the two race groups, 
several studies have been undertaken by the kidney stone research group at the 
University of Cape Town.  These have identified different inhibitory roles for different 
urinary proteins (Craig et  al. 1999, Webber et  al. 2002, Rodgers et  al. 2006).  
However, more importantly in the context of the present thesis, intriguing results have 
emerged from dietary studies.  Among these, it has been demonstrated that South 
African black and white male subjects display different renal responses to various 
lithogenic and anti-lithogenic dietary challenges (Lewandowski et al. 2001, Rodgers 
and Lewandowski 2002, Lewandowski and Rodgers 2004).  In addition, 
Lewandowski and co-workers (2005) found that despite a higher consumption of 
dietary oxalate in blacks compared to their white compatriots, urinary oxalate levels 
were equal to or lower in the former group.  These findings prompted the authors to 
suggest that blacks have a superior renal handling mechanism for oxalate.  As 
mentioned previously in this Chapter, dietary oxalate may lead to cellular injury.  This 
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1.7  Objectives  
 
Based on the aforementioned studies and the ongoing interest of the Kidney Stone 
Research Laboratory at the University of Cape Town in the different renal handling 
mechanisms of black and white South Africans in response to different dietary and 
supplementary challenges, the following general objectives were defined for the 
present thesis: 
 
 to investigate in healthy South African black and white subjects their response 
to the ingestion of refined carbohydrates 
 
 to investigate the effect of the ingestion of dietary oxalate challenges on renal 
cell injury in the two race groups 
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2.1   Introduction 
 
As discussed in the previous Chapter, numerous studies over the years have 
commonly identified a high-carbohydrate diet as one of the causes of increased 
excretion of urinary risk factors which result in CaOx kidney stone formation 
(Hodgkinson and Heaton 1965, Lemann et  al. 1969, Thom et  al. 1978, Rao et  al. 
1982).  Evaluation of the effect of intake of sugars such as glucose (Glu) or sucrose 
(Suc) in CaOx stone formers and normal subjects, indicated a marked increase in 
urinary calcium excretion in the former (Lemann 1969).  Nguyen and coworkers 
(1994) observed an increase in urinary calcium and oxalate excretion in healthy 
subjects after ingestion of dark chocolate containing Suc.  Whilst a rise in plasma 
insulin with hypercalciuria following a carbohydrate load has been reported in 
idiopathic calcium stone formers (Rao et al. 1982), a comparative study showed no 
hypercalciuretic effect in spite of the high plasma insulin levels in                
noninsulin-dependent diabetics and controls (Garg et al. 1990).  The latter study was 
contrary to the suggestions by DeFronzo et al. (1975) that high plasma insulin levels 
are a prelude to higher urinary calcium excretion.   
 
The association of carbohydrate ingestion and kidney stone formation prompted 
investigators to study another class of carbohydrates known as polyols such as 
lactitol (Lac), mannitol (Man), sorbitol (Sor), xylitol (Xyl) and maltitol (Mal).  Also 
known as sugar alcohols, polyols are low digestible carbohydrates which are 
commonly used in the food industry as sweeteners. Chemically, the aldehyde or 
ketone group found in other common sugars like Glu is replaced by a hydroxyl group 
in polyols which would account, partly, to their metabolic differences. Structural 
differences in the polyols themselves are worthy of note, for example, Xyl has a 
shorter chain than Sor and even though they are both monosaccharides their 
metabolism could be different.  With the exception of erythrol (Ery), polyols are 
produced by hydrogenation of glucose, lactose, maltose, palatinose, xylose and 
partially hydrolysed starch derivatives (Oku and Nakamura 2002).  What sparked 
interest in studying these is that, unlike other carbohydrates, they are slowly and 
partially absorbed (ranging from 0% for Lac to about 80% for Sor) (Patil et al. 1987, 
Langkilde et  al. 1994) from the small intestine and are metabolized in an insulin-
independent manner and thus have little or no effect on plasma glucose, which 
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A number of clinical and experimental studies on polyols conducted in humans and 
animals have been well documented.  Hypercalciuria has been observed in rats after 
administration of high dietary concentration of certain polyols and this has been 
attributed to the likelihood of increased calcium absorption (Hämäläinen et al. 1985, 
Amman et  al. 1988, Brommage et  al. 1993).  Several human studies have 
demonstrated that polyols have little or no adverse effects on the urinary risk 
parameters for CaOx kidney stone formation even at elevated rates of consumption 
(Förster et al. 1981, Francis et al. 1986, Egger et al. 1989).   For example, in contrast 
to the observation of hypercalciuria in rats, when healthy male and female subjects 
were given a 40-100 g oral dose of Xyl per day over a period of 18 days, no increase 
in plasma or urinary calcium was observed (Förster et al. 1981).  Results of a study 
conducted by Mäkinen and colleagues (1981) showed that intake of 50 g per day of 
Xyl for 2 years by a group of 41 male and female subjects produced no differences in 
urinary calcium in comparison to the control groups which were administered 
fructose or sucrose.  Similarly, no changes in the urinary excretion of calcium were 
observed after ingestion of 20-40 g of Lac per day for one month by 12 subjects 
(Egger et al. 1989).  On the other hand, 10 g of Sor resulted in the reduction of the 
fractional absorption of radiolabeled calcium in 10 women (Francis et al. 1986).  
 
Furthermore, in a study undertaken by Nguyen et al. (1993) to compare the effects of 
a 20 g oral load of four polyols-Sor, Xyl, Lyc and Mal- with that of Glu in 10 healthy 
subjects over a 5-day period, Xyl was the only polyol that overtly increased the 
urinary excretion of calcium as well as that of oxalate and phosphate.   
 
In view of the reported differences between black and white subjects in terms of their 
renal handling of different lithogenic agents, the present study was undertaken to 
measure the response to the two polyols sorbitol (Sor) and xylitol (Xyl), as well as 
glucose (Glu) in subjects of South Africa’s two population groups and to examine 
whether different handling mechanisms of the three sugars exist in the two groups. 
 
 
The main objectives of this study are: 
 
 to examine the effect of oral administration of Glu, Sor and Xyl on the 
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 to assess the physico-chemical properties of the urines from the two groups 
before and after ingestion of the three sugars. 
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Ten black and ten white healthy male subjects (age range 18-30 years) from the 
student cohort of the University of Cape Town volunteered for the study.  The 
protocol was submitted to the Ethics Committee of the University and approval was 
granted.  Clinical examinations revealed normal renal function, no history of renal 
stone disease or diabetes mellitus.  Subjects were not allowed to ingest any drugs or 




 Glu (Tongaat Hulett Starch, Germiston, South Africa, 99% purity with composition 
[mol/l x 10-3] Cit: 3.34, Ox: 0.01, Ca: 0.42, Mg: 0.06, Na: 7.41, K: 0.12, P: <0.2), Sor 
(Sigma Aldrich, Steinheim, Germany, 97% purity with composition [mol/l x 10-3] Cit: 
3.35, Ox: 0.01, Ca: 0.32, Mg: 0.16, Na: 5.23, K: 0.56, P: <0.2) and Xyl (Sigma 
Aldrich, Steinheim, Germany, 99% purity with composition [mol/l x 10-3] Cit: 1.11, Ox: 
0.01, Ca: 0.25, Mg: 0.04, Na: 7.41, K: 0.02, P: <0.2) were administered randomly to 




A double-blind design was adopted for the study and a 1 week washout period was 
observed between the protocols.  Subjects were on a self-selected diet which 
controlled for calcium (1 g/day) and carbohydrate (300 g/day) intake for 7 days.  
Table 2.1 shows a diet sheet comprising foods and portions that subjects were 
instructed to choose from and consume daily during the 7-day period.  On day 8, 
subjects consumed a strict standardized diet (Table 2.2) with the nutrient content as 
shown in Table 2.3 and collected urine for 24 h.  During this period, subjects fasted 
overnight for 12 h and on day 9 they drank 250 ml of water (Caledon Natural Spring 
Water with composition (mg/l) of Ca: 6.1, Mg: 1.0, Na: 17.0, K: 5.0, Fe: 0.01, Cl: 
23.0, SO4: 1.7, bicarbonate: 32.0, pH: 6.4) in the morning (corresponding to time 0h),  
collected a baseline urine sample 1 h later and then ingested immediately a solution 
of Glu, Sor or Xyl (20 g in 250 ml water).  Blood samples were drawn at the end of 
the baseline period and 30 min after ingestion of the sugar solutions by a 
professional nurse.  Urine was collected hourly for the next 3 hours.  The 
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of the 24 h test period.  Sera and urine samples were stored at 4°C until analysis.  
After each test, the full 24 h urine collection was reconstituted by volumetric addition 
of the various fractions. 
 
Table 2.1: Self-selected standardized sheet depicting the variety of foods and 




PORTION SIZE (1 PORTION EXAMPLES) 
3 milk portions 
 
1 cup milk 
1 cup yoghurt 
Choose any 7 fat portions 1 tsp butter 
1 tsp margarine 
1 tsp sunflower, canola or olive oil 
1 tsp mayonnaise 
¼ of a avocado pear 
2 tsp peanut butter 
Choose any 3 vegetable portions ½ cup cooked vegetables 
1 cup green fresh salad 
* see critical food list  
Choose any 3 fruit portions any medium-sized fruit 
½ cup fruit juice 
* see critical food list 
Choose any 14 starch portions 1 slice of bread 
½ cup cooked porridge 
½ cup cereal 
1 weetbix 
3 provitas 
1 medium / 2 small potatoes 
½ cup cooked rice, samp, pasta 
½ cup legumes (eg lentils, beans, chickpeas, soya) 
Choose any 7 protein portions 30g meat/chicken/fish = 1matchbox 
45g cottage cheese = 1 heaped Tbsp 
30g hard cheese = 1 matchbox 
2 cheese wedges/4tsp cheese spread 
1 egg 
Choose any  3 sugar portions 1 tsp sugar 
200ml pudding 
50ml cool drink 
2 blocks chocolate (not to be exceeded) 
2 Jelly Beans 
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Table 2.2: Constituents of the strict standardized diet ingested at day 8 and 9 and the 
time of consumption of each meal 
 




50 g bread roll  
8 g butter 
25 g strawberry jam 
60 g cornflakes 
250 ml 2% low fat milk 
250 ml coffee 
50 g bread roll  
8 g butter 
25 g strawberry jam 
60 g cornflakes 




27 g muesli bar  
½ cup fruit salad 
27 g muesli bar  
½ cup fruit salad 
Lunch: 
13h00  
140 g soya mince* 
120 g mixed vegetables  
200 g pasta 
140 g soya mince 
120 g mixed vegetables  
200 g pasta 
Snack: 
16h00  
150 g apple  
175 g low fat fruit yoghurt 
150 g apple  
175 g low fat fruit yoghurt 
Supper: 




4 slices of whole wheat bread 
16 g butter 
56 g cheddar cheese 
50 g tomato 
4 slices of whole wheat bread 
16 g butter 
56 g cheddar cheese 
50 g tomato 
Snack: 
20h00  
1 slice of whole wheat bread 
20 g peanut butter 
1 slice of whole wheat bread 
20 g peanut butter 
 
* soya mince for 7 portions: 1 onion, 1 heaped tsp garlic, 125 g button mushrooms, 1 tin 
peeled tomatoes, 1 cup soya mince (3 cups water), salt, pepper, paprika, cayenne pepper 
 
Beverages (2.25 l/day): 
 
250 ml coffee (4 g coffee powder, 4 g creamer, 10 g sugar in 250 ml water (Day 8 only)) 
700 ml Caledon water until 13h00 
600 ml Caledon water until 19h00 
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Table 2.3:  Nutrient content of the standardized diet 
 
VARIABLE AMOUNT 
Energy (kJ) 1434 
Total protein (g) 109.5 
Total fat (g) 112 
Carbohydrate (g) 302 
Calcium (mg) 1001 
Magnesium (mg) 415 
Phosphorus (mg) 1781 
Citric acid (mg) 1509 





The hourly urine fractions (0-3 h) as well as the reconstituted 24 h urines were tested 
in order to detect any unfavourable presence of blood and/or infection (Combur 10 
test strip, Boehringer Mannheim, Germany).  Samples which tested positive were 
discarded.  The pH and volume of each urine sample were measured routinely.  
Urinary calcium, potassium, magnesium and sodium (Fernandez and Kahn  1971, 
Trudeau and Freier 1967 and Willis 1961) were determined using a Varian 1275 
flame atomic absorption spectrometer, whereas uric acid was measured using 
uricase (Fossati et al. 1980) and chloride using an ion selective electrode.  Oxalate 
was determined using oxalate by an enzymatic method involving oxalate 
decarboxylase (Chiriboga 1963), citrate using citrate lyase (Gruber and Mollering 
1966), inorganic phosphorus using ammonium molybdate (Dryer and Routh 1963) 
and creatinine using picric acid (Rock et al. 1986).     
 
Serum glucose was measured using an oxygen rate method employing a Beckman 
Oxygen electrode in which 10 μl of a blood sample was injected in a reaction cup 
containing a glucose oxidase solution.  The concentration of glucose which is directly 
proportional to the peak rate at which oxygen is consumed when reacting with 
glucose to form gluconic acid, was then determined (Kadish et al.  1968). 
 
The relative supersaturations (RS) of calcium oxalate (CaOx), brushite and uric acid 
were computed using the EQUIL 2 programme (Werness et al. 1985), whereas the 
Bonn Risk Index (BRI) was measured using a calcium electrode (Laube et al. 2004).  
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Crystallization Experiments 
 
CaOx crystallization kinetics experiments were performed on 24 h urines filtered 
consecutively through a 0.75 m pre-filter (Macherey-Nagel; GmBH and Co., 
Germany) and 0.45 m nitrocellulose filter (Sartorius AG, Germany).  These 
experiments were done in order to measure CaOx Metastable Limit, 14C-oxalate 
deposition and crystal aggregation.  In addition, the particle volume-size distribution 
was also measured to assess the particle formation kinetics.  The description of 
these experiments follows  
 
CaOx Metastable Limit 
 
Filtered 10 ml aliquots of urine were spiked with increasing 100 μl concentrations of 
Na2Ox every 2 min to induce CaOx crystallization and were incubated for 30 minutes 
at 37°C in a shaking water bath (Labcon Marketing Services, J hannesburg).  The 
number of particles in the aliquots of urine was measured using a Coulter Counter 
Multisizer (Multisizer II, Coulter Electronic Ltd, England) (140 μm orifice, 2.8-90.0 μm 
particle size range).  The minimum Na2Ox concentration which was able to induce 
crystallization was used to determine the metastable limit (MSL) from a plot of 
particle number versus concentration of Na2Ox (Ryall et al. 1985).  An example of a 
graph for the determination of MSL is shown in Figure 2.1 in which the green dot 







































_______________________________________________________________________________________   53 
Crystal Deposition 
 
30 ml aliquots of the urine samples were incubated at 30°C in a shaking water bath 
for approximately 10 min after being filtered.  To each aliquot, 3.125 (Ci/100ml of 
radiolabeled oxalate (14C-oxalate) (NEN, Boston, USA) was added, followed by 
spiking with 300 μl of the similar concentration of Na2Ox used for the particle volume-
size distribution experiment described shortly (page 55).  Over 120 min, at 30 min 
intervals, the reaction was quenched by passing 2.5 ml of the aliquots into 250 μl of 
concentrated hydrochloric acid through a 0.22 μm Millipore filter. To each 10 ml of 
scintillation fluid (Zinsser Analytic, Frankfurt), 1000 μl of the acidified aliquots were 
then added and this step was performed in duplicate.  The number of precipitated 
14C-oxalate crystals was then counted using a scintillation counter (1900CA Tri-Carb 
Liquid Scintillation Analyser, Packard Instruments Co, Inc., Meriden CT, USA).  The 
percentage of precipitated 14C-oxalate was determined from the following equation 
(Doyle et al. 1995):  
 
% 14C-oxalate precipitated = 100 - 100x (cpm x min / cpm 0 min) 
[cpm x min = counts per minute at x min, cpm 0 min = counts per minute at 0 min] 
 
CaOx Crystal Aggregation  
I. Preparation of COM crystals 
 
COM crystals were prepared prior to the aggregation experiment using a method by 
Pak et al. (1975).  Calcium chloride (100 mM) and Na2Ox (100 mM) were mixed by 
introducing equal volumes at a constant speed of 1.0 ml/min using a peristaltic pump 
(Gilson, France), with stirring, at room temperature. The mixture was stirred at 4°C 
for 1 week and then filtered using a 0.22 μm filter paper.  Methanol was used to wash 
the crystals followed by drying at 37 °C for 1 h.  The composition of the crystals was 
characterized by x-ray powder diffraction (XRD).  X-ray diffraction patterns, as shown 
in Figure 2.2, were recorded using a Philips PW 1050/80 vertical goniometer in the 
12-40 o 2θ range with CuKα radiation wavelength of 1.5418 Å produced at 40 kV and 
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Figure 2.2:  XRD pattern of COM crystals 
 
II. Determination of inhibition of COM crystal aggregation 
 
COM crystal slurry was prepared by mixing 0.8 mg of COM crystals with 1 ml of a 
buffer containing Tris-aminomethane (Tris).HCL (10 mM) and NaCl (90 mM) and the 
pH was adjusted to 7.2. The slurry was equilibrated while stirring at 1100 rpm 
overnight at 37°C.  Filtered urine aliquots (400 μl) were then combined with the COM 
slurry (1600 μl) and the mixture was equilibrated at 37°C for 2 h with stirring.  The 
control was 2000 μl of the slurry alone.  The absorbance of was monitored at 620 nm 
using a spectrophotometer (Specord 40, United Scientific, South Africa) coupled with 
a stirrer for 15 min.  Initially, slow stirring at 1100 rpm to induce crystal aggregation 
was applied until equilibrium was reached. Thereafter, the stirrer was stopped and 
the decreasing absorbance which indicated the aggregation rate of the COM crystals 
was then monitored.  The rate of crystal aggregation was determined from the slope 
of the linear decrease in absorbance in the graph of absorbance vs time. The 
following equation was then used to determine percentage inhibition of aggregation 
(Hess et al. 1989):  
 
% Inhibition of aggregation = 100-100(Sc/St) 
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Particle Volume-Size Distribution 
 
The urine was spiked with 0.5 ml Na2Ox/50 ml urine using a 15 mmol/dm3 
concentration above the previously determined MSL and was then incubated at 37°C 
in a shaking water bath for 120 min. The particle volume-size distribution was 
measured over 120 min using a Coulter Multisizer followed by the determination of 





Data were analysed by one-way analysis of variance (ANOVA) at statistical 
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The mean 24 h urinary excretions of various parameters before the ingestion of Glu, 
Sor or Xyl are presented in Table 2.4.  Blacks had significantly lower urinary calcium, 
magnesium, sodium, urate and phosphate.  In addition, the RS of brushite was lower 
in blacks while the RS of uric acid was lower in whites.  Moreover, the BRI was 
higher in the latter group.  No further statistically significant differences were 






Subsequent to the ingestion of Glu, no statistically significant changes were 
observed in the 24 h urine parameters in either race group, except for a significant 
increase in urine volume in blacks as shown in Table 2.5.   
 
Fractional Collections (Non-Normalized Excretion) 
 
At 0 h (Table 2.6) prior to the ingestion of Glu, the urinary citrate and potassium 
excretion were higher in blacks, with chloride approaching significance.  Following 
the intake of Glu, at 1 h, the only significant difference was the decrease in urinary 
sulphate in whites, while the urine volume was approaching a significant increase in 
this group, as indicated in Table 2.7.   
 
However, at 2 h a number of significant differences were observed (Table 2.8).  Glu 
caused an increase in urine volume and a decrease in urinary potassium, creatinine 
and phosphate in blacks.  On the other hand, it decreased the urinary excretion of 
sulphate in whites.  Elevated urine volume levels were also observed in this group. 
 
Glu provoked a significant increase in the urinary pH and a decrease in urinary 
potassium and phosphate, with creatinine approaching a significant decrease in 
blacks at 3 h (Table 2.9).  The urine volume also increased significantly in this group.  
Similarly, in the white group the urinary pH increased as well as the urine volume.  A 
rise in urinary citrate excretion was also noted and a fall in urinary sulphate levels.  In 
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Blacks Whites p 
 
pH 6.07 ± 0.08 6.22 ± 0.06 0.0865 
Volume (ml/24h) 1924 ± 110 2060 ± 87.6 0.2698 
Citrate (mmol/24h) 2.99 ± 0.23 3.04 ± 0.23 0.7885 
Oxalate (mmol/24h) 0.27 ± 0.01 0.29 ± 0.01 0.1881 
Calcium (mmol/24h) 2.60 ± 0.27 4.19 ± 0.24 *0.0001 
Magnesium (mmol/24h) 1.79 ± 0.22 3.45 ± 0.18 *0.0001 
Sodium (mmol/24h) 93.1 ± 12.0 148 ± 20.5 *0.0328 
Potassium (mmol/24h) 46.0 ± 4.98 54.4 ± 4.82 0.1560 
Urate (mmol/24h) 2.94 ± 0.15 3.51 ± 0.14 *0.0061 
Creatinine (mmol/24h) 17.8 ± 3.84 15.5 ± 0.68 0.5237 
Phosphate (mmol/24h) 18.6 ± 1.16 27.3 ± 1.68 *0.0001 
Chloride (mmol/24h) 160 ± 8.25 164 ± 7.71 0.9577 
Sulphate (mmol/24h) 17.4 ± 0.86 20.3 ± 1.28 0.0815 
Tiselius risk index 198 ± 24.2 284 ± 19.8 0.6843 
RS Brushite 0.32 ± 0.24 4.39 ± 1.67 *0.0002 
RS CaOx 3.29 ± 1.25 4.39 ± 1.67 0.2119 
RS Uric Acid 1.54 ± 1.24 0.83 ± 0.77 *0.0231 
MSL (mol/dm3) 0.15 ± 0.01 0.13 ± 0.01  0.1313 
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Table 2.5:  Mean 24 h urinary variables ± SE in black and white subjects after 
























pH 6.07±0.08 6.37±0.16 0.0628 6.22±0.06 6.41±0.07 0.0931 0.8093 
Volume (ml/24h) 1924±110 2452±126  *0.0201 2060±87.6 2453±147 0.2850 0.9986 
Citrate (mmol/24h) 2.99±0.23 2.92±0.51 0.9858 3.04±0.23 3.17±0.35 0.7675 0.6822 
Oxalate (mmol/24h) 0.27±0.01 0.31±0.02 0.0907 0.29±0.01 0.32±0.03 0.9771 0.8157 
Calcium (mmol/24h) 2.60±0.27 2.22±0.20 0.5020 4.19±0.24 3.57±0.46 0.1873 *0.0245 
Magnesium (mmol/24h) 1.79±0.22 1.77±0.28 0.9292 3.45±0.18 2.45±1.20 0.0647 0.2813 
Sodium (mmol/24h) 93.1±12.0 112±18.2 0.4815 148±20.5 155±41.9 0.3478 0.2551 
Potassium (mmol/24h) 46.0±4.98 36.1±10.2 0.4462 54.4±4.82 36.6±8.77 0.2074 0.9624 
Urate (mmol/24h) 2.94±0.15 2.59±0.25 0.2851 3.51±0.14 3.35±0.28 0.5881 0.0705 
Creatinine (mmol/24h) 17.8±3.84 13.1±1.68 0.5287 15.5±0.68 15.5±1.40 0.9606 0.2991 
Phosphate (mmol/24h) 18.6±1.16 18.5±3.83 0.9748 27.3±1.68 25.5±3.73 0.6274 0.2237 
Chloride (mmol/24h) 160±8.25 153±11.8 0.5612 164±7.71 180±17.3 0.3397 0.2663 
Sulphate (mmol/24h) 17.4±0.86 18.9±1.08 0.4202 20.3±1.28 17.1±2.24 0.2266 0.5450 
Tiselius Risk Index 198±24.2 299±48.1 0.6368 284±19.8 254±27.4 0.7381 0.3697 
RS Brushite 0.32±0.24 0.28±0.02 0.7374 4.39±1.67 0.65±0.04 0.0859 *0.0315 
RS CaOx 3.29±1.25 2.65±0.38 0.3782 4.39±1.67 2.79±0.99 0.1084 0.8681 
RS Uric Acid 1.54±1.24 0.52±0.03 0.1014 0.83±0.77 0.49±0.03 0.0843 0.8602 
MSL (mol/dm3) 0.15±0.01 0.17±0.02 0.3650 0.13±0.01 0.13±0.02 0.9140 0.1198 
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Blacks Whites p 
 
pH 6.10 ± 0.25 6.13 ± 0.22 0.9316 
Volume (ml/h) 198 ± 49.8 101 ± 21.5 0.0641 
Citrate (mmol/h) 0.34 ± 0.10 0.11 ± 0.02 *0.0133 
Oxalate (mmol/h) 0.05 ± 0.01 0.04 ± 0.01 0.8771 
Calcium (mmol/h) 0.16 ± 0.06 0.14 ± 0.03 0.6595 
Magnesium (mmol/h) 0.15 ± 0.06 0.13 ± 0.02 0.6636 
Sodium (mmol/h) 8.30 ± 2.93 5.50 ± 1.56 0.3756 
Potassium (mmol/h) 6.31 ± 1.85 1.95 ± 0.58 *0.0202 
Urate (mmol/h) 0.23 ± 0.08 0.09 ± 0.02 0.0667 
Creatinine (mmol/h) 1.79 ± 0.58 0.85 ± 0.10 0.0778 
Phosphate (mmol/h) 3.76 ± 1.63 1.07 ± 0.25 0.0704 
Chloride (mmol/h) 18.3 ± 6.34 6.70 ± 1.62 †0.0555 
Sulphate (mmol/h) 1.36 ± 0.55 0.71 ± 0.10 0.1631 
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Table 2.7:  Mean 1 h urinary variables ± SE in black and white subjects after 
ingestion of Glu  




























pH 6.10±0.25 6.05±0.19 0.8605 6.13±0.22 6.08±0.31 0.7011 0.9258 
Volume (ml/h) 198±49.8 449±276 0.4663 101±21.5 164±37.8 †0.0546 0.3204 
Citrate (mmol/h) 0.34±0.10 0.31±0.12 0.8375 0.11±0.02 0.12±0.02 0.9028 0.1630 
Oxalate (mmol/h) 0.05±0.01 0.07±0.04 0.6367 0.04±0.01 0.03±0.01 0.2543 0.3114 
Calcium (mmol/h) 0.16±0.06 0.28±0.19 0.6467 0.14±0.03 0.14±0.03 0.4661 0.4878 
Magnesium (mmol/h) 0.15±0.06 0.24±0.17 0.7027 0.13±0.02 0.13±0.03 0.7651 0.5304 
Sodium (mmol/h) 8.30±2.93 9.84±6.59 0.8551 5.50±1.56 4.46±1.31 0.3976 0.4334 
Potassium (mmol/h) 6.31±1.85 8.26±6.06 0.6467 1.95±0.58 1.91±0.55 0.3424 0.3109 
Urate (mmol/h) 0.23±0.08 0.47±0.34 0.5679 0.09±0.02 0.10±0.02 0.6275 0.2890 
Creatinine (mmol/h) 1.79±0.58 2.66±1.68 0.6821 0.85±0.10 0.83±0.07 0.3381 0.2930 
Phosphate (mmol/h) 3.76±1.63 4.41±3.47 0.8840 1.07±0.25 0.84±0.23 0.2284 0.3183 
Chloride (mmol/h) 18.3±6.34 26.6±17.1 0.7024 6.70±1.62 7.00±1.28 0.9163 0.2692 
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Table 2.8:  Mean 2 h urinary variables ± SE in black and white subjects after 






























pH 6.10±0.25 6.70±0.18 0.1091 6.13±0.22 6.42±0.25 0.3992 0.3919 
Volume (ml/h) 198±49.8 328±26.6 *0.0286 101±21.5 291±38.4 *0.0004 0.4447 
Citrate (mmol/h) 0.34±0.10 0.39±0.11 0.7307 0.11±0.02 0.19±0.04 0.0739 0.1099 
Oxalate (mmol/h) 0.05±0.01 0.02±0.00 0.0988 0.04±0.01 0.03±0.01 0.2193 0.6189 
Calcium (mmol/h) 0.16±0.06 0.07±0.02 0.1283 0.14±0.03 0.11±0.02 0.4506 0.1324 
Magnesium (mmol/h) 0.15±0.06 0.06±0.01 0.1152 0.13±0.02 0.54±0.42 0.3438 0.2739 
Sodium (mmol/h) 8.30±2.93 2.68±1.47 0.1007 5.50±1.56 4.14±1.19 0.4970 0.4510 
Potassium (mmol/h) 6.31±1.85 1.48±0.45 *0.0112 1.95±0.58 2.05±0.54 0.8996 0.4250 
Urate (mmol/h) 0.23±0.08 0.13±0.02 0.2134 0.09±0.02 0.13±0.02 0.1686 1.0000 
Creatinine (mmol/h) 1.79±0.58 0.64±0.05 *0.0450 0.85±0.10 0.67±0.07 0.1670 0.7272 
Phosphate (mmol/h) 3.76±1.63 0.35±0.07 *0.0314 1.07±0.25 0.55±0.14 0.0885 0.2161 
Chloride (mmol/h) 18.3±6.34 6.60±0.93 0.0632 6.70±1.62 7.90±1.23 0.5629 0.4117 
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Table 2.9:  Mean 3 h urinary variables ± SE in black and white subjects after 
ingestion of Glu 
*statistically significant; †approaching statistical significance 
 
Fractional Collections (Excretion Normalized to Creatinine) 
 
The concentrations of calcium, oxalate and phosphate were normalized by using 
creatinine as a reference standard, due to its constant excretion throughout the urine 
collection.  The ratio of the urine parameters to creatinine provides a more accurate 
index which serves as a measure of the excretion of each parameter in urine 
samples collected randomly (Nordin 1959).  Nguyen and coworkers (1993) 
expressed their urinary outputs as ratios.   
 
The mean calcium, oxalate and phosphate to creatinine ratios at 0 h (baseline), 1 h, 
2 h and 3 h for the two race groups before and after the intake of Glu are shown in 
Figures 2.3, 2.4 and 2.5, respectively.  No changes in the urinary excretion of 
calcium (Ca), oxalate (Ox) and phosphate (P) were noted within the white group. 
However, phosphate excretion was significantly decreased in blacks at 2 h 
(p=0.0153) and 3 h (p=0.0269). 













pH 6.10±0.25 6.89±0.14 *0.0128 6.13±0.22 6.72±0.13 *0.0343 0.4088 
Volume (ml/h) 198±49.8 343±31.5 *0.0219 101±21.5 322±19.5 *0.0001 0.5638 
Citrate (mmol/h) 0.34±0.10 0.61±0.17 0.2200 0.11±0.02 0.21±0.04 *0.0395 *0.0259 
Oxalate (mmol/h) 0.05±0.01 0.02±0.00 0.1019 0.04±0.01 0.02±0.00 0.0609 0.8271 
Calcium (mmol/h) 0.16±0.06 0.07±0.02 0.1181 0.14±0.03 0.13±0.03 0.9824 0.0807 
Magnesium (mmol/h) 0.15±0.06 0.73±0.66 0.4555 0.13±0.02 0.53±0.41 0.3382 0.7883 
Sodium (mmol/h) 8.30±2.93 4.48±2.84 0.3710 5.50±1.56 5.59±1.44 0.9659 0.7230 
Potassium (mmol/h) 6.31±1.85 2.17±0.63 *0.0346 1.95±0.58 3.85±1.79 0.3271 0.4107 
Urate (mmol/h) 0.23±0.08 0.14±0.02 0.2706 0.09±0.02 0.14±0.02 †0.0541 0.8550 
Creatinine (mmol/h) 1.79±0.58 0.71±0.05 †0.0533 0.85±0.10 0.74±0.09 0.4378 0.7916 
Phosphate (mmol/h) 3.76±1.63 0.43±0.09 *0.0354 1.07±0.25 0.65±0.14 0.1641 0.2194 
Chloride (mmol/h) 18.3±6.34 8.11±1.24 0.0966 6.70±1.62 8.70±1.45 0.3691 0.7636 
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                                            Histograms labelled with the same symbol are significantly different (p<0.05) 
Figure 2.3:  Mean hourly 
values for urinary calcium 
excretion [(mmol Ca per 
mmol Creatinine) x 102] for 
black and white subjects 
following the Glu challenge 
 
 
Figure 2.4:  Mean hourly 
values for urinary oxalate 
excretion [(mmol Ox per 
mmol Creatinine) x 102] for 
black and white subjects 
following the Glu challenge 
 
 
Figure 2.5:  Mean hourly 
values for urinary phosphate 
excretion [(mmol P per mmol 
Creatinine) x 102] for black 
and white subjects following 
the Glu challenge 
 
*   # 
*
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Particle Formation Kinetics 
 
Particle Volume-Size Distributions 
 
The mean particle volume-size distribution at 120 min in urines of black and whites 
subjects before and after the ingestion of Glu is shown in Figure 2.6.  The total area 
under the curve represents the total volume of precipitated particles, while the mode 
of the curve gives the mean size of the precipitated particles.  The mean particle size 
values are given in Table 2.10.  Glu induced a decrease in mean particle size in 
blacks but no change in whites.  The mean particle volume was reduced in both 
groups.   
 
Table 2.10: Mean particle size (μm) in urines of black and white subjects before and 
after ingestion of Glu 
 
 Blacks Whites 
Baseline 4.37 4.37 








































Figure 2.6: Particle volume-size distribution in pre- and post-Glu ingestion in 
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Particle Number 
 
The plots for the mean particle number versus time are shown in Figure 2.7.  At 120 
min the particle number decreased in whites post Glu load.  Similarly, in blacks the 





































Figure 2.7: Particle number in urines of blacks and whites before and after 
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Crystallization Experiments 
 
14C-Oxalate Crystal Deposition 
 
The rate of CaOx deposition is indicated by the gradient of each curve (top right-hand 
corner) for black and white subjects pre- and post-intake of Glu (Figure 2.8).  A 
reduction in CaOx deposition rate was observed in the both groups after a Glu load.   
 
 
y = 0.2933x - 3.6591
y = 0.2798x + 15.738
y = 0.0596x + 14.518





































Figure 2.8: Percentage precipitated 14C-oxalate pre- and post-Glu ingestion 






















_______________________________________________________________________________________   67 
Crystal Aggregation 
 
The mean percentages for the inhibition of CaOx crystal aggregation in black and 
white subjects are given in Table 2.11, corresponding to the plots shown in Figure 
2.9.  Within each group no significant changes were noted after a Glu load.  Similarly, 
inter-group comparisons revealed no changes both before and after Glu ingestion.   
 
Table 2.11: Mean percentage inhibition of aggregation (SE) in black and white 
subjects before and after a Glu load 
 
Variables Blacks Whites Blacks 
 vs  
Whites 
% Ia (SE)  P % Ia (SE) P P 
Baseline 91.1 (3.33)  62.4 (15.2)  0.0988 






































Figure 2.9: Plot of absorbance versus time pre- and post-Glu load in urines of 
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Summary of Urine Chemistry and Crystalluria Properties After Glu Load 
 
 Blacks Whites 
 






Fractional (non-normalized)      pH,             K,         Creat, 
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Table 2.12 shows the 24 h excretion of urinary parameters before and after a Sor 
load.  In blacks, the urinary citrate excretion increased significantly.  A decrease in 
urinary calcium, magnesium, urate, creatinine and phosphate excretion was noted in 
whites.  The RS of brushite and BRI also decreased in this group. No other 
differences were observed. 
 
Fractional Collections (Non-Normalized Excretion) 
 
When comparing the two race groups at 0 h before Sor intake (Table 2.13), no 
significant differences were found between the two groups.  At 1 h following the Sor 
ingestion (Table 2.14), phosphate decreased significantly in blacks but no changes 
were observed in whites.  A significant decrease in urinary phosphate was further 
observed at 2 h in blacks (Table 2.15) and no other changes were observed in either 
group.  At 3 h (Table 2.16), the only significant differences which were observed were 
an increase in the urinary pH and urine volume in blacks and whites, respectively, with 
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Table 2.12:  Mean 24 h urinary variables ± SE in black and white subjects after 
























pH 6.07±0.08 6.21±0.11 0.2627 6.22±0.06 6.16±0.20 0.7271 0.8361 
Volume (ml/24h) 1924±110 2008±139 0.6046 2060±87.6 1811±311 0.2872 0.5433 
Citrate (mmol/24h) 2.99±0.23 4.27±0.32 *0.0035 3.04±0.23 2.36±0.55 0.2101 *0.0065 
Oxalate (mmol/24h) 0.27±0.01 0.30±0.03 0.1613 0.29±0.01 0.24±0.04 0.0852 0.1510 
Calcium (mmol/24h) 2.60±0.27 1.89±0.35 0.1635 4.19±0.24 2.45±0.50 *0.0020 0.3576 
Magnesium (mmol/24h) 1.79±0.22 1.37±0.21 0.3403 3.45±0.18 2.25±0.46 *0.0069 0.0813 
Sodium (mmol/24h) 93.1±12.0 76.5±19.5 0.4455 148±20.5 101±27.6 0.2728 0.4660 
Potassium (mmol/24h) 46.0±4.98 32.3±7.64 0.2019 54.4±4.82 51.2±13.1 0.7784 0.2104 
Urate (mmol/24h) 2.94±0.15 2.42±0.23 0.0780 3.51±0.14 2.34±0.32 *0.0006 0.8322 
Creatinine (mmol/24h) 17.8±3.84 12.3±1.29 0.3792 15.5±0.68 11.5±1.96 *0.0190 0.7235 
Phosphate (mmol/24h) 18.6±1.16 14.3±2.57 0.0971 27.3±1.68 17.6±4.70 *0.0208 0.5245 
Chloride (mmol/24h) 160±8.25 149±15.2 0.3895 164±7.71 132±21.7 0.0888 0.5071 
Sulphate (mmol/24h) 17.4±0.86 24.1±6.24 0.1107 20.3±1.28 15.3±3.01 0.0967 0.2620 
Tiselius Risk Index 198±24.2 263±43.8 0.8855 284±19.8 268±40.4 0.9929 0.5508 
RS Brushite 0.32±0.24 0.13±0.02 0.0713 4.39±1.67 0.39±0.04 *0.0148 *0.0259 
RS CaOx 3.29±1.25 2.34±0.22 0.1559 4.39±1.67 3.73±0.86 0.5546 0.1561 
RS Uric Acid 1.54±1.24 0.67±0.04 0.0976 0.83±0.77 1.25±0.29 0.3705 0.3728 
MSL (mol/dm3) 0.15±0.01 0.15±0.02 0.8765 0.13±0.01 0.15±0.02 0.3898 0.7979 
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Blacks Whites p 
 
pH 5.97 ± 0.17 6.17 ± 0.19  0.4475 
Volume (ml/h) 112 ± 22.8 101 ± 32.2 0.7746 
Citrate (mmol/h) 0.28 ± 0.07 0.20 ± 0.07 0.4606 
Oxalate (mmol/h) 0.04 ± 0.01 0.02 ± 0.01 0.3599 
Calcium (mmol/h) 0.20 ± 0.09 0.20 ± 0.09 0.9892 
Magnesium (mmol/h) 0.12 ± 0.04 0.48 ± 0.24 0.1440 
Sodium (mmol/h) 6.43 ± 1.81 15.2 ± 8.80 0.3191 
Potassium (mmol/h) 3.98 ± 1.80 4.73 ± 2.19 0.7934 
Urate (mmol/h) 0.11 ± 0.03 0.21 ± 0.09 0.3073 
Creatinine (mmol/h) 0.94 ± 0.20 1.58 ± 0.65 0.3413 
Phosphate (mmol/h) 0.97 ± 0.17 2.02 ± 1.29 0.4053 
Chloride (mmol/h) 9.50 ± 1.88 13.6 ± 4.49 0.4000 
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Table 2.14:  Mean 1 h urinary variables ± SE in black and white subjects after 
ingestion of Sor 






























pH 5.97±0.17 5.87±0.24 0.7257 6.17±0.19 6.28±0.24 0.6399 0.2439 
Volume (ml/h) 112±22.8 116±38.3 0.9392 101±32.2 75.1±19.3 0.5719 0.3583 
Citrate (mmol/h) 0.28±0.07 0.23±0.06 0.6584 0.20±0.07 0.19±0.06 0.9225 0.6192 
Oxalate (mmol/h) 0.04±0.01 0.02±0.01 0.1260 0.02±0.01 0.02±0.01 0.2714 0.7922 
Calcium (mmol/h) 0.20±0.09 0.05±0.01 0.1591 0.20±0.09 0.11±0.02 0.2795 *0.0228 
Magnesium (mmol/h) 0.12±0.04 0.05±0.02 0.1323 0.48±0.24 0.11±0.02 0.1440 *0.0450 
Sodium (mmol/h) 6.43±1.81 2.90±1.04 0.1183 15.2±8.80 7.15±2.49 0.3153 0.1351 
Potassium (mmol/h) 3.98±1.80 2.99±0.74 0.6352 4.73±2.19 3.34±0.60 0.623 0.7180 
Urate (mmol/h) 0.11±0.03 0.08±0.02 0.1260 0.21±0.09 0.09±0.02 0.1936 0.5041 
Creatinine (mmol/h) 0.94±0.20 0.66±0.08 0.1591 1.58±0.65 0.74±0.11 0.2568 0.0963 
Phosphate (mmol/h) 0.97±0.17 0.45±0.08 *0.0097 2.02±1.29 0.43±0.09 0.3273 0.7511 
Chloride (mmol/h) 9.50±1.88 6.24±1.28 0.1156 13.6±4.49 7.11±1.50 0.2268 0.3711 












_______________________________________________________________________________________   73 
Table 2.15:  Mean 2 h urinary variables ± SE in black and white subjects after 





























pH 5.97±0.17 5.70±0.57 0.2168 6.17±0.19 6.39±0.22 0.4553 0.2889 
Volume (ml/h) 112±22.8 130±24.9 0.6727 101±32.2 145±28.4 0.3162 0.4840 
Citrate (mmol/h) 0.28±0.07 0.23±0.05 0.6246 0.20±0.07 0.17±0.07 0.7860 0.5765 
Oxalate (mmol/h) 0.04±0.01 0.03±0.01 0.4244 0.02±0.01 0.02±0.00 0.9280 0.7759 
Calcium (mmol/h) 0.20±0.09 0.09±0.03 0.3004 0.20±0.09 0.13±0.02 0.4571 0.4407 
Magnesium (mmol/h) 0.12±0.04 0.07±0.02 0.2944 0.48±0.24 0.12±0.03 0.1607 0.2561 
Sodium (mmol/h) 6.43±1.81 3.89±1.50 0.2935 15.2±8.80 5.32±1.70 0.2870 0.5159 
Potassium (mmol/h) 3.98±1.80 2.76±0.60 0.5298 4.73±2.19 3.49±0.61 0.5956 0.4518 
Urate (mmol/h) 0.11±0.03 0.08±0.01 0.3914 0.21±0.09 0.11±0.02 0.2963 0.2230 
Creatinine (mmol/h) 0.94±0.20 0.67±0.06 0.2168 1.58±0.65 0.80±0.07 0.2524 0.2157 
Phosphate (mmol/h) 0.97±0.17 0.33±0.06 *0.0022 2.02±1.29 0.36±0.10 0.2145 0.7411 
Chloride (mmol/h) 9.50±1.88 13.5±6.72 0.5717 13.6±4.49 7.33±1.35 0.2036 0.4469 
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Table 2.16:  Mean 3 h urinary variables ± SE in black and white subjects after 
ingestion of Sor 
*statistically significant; †approaching statistical significance 
 
Fractional Collections (Excretion Normalized to Creatinine) 
 
No significant changes were observed in the excretion of urinary calcium before and 
after Sor intake in both groups (Figure 2.10).  However, oxalate was significantly 
increased within the white group at 3 h (p=0.0347) but there were no changes in 
blacks (Figure 2.11).  A decrease in urinary phosphate was observed in blacks at 1 h 
(p=0.0181) and 2 h (p=0.0002), whereas in whites it was only observed at 2 h 






















pH 5.97±0.17 6.63±0.17 *0.0141 6.17±0.19 6.59±0.23 0.1775 0.9058 
Volume (ml/h) 112±22.8 690±414 0.1806 101±32.2 273±39.4 *0.0038 0.3562 
Citrate (mmol/h) 0.28±0.07 0.57±0.12 †0.0515 0.20±0.07 0.21±0.06 0.9269 *0.0214 
Oxalate (mmol/h) 0.04±0.01 0.04±0.01 1.0000 0.02±0.01 0.03±0.01 0.3987 0.7112 
Calcium (mmol/h) 0.20±0.09 0.11±0.03 0.4049 0.20±0.09 0.11±0.02 0.3741 0.9929 
Magnesium (mmol/h) 0.12±0.04 0.05±0.02 0.1270 0.48±0.24 0.09±0.02 0.1246 0.1597 
Sodium (mmol/h) 6.43±1.81 4.14±1.25 0.3112 15.2±8.80 5.05±1.27 0.2708 0.6179 
Potassium (mmol/h) 3.98±1.80 2.87±0.67 0.5735 4.73±2.19 4.79±1.08 0.9800 0.1412 
Urate (mmol/h) 0.11±0.03 0.16±0.02 0.2282 0.21±0.09 0.16±0.02 0.5612 0.8072 
Creatinine (mmol/h) 0.94±0.20 0.69±0.05 0.2599 1.58±0.65 0.72±0.07 0.2105 0.7474 
Phosphate (mmol/h) 0.97±0.17 0.55±0.13 0.0624 2.02±1.29 0.57±0.14 0.2770 0.9352 
Chloride (mmol/h) 9.50±1.88 8.28±1.07 0.5786 13.6±4.49 9.33±0.94 0.3715 0.4745 










































































































                                                 Histograms labelled with the same symbol are significantly different (p<0.05) 
Figure 2.10:  Mean 
hourly values for urinary 
calcium excretion [(mmol 
Ca per mmol Creatinine) 
x 102] for black and 
white subjects following 
the Sor challenge 
 
Figure 2.11: Mean hourly 
values for urinary oxalate 
excretion [(mmol Ox per 
mmol Creatinine) x 102] for 
black and white subjects 




Figure 2.12:  Mean hourly 
values for urinary 
phosphate excretion 
[(mmol P per mmol 
Creatinine) x 102] for black 
and white subjects 
following the Sor challenge 
* 
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# *
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Particle Formation Kinetics 
 
Particle Volume-Size Distributions 
 
The mean particle size values are given in Table 2.17.  Sor provoked an increase in 
the mean particle size in blacks. Conversely, in whites the mean particle size 
decreased.  The mean volume of precipitated particles decreased in both groups and 
was more pronounced in blacks.  The mean particle volume-size distribution of urine 
from black and white subjects before and after Sor load is shown in Figure 2.13.   
 
Table 2.17: Mean particle size (μm) in urines of black and white subjects before and 
after ingestion of Sor 
 
 Blacks Whites 
Baseline 3.64 4.37 







































Figure 2.13: Particle volume-size distribution in pre- and post-Sor ingestion 
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Particle Number 
 
The curves for particle number versus time are shown in Figure 2.14.  At 120 min the 
mean particle number decreased in both groups (largely in the black group) post Sor 






































Figure 2.14: Particle number in urines of blacks and whites before and after 
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Sor induced a significant decrease in the rate of CaOx crystal deposition at 120 min 




y = 0.2798x + 15.738
y = 0.2804x - 2.1595
y = 0.2933x - 3.6591






































Figure 2.15: Percentag  precipitated 14C-oxalate pre- and post-Sor ingestion in 
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Crystal Aggregation 
 
The mean percentages for the inhibition of CaOx crystal aggregation in black and 
white subjects are given in Table 2.18, corresponding to the plots shown in Figure 
2.16.  Sor provoked a significant decrease in percentage inhibition of aggregation in 
blacks but no change was observed in whites.  Inter-group comparisons revealed no 
changes both before and after Sor ingestion.   
 
Table 2.18: Mean percentage inhibition of aggregation (SE) in black and white 
subjects before and after a Sor load 
 
Variables Blacks Whites Blacks 
 vs  
Whites 
% Ia (SE)  p % Ia (SE) p p 
Baseline  85.1 (4.99)  61.3 (10.4)  0.0995 
Post Sor 67.5 (3.82) *0.0231 68.8 (6.99) 0.9776 0.9012 
 




































Figure 2.16: Plot of absorbance versus time pre- and post-Sor load in urines 
of black and white subjects. The time at which stirring was stopped is 
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Summary of Urine Chemistry and Crystalluria Properties After Sor Load 
 
 Blacks Whites 
 
24 h 
     




   Ca,              Mg,              Ur, 
  
   Creat,       P,      RS brushite 
   BRI 
 
Fractional (non-normalized) 
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Xyl augmented the 24 h urinary excretion of oxalate and magnesium subsequent to 
its ingestion in blacks, as shown in Table 2.19.  In the white group a significant 
decrease in the BRI was noted.  No other significant changes were observed within 
the two groups.   
 
Fractional Collections (Non-Normalized Excretion) 
 
At 0 h, there were no differences in the two groups prior to a Xyl load (Table 2.20).  
After Xyl intake, at 1 h (Table 2.21), urinary potassium excretion increased in blacks.  
No additional changes in either group were observed.  At 2 h (Table 2.22), the 
urinary sulphate excretion decreased and the urine volume increased in whites.  The 
other variables within the two groups remained unchanged.  The urinary pH 
increased in blacks 3 h post a Xyl load and the urine volume increased in both 
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Table 2.19:  Mean baseline 24 h urinary variables ± SE in black and white subjects 
after ingestion of Xyl 













pH 6.07±0.08 6.17±0.13 0.4245 6.22±0.06 6.34±0.17 0.4176 0.4380 
Volume (ml/24h) 1924±110 1982±74.0 0.6909 2060±87.6 1924±140 0.4610 0.7083 
Citrate (mmol/24h) 2.99±0.23 2.87±0.36 0.8673 3.04±0.23 2.78±0.36 0.5953 0.8550 
Oxalate (mmol/24h) 0.27±0.01 0.33±0.02 *0.0037 0.29±0.01 0.28±0.02 0.7337 0.0866 
Calcium (mmol/24h) 2.60±0.27 2.18±0.33 0.4198 4.19±0.24 3.25±0.55 0.0867 0.1070 
Magnesium (mmol/24h) 1.79±0.22 2.75±0.41 *0.0277 3.45±0.18 3.00±0.36 0.2598 0.6523 
Sodium (mmol/24h) 93.1±12.0 87.1±23.5 0.8050 148±20.5 189±46.2 0.3779 0.0629 
Potassium (mmol/24h) 46.0±4.98 51.7±8.82 0.4667 54.4±4.82 60.7±14.0 0.5899 0.5848 
Urate (mmol/24h) 2.94±0.15  2.99±0.15 0.8183 3.51±0.14 3.19±0.16 0.2610 0.3719 
Creatinine (mmol/24h) 17.8±3.84 14.5±0.88 0.6141 15.5±0.68 13.7±1.68 0.2529 0.6568 
Phosphate (mmol/24h) 18.6±1.16 22.5±2.44 0.1061 27.3±1.68 29.1±4.71 0.5036 0.1639 
Chloride (mmol/24h) 160±8.25 136±14.0 0.1066 164±7.71 151±9.16 0.8584 0.1704 
Sulphate (mmol/24h) 17.4±0.86 18.7±1.97 0.5060 20.3±1.28 15.6±2.93 0.1090 0.3738 
Tiselius Risk Index 198±24.2 243±32.5 0.6992 284±19.8 288±39.9 0.5830 0.9478 
RS Brushite 0.32±0.24 0.37±0.03 0.7108 4.39±1.67 0.78±0.06 0.2817 *0.0251 
RS CaOx 3.29±1.25 3.35±0.33 0.9264 4.39±1.67 3.22±0.40 0.2696 0.8667 
RS Uric Acid 1.54±1.24 1.00±0.20 0.3369 0.83±0.77 0.94±0.19 0.7209 0.8924 
MSL (mol/dm3) 0.15±0.01 0.15±0.01 0.9478 0.13±0.01 0.15±0.02 0.3388 0.9695 
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Blacks Whites p 
 
pH 5.90 ± 0.18  5.95 ± 0.18 0.8947 
Volume (ml/h) 102 ± 22.8 113 ± 24.7 0.4155 
Citrate (mmol/h) 0.16 ± 0.03 0.19 ± 0.05 0.3412 
Oxalate (mmol/h) 0.02 ± 0.01 0.04 ±0.01 0.1906 
Calcium (mmol/h) 0.06 ± 0.01 0.24 ± 0.09 0.0774 
Magnesium (mmol/h) 0.09 ± 0.01 0.30 ± 0.11 0.0796 
Sodium (mmol/h) 4.76 ± 2.10 13.9 ± 5.87 0.1605 
Potassium (mmol/h) 2.46 ± 0.57 3.06 ± 0.55 0.4577 
Urate (mmol/h) 0.10 ± 0.02 0.17 ± 0.04 0.2011 
Creatinine (mmol/h) 0.87 ± 0.15 1.39 ± 0.41 0.2510 
Phosphate (mmol/h) 1.07 ± 0.31 2.02 ± 0.69 0.2230 
Chloride (mmol/h) 8.22 ± 1.90 10.7 ± 2.35 0.4305 
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Table 2.21:  Mean 1 h urinary variables ± SE in black and white subjects after 






























pH 5.90±0.18 6.10±0.31 0.5650 5.95±0.18 6.04±0.23 0.9183 0.8777 
Volume (ml/h) 102±22.8 86.3±33.6 0.7009 113±24.7 90.4±16.3 0.7906 0.9063 
Citrate (mmol/h) 0.16±0.03 0.14±0.05 0.6706 0.19±0.05 0.14±0.03 0.2115 0.9655 
Oxalate (mmol/h) 0.02±0.01 0.01±0.00 0.6289 0.04±0.01 0.02±0.00 0.4441 0.2289 
Calcium (mmol/h) 0.06±0.01 0.07±0.02 0.8939 0.24±0.09 0.20±0.06 0.5293 0.0655 
Magnesium (mmol/h) 0.09±0.01 0.11±0.03 0.5743 0.30±0.11 0.21±0.07 0.3317 0.2109 
Sodium (mmol/h) 4.76±2.10 5.15±2.73 0.9102 13.9±5.87 10.6±2.89 0.4171 0.2024 
Potassium (mmol/h) 2.46±0.57 3.08±0.75 *0.0025 3.06±0.55 3.80±0.72 0.6257 0.5050 
Urate (mmol/h) 0.10±0.02 0.09±0.04 0.9045 0.17±0.04 0.16±0.03 0.3514 0.2031 
Creatinine (mmol/h) 0.87±0.15 0.81±0.14 0.8609 1.39±0.41 0.93±0.14 0.4422 0.5561 
Phosphate (mmol/h) 1.07±0.31 0.53±0.13 0.1739 2.02±0.69 1.01±0.28 0.2395 0.1812 
Chloride (mmol/h) 8.22±1.90 7.43±2.58 0.8034 10.7±2.35 9.56±1.60 0.6489 0.4755 
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Table 2.22:  Mean 2 h urinary variables ± SE in black and white subjects after 
ingestion of Xyl  






























pH 5.90±0.18 6.32±0.20 0.1372 5.95±0.18 6.19±0.19 0.3731 0.6413 
Volume (ml/h) 102±22.8 169±25.9 0.0695 113±24.7 216±15.8 *0.0023 0.1306 
Citrate (mmol/h) 0.16±0.03 0.28±0.06 0.1054 0.19±0.05 0.21±0.03 0.8270 0.2717 
Oxalate (mmol/h) 0.02±0.01 0.02±0.00 0.9196 0.04±0.01 0.04±0.01 0.9846 0.0743 
Calcium (mmol/h) 0.06±0.01 0.09±0.01 0.1644 0.24±0.09 0.16±0.03 0.3651 †0.0520 
Magnesium (mmol/h) 0.09±0.01 0.13±0.03 0.3280 0.30±0.11 0.13±0.02 0.1262 0.9699 
Sodium (mmol/h) 4.76±2.10 3.91±2.01 0.7751 13.9±5.87 5.85±1.74 0.1846 0.4749 
Potassium (mmol/h) 2.46±0.57 2.46±0.48 1.0000 3.06±0.55 3.69±0.91 0.5731 0.2628 
Urate (mmol/h) 0.10±0.02 0.17±0.04 0.2011 0.17±0.04 0.16±0.02 0.8907 0.8907 
Creatinine (mmol/h) 0.87±0.15 0.92±0.20 0.8524 1.39±0.41 0.78±0.04 0.1404 0.4792 
Phosphate (mmol/h) 1.07±0.31 0.49±0.07 0.0914 2.02±0.69 0.75±0.15 0.0730 0.1531 
Chloride (mmol/h) 8.22±1.90 8.22±2.05 1.0000 10.7±2.35 9.50±1.26 0.6582 0.5942 
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Table 2.23:  Mean 3 h urinary variables ± SE in black and white subjects after 
ingestion of Xyl 
*statistically significant 
 
Fractional Collections (Excretion Normalized to Creatinine)  
 
The intake of Xyl did not have any significant effect on the urinary excretion of any of 
the three urinary parameters (Ca, Ox and P) within the white group (Figures         
2.17-2.19).  In blacks, on the other hand, Xyl induced an increase in the urinary 


























pH 5.90±0.18 6.70±0.12 *0.0017 5.95±0.18 6.39±0.23 0.1469 0.2484 
Volume (ml/h) 102±22.8 346±43.6 *0.0001 113±24.7 326±32.5 *0.0001 0.7199 
Citrate (mmol/h) 0.16±0.03 0.30±0.06 0.0608 0.19±0.05 0.22±0.06 0.7953 0.3413 
Oxalate (mmol/h) 0.02±0.01 0.04±0.01 0.1423 0.04±0.01 0.02±0.00 0.1242 0.8690 
Calcium (mmol/h) 0.06±0.01 0.11±0.02 0.1205 0.24±0.09 0.14±0.03 0.2751 0.4668 
Magnesium (mmol/h) 0.09±0.01 0.16±0.05 0.1724 0.30±0.11 0.13±0.02 0.1241 0.4783 
Sodium (mmol/h) 4.76±2.10 2.29±0.69 0.2816 13.9±5.87 5.08±1.45 0.1427 0.1124 
Potassium (mmol/h) 2.46±0.57 2.84±0.60 0.6527 3.06±0.55 3.65±0.60 0.4812 0.3502 
Urate (mmol/h) 0.10±0.02 0.14±0.02 0.1501 0.17±0.04 0.18±0.02 0.7902 0.2698 
Creatinine (mmol/h) 0.87±0.15 0.62±0.04 0.1261 1.39±0.41 0.69±0.08 0.0998 0.4961 
Phosphate (mmol/h) 1.07±0.31 0.64±0.07 0.2059 2.02±0.69 0.92±0.17 0.1192 0.1590 
Chloride (mmol/h) 8.22±1.90 7.22±1.30 0.6696 10.7±2.35 9.80±1.08 0.7332 0.1432 















































































































                                     Histograms labelled with the same symbol are significantly different (p<0.05) 
 Figure 2.17: Mean 
hourly values for urinary 
calcium excretion [(mmol 
Ca per mmol Creatinine) 
x 102] for black and 
white subjects following 
the Xyl challenge 
 
Figure 2.18:  Mean 
hourly values for urinary 
oxalate excretion [(mmol 
Ox per mmol Creatinine) 
x 102] for black and 
white subjects following 
the Xyl challenge 
 
 
Figure 2.19:  Mean 
hourly values for urinary 
phosphate excretion 
[(mmol P per mmol 
Creatinine) x 102] for 
black and white subjects 
following the Xyl 
challenge 
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Particle Formation Kinetics 
 
Particle Volume-Size Distributions 
 
Subsequent to Xyl ingestion the mean particle size did not change in the black group 
but it decreased slightly in the white group (Table 2.24).  The mean particle volume 
was decreased significantly in the former group and not in the latter (Figure 2.20). 
 
Table 2.24: Mean particle size (μm) in urines of black and white subjects before and 
after ingestion of Xyl 
 
 Blacks Whites 
Baseline 4.37 4.37 







































Figure 2.20: Particle volume-size distribution in pre- and post-Xyl ingestion in 
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Particle Number 
 
At 120 min the particle number decreased in both group subsequent to Xyl ingestion 






































Figure 2.21: Particle number in urines of blacks and whites before and after 
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A significant decrease in the rate of CaOx crystal deposition at 120 min was 
observed in whites following a Xyl load as shown in Figure 2.22, whereas no 
significant difference was noted in blacks. 
 
 
y = 0.2798x + 15.738
y = 0.2554x - 0.0513
y = 0.2933x - 3.6591



































Figure 2.22: Percentage precipitated 14C-oxalate pre- and post-Xyl ingestion in 
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Crystal Aggregation 
 
The percentages for the inhibition of aggregation (% Ia) in the urines of black and 
white subjects after the ingestion of Xyl relative to baseline are shown in Table 2.25. 
Xyl did not provoke any change in the two groups.  Inter-group comparisons also 
revealed no changes both before and after Xyl ingestion.  The corresponding plots 
for both groups are shown in Figure 2.23. 
 
Table 2.25: Mean percentage inhibition of aggregation (SE) in black and white 
subjects before and after a Xyl load 
 
Variables Blacks Whites Blacks 
 vs  
Whites 
% Ia (SE)  p % Ia (SE) p p 
Baseline  84.7 (5.52)  84.5 (5.05)  0.9907 




































Figure 2.23: Plot of absorbance versus time pre- and post-Xyl load in urines 
of black and white subjects. The time at which stirring was stopped is 
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Summary of Urine Chemistry and Crystalluria Properties After Xyl Load 
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Serum 
 
Blood glucose results are shown in Table 2.26.  As expected, Glu ingestion caused 
an increase in blood glucose in both groups, whereas after the intake of Sor or Xyl 
the blood glucose levels did not change in either of the two race groups.    
 
Table 2.26.  Mean blood glucose levels ± SE (mmol/l) at baseline and 30 min after 
ingestion of each sugar 
 
Sugar Blacks Whites Black vs Whites 






6.02±0.83 *0.002 4.60±0.50 6.32±0.96 *0.004 1.000 0.576 
Sor 4.67±0.48 
 
4.68±0.54 0.806 4.60±0.50 4.70±0.76 0.849 0.684 0.946 
Xyl 4.67±0.48 
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2.4   Discussion 
 
Several intriguing observations emerged from this study which explored whether 
differences in renal handling of Glu and the two sugar alcohols, Sor and Xyl, exist in 
the two South African ethnic groups.  The non-normalized excretions for the hourly 
fractions revealed a decrease in the urinary excretion of phosphate in blacks after 
the ingestion of Glu but this was not retained after 24 h.  Interestingly, the normalized 
hourly excretions were in agreement with these findings.  Moreover, Nguyen and 
coworkers (1993) also observed a decrease in phosphate excretion following a Glu 
load.  The decrease in phosphaturia after Glu ingestion which was observed in black 
subjects in this study may be a consequence of the penetration of phosphorus into 
cells, which leads to a decrease in phosphoremia (Maina et al. 1975).  This in turn 
reduces the renal filtered load of phosphate, thereby decreasing the urinary excretion 
of the phosphate (Nguyen et al. 1993).   
 
In the present study changes in calciuria and oxaluria were not observed unlike the 
increase in both of these which has been observed in other studies (Nguyen et al. 
1989).  This can be attributed to the dose dependency effect as only 20 g of Glu was 
administered in this study compared to 75 g and 100 g loads in other studies.  The 
increase in urinary citrate observed in white subjects is noteworthy.  As stated in the 
previous Chapter, citrate is one of the most potent inhibitors of stone formation as it 
binds calcium ions thereby hindering CaOx and CaP precipitation.  The 
hypercitraturic effect of Glu in this group provides explanation for the unchanged 
calciuria and oxaluria.  With respect to the relative supersaturations, the results 
showed no significant changes in the RS of CaOx, brushite or uric acid within the two 
groups. 
 
Similar to Glu, Sor provoked a decrease in phosphaturia in black subjects, noted in 
both the normalized and the non-normalized hourly excretions but not sustained after 
24 h.  On the other hand, their white compatriots also had reduced phosphate levels 
following a Sor load even though to a lesser extent, and this was observed in 
normalized excretions and only at 24 h in non-normalized excretions.  The same 
proposed mechanism for the decrease in phosphaturia after Glu ingestion is thought 
to perhaps occur after Sor ingestion.  The decrease in phosphaturia was more 
prominent in the black group than in the white group, suggesting that cell penetration 
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excretion occurs to a greater extent in the former.  Of note is also the significant 
decrease in RS of brushite in black subjects which can be attributed to the decrease 
in phosphate excretion or to the increase in urinary pH, or both, in this group.  In 
addition to the fall in phosphaturia, Sor overtly increased the urinary excretion of 
oxalate in white subjects.  However, this was apparent only in normalized excretions 
but was not in agreement with the findings reported by Nguyen et al. (1993) wherein 
they indicated that Sor had no effect on oxalate excretion.  Two possible 
explanations for the rise in oxaluria are firstly, the hepatic transformation of sorbitol 





 Scheme 1:  Metabolic pathway of sorbitol leading to the production of glucose 
(Adcock and Gray (1957) 
 
It has been shown that Glu ingestion increases oxaluria at doses 20-100 g (Nguyen 
et al. 1986, Nguyen et al. 1989, Nguyen et al. 1993, Nguyen et al. 1998), therefore it is 
suggested that Sor ingestion has a similar effect due to its metabolic conversion to 
glucose.  However, since no increase in urinary oxalate was observed after glucose 
ingestion in the present study, it is not likely that this mechanism can account for the 
rise in oxaluria following sorbitol intake.  Secondly, another mechanism which can 
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the hepatic transformation of sorbitol into glyoxylate and then into oxalate (Scheme        
2).   
 
                                          
Scheme 2:  Metabolic pathway of sorbitol and enzymes involved leading to 
the production of oxalate (Conyers et al. 1990) 
 
It is therefore suggested that the increase in oxaluria in white subjects occurs via this 
mechanism and it seems that the baseline activity of one or more of the enzymes 
involved in this pathway is lower in black subjects.  This provides evidence that the 
two groups differ in the renal handling of certain agents, implying different 
mechanisms as hypothesized earlier.  Urinary changes in calcium excretion were 
apparent in the white group but only at 24 h.  The decrease in excretion of this 
parameter was supported by the concomitant decrease in BRI in this group.  Since 
Sor augmented the non-normalized citrate excretion in black subjects, the 
unchanged calcium and oxalate levels in this group can be ascribed to 
hypercitraturia. 
 
Ingestion of Xyl gave rise to an increased normalized excretion of urinary oxalate in 
black subjects, which is in accordance with Nguyen and co-workers’ results (1993). 
sorbitol 
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This rise in oxaluria was also observed in non-normalized excretions at 24 h.  This 
probably occurred via the metabolic pathway proposed by Conyers et  al.  (1990) 
leading to the production of oxalate, as depicted below in Scheme 3.  It is believed 
that in the pathway, D-xylulose is converted to xylulose-1-phosphate by an enzyme 
known as ketohexokinases.  The generated xylulose-1-phosphate is then cleaved by 





Scheme 3:  Metabolic pathway of xylitol and enzymes involved leading to the 
production of oxalate (Conyers et al. 1990) 
 
The observed rise in oxaluria in black subjects but not in their white counterparts 
suggests that the hepatic transformation of Xyl to oxalate may be operating in the 
former and is hindered in the latter group.  The implication of this is that one, two or 
all three of the enzymes in the pathway may be more active in the former group.  
Alternatively, the increased oxaluria in this group could have resulted from the 
reduction of fractional calcium reabsorption.  The results showed that black subjects 
excreted lower urinary calcium than white subjects (normalized excretion), which 
could facilitate reduction of complexation with oxalate and thus increased absorption 
in the GI tract leading to higher urinary oxalate (Messa et  al. 1997).  The non-
xylitol 
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normalized excretion of calcium at 24 h did not change in both groups following Xyl 
load, which is in accordance with the findings of a previous study (Bär 1985). 
It is noted that some parameters are significantly different from the baseline within 
the groups after ingestion of a sugar but when intergroup comparisons are made 
statistical differences disappear. This is expected and not entirely surprising since 
such differences will depend on the extent to which each parameter changes in each 
group. 
 
Crystallization experiments were performed in the reconstituted 24 h urines which 
were obtained pre- and post-ingestion of the three sugars.  Since there were no 
statistically significant changes in the 24 h urinary parameters after Glu ingestion, the 
changes observed in the crystallization experiments must be due to subtle alterations 
in urine chemistry, which affect its overall crystallization capacity.  It is noted that the 
changes in the latter were all favourable, indicating that despite earlier reports, Glu 
ingestion appears to have reduced the risk of stone formation.  The changes in the 
24 h urine parameters observed in both groups after ingestion of Sor were all such 
that they would have increased inhibition towards CaOx crystal formation.  This is 
reflected in the decrease in size and volume of the crystals.  The unfavourable 
decrease in inhibition of aggregation in black subjects again draws attention to the 
differences between the two groups in their respective responses to dietary 
challenges.  The decrease in crystal volume observed in black subjects after Xyl 
ingestion might be attributed to the increase in the 24 h excretion of magnesium 
which occurred in this group.  This is surprising since urinary oxalate also increased.  
The decrease in the deposition kinetics in whites is attributed to non-dietary subtle 
changes in urine chemistry. 
  
It is rather surprising that neither of the two polyols raised the urinary calcium levels.  
It has been postulated that non-absorbed polyols are passed through to the lower 
gut where they are fermented to short-chain volatile fatty acids which give rise to acid 
loading in the body.  This may consequently result in elevated urinary excretion of 
calcium (de Groot et al. 1995).  Perhaps ingestion of larger quantities of these sugar 
alcohols might trigger elevated calcium excretion.  Their difference in chemical 
structure might offer some explanation for the difference in metabolic behaviours, if 
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Blood glucose levels were measured to asses the response to an oral load of Glu 
and the two polyols.  As expected, Glu ingestion augmented blood glucose levels in 
the two groups, whereas Sor and Xyl did not change significantly.  This is in 
agreement with Adcock and Gray (1957) and Nguyen et al. (1993).  It is primarily due 
to the fact that unlike Glu, Sor and Xyl are more slowly and partially absorbed from 
the small intestine at virtually the same rate, thereby resulting in lower blood glucose 
and insulin response (Olefsky and Crapo 1980). 
 
In summary, the results of the present study have demonstrated that the two ethnic 
groups differ in the renal handling of the carbohydrate challenges, judging by their 
responses to the ingestion of each of the three sugars.  By consideration of 
established pathways, it is possible to hypothesize enhanced or diminished 
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3.1   Introduction 
 
In the study described in Chapter Two, Sor escalated the normalized urinary 
excretion of oxalate in the white subjects at 3 h after its ingestion.  Other effects 
were observed in the 24 h samples from whites.  In black subjects, phosphate 
excretion decreased and citrate excretion increased in various fractions following 
Sor ingestion. An obvious area for further investigation was whether dose 
dependency effects were operative in this mechanism.  The present chapter 
describes a study which addresses this question. 
 
In addition, the previous chapter also reported significant increases in oxaluria 
following the ingestion of Xyl in black subjects.  It is now hypothesised that this 
elevation in oxaluria as well as that occurring in whites after Sor ingestion may be a 
consequence of differences in the baseline activity of one or more enzymes in the 
proposed metabolic polyol pathways, in the two groups.  In order to lend credence 
to this hypothesis, a literature survey was conducted to stablish which enzyme(s) 
might be common to both the Sor and Xyl metabolic pathways for conversion to 
oxalate and which might be linked to CaOx urolithiasis.  Literature revealed that 
aldolase, which catalyses the conversion of fructose-1-phosphate to 
glyceraldehyde in the Sor pathway, and xylulose-1-phosphate to glycoladehyde (a 
precursor of oxalate) in the Xyl pathway, is indeed such an enzyme as it has been 
implicated in kidney stone formation (Hautman and Lutzeyer 1976, Tiktinskiĭ et al. 
1985).  As such, it was decided to investigate the respective baseline activities of 
this enzyme in an independent study to that mentioned above.  This study 
constitutes the second part of the present chapter. 
 
 
The main objectives of this study are: 
 
 to investigate the potential dose dependency effects of Sor ingestion on 
urinary risk factors in healthy black and white male South African subjects 
 
 to assess the physico-chemical properties of urines from the two groups 
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 to measure serum calcium and phosphorus with a view to comparing these 
with corresponding urine variables before and after the Sor loads in the two 
groups in an attempt to understand and elucidate the mechanistic pathways 
involved 
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Ten black and ten white healthy male subjects (age range 18-30 years) with no 
history of kidney stone disease or diabetes mellitus were recruited from the student 
cohort of the University of Cape Town for the Sor study.  This group of subjects 
was different from the group which was studied in Chapter Two.   
 
For the evaluation of the aldolase activity, twenty black and twenty white healthy 
male subjects (age range 18-30 years) participated in the study.   
 
The inclusion and exclusion criteria described in Chapter Two were also applied in 
the present studies.  For the aldolase study, in particular, none of the subjects had 










The protocol which was employed in the present Sor study was identical to that 
described in the previous chapter.  Each subject was on a self-selected diet 
controlled for calcium (1 g/day) and carbohydrates (300 g/day) for 7 days.  On day 
8, subjects consumed a strict standardized diet which was slightly modified in 
comparison to that shown in Chapter Two as illustrated in Table 3.1.  Subjects 
fasted overnight over a period of 12 h.  A 24 h urine sample was provided by the 
subjects at the end of day 8.  Subjects were instructed to drink 250 ml of water 
(Caledon Natural Spring Water) on waking and to collect a 1 h baseline urine 
sample.  At the end of the baseline period, a blood sample was drawn from each 
subject.  Immediately after the blood drawing, subjects drank a solution of Sor (20 
g in 250 ml water) and 30 min subsequent to that another blood sample was 
drawn.  Three hourly urine fractions were then collected and at the end of the urine 
fraction collection subjects consumed a standardized diet and collected urine for 
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4°C until analysis.  Volumetric addition of the urine fractions was performed to 
reconstitute the 24 h sample. Subjects followed a wash-out period for 7 days 
before commencing the next cycle with 30 g of Sor in 250 ml water.   
 
Although the 20 g dose was also administered in the previous study (Chapter 
Two), serum calcium and phosphorus levels were not determined. Hence, this 
dose was repeated in the present study. 
 
Table 3.1: Constituents of the strict standardized diet ingested at day 8 and 9  
 





 50 g bread roll  
 8 g butter 
 25 g apricot jam 
 60 g cornflakes 
 250 ml 2% low fat milk 
 250 ml coffee 
50 g bread roll  
8 g butter 
25 g apricot jam 
60 g cornflakes 




 27 g muesli bar 
 ½ cup fruit salad 
27 g muesli bar 
½ cup fruit salad 
Lunch:  
13h00  
 4 slices of whole wheat bread 
16 g butter 
28 g cheddar cheese 
28 g salami pressed beef 
50 g tomato 
4 slices of whole wheat bread 
16 g butter 
28 g cheddar cheese 
28 g salami pressed beef 
50 g tomato 
Snack:  
16h00  
150 g apple  
175 g low fat fruit yoghurt 
150 g apple 




140 g beef mince* 
120 g mixed vegetables  
200 g pasta 
140 g beef mince* 
120 g mixed vegetables  
200 g pasta 
Snack:  
20h00  
1 slice of whole wheat bread 
20 g peanut butter 
1 slice of whole wheat bread 
20 g peanut butter 
 
* beef mince for 7 portions: 1 tbsp oil, 1 onion, 1 heaped tsp garlic, 125 g button 
mushrooms, 1 tin peeled tomatoes, 1 cup beef mince, salt, pepper, paprika, chilli powder 
 
Beverages (2.25 l/day): 
250 ml coffee (4 g coffee powder, 4 g creamer, 10 g sugar in 250 ml water (Day 8 only)) 
700 ml Caledon water until 13h00 
600 ml Caledon water until 19h00 
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Table 3.2:  Nutrient content of the standardized diet 
 
VARIABLE AMOUNT 
Energy (kJ) 11872 
Total protein (g) 103.1 
Total fat (g) 112.7 
Carbohydrate (g) 301.5 
Calcium (mg) 1000 
Magnesium (mg) 347 
Phosphorus (mg) 1554 
Citric acid (mg) 509 
Oxalic acid (mg) 66 
 
Aldolase Study  
 
Specific dietary protocols were not followed in the aldolase study since baseline 
values were investigated. However, subjects were instructed to abstain from the 
intake of dietary supplements and any medication or prescription drugs.  Each 
subject provided a 24 h baseline urine sample and a fasting blood sample which 
was drawn in the morning in a gel tube and then centrifuged.  Sera were stored at   




For the Sor study, urines were analyzed as previously described in Chapter Two 
(page 51) but chloride and sulphate were not measured. In addition, serum calcium 
was measured using an ion selective electrode and serum phosphorus (inorganic) 
using ammonium molybdate (Dryer and Routh 1963) in the blood samples.   
 
Only oxalate and creatinine were measured in the baseline urine samples obtained 
in the aldolase study.  Commercial kits were used to measure serum aldolase 
activities both colorimetrically and spectrophotometrically.  The procedures were 
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Sorbitol Study  
 
Determination of Urinary Sorbitol 
 
The concentration of Sor recovered in urine subsequent to metabolism was 
measured by two different techniques, that is, high-performance anion-exchange 
chromatography (HPAEC) with pulsed amperometric detection (PAD) and 
fluorescent assay. 
 
HPAEC-PAD Method   
 
I.   Preparation of Samples 
 
Urine samples (which had been kept at -80°C prior to analysis) were thawed, 
pooled and then diluted 50% with water. The diluted samples were filtered, firstly 
through 0.45 μm membranes and then C18 reverse phase solid phase extraction 
cartridges, to remove proteins.  The following selection of internal standards: 
glycerol, erythritol, ribose, rhamnose and galactose were tried but all overlapped 
with other peaks in the chromatograms.  
 
II.   Chromatographic Procedure 
 
Carbohydrate profiling was performed on a Dionex BioLC ion chromatograph 
system equipped with an AS50 autosampler (Rheodyne rotary injection valve with 
a 25-μL PEEK sample loop), ED50 electrochemical detector, LC30 oven and GS50 
pump. The detector cell incorporated a gold working electrode and a pH (Ag/AgCl) 
reference electrode. Chromatographic data were recorded on a personal computer 
equipped with Chromeleon software. 
 
Profiling of Sor was achieved using a CarboPac MA1 column (250 mm × 4 mm) 
coupled with a CarboPac MA1 guard column.  Isocratic elution was performed with 
NaOH (250 mM for the 30 g Sor dose batch) and (470 mM for the 30 g Sor dose 
batch) at a flow rate of 0.4 ml/min. The concentration of Sor was determined from 
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Fluorescent Assay Method 
 
An assay method by Nakano and co-workers (2003) was applied for the 
determination of Sor in urine, which involved the removal of interfering ionic and 
non-ionic substances using an ion exchange resin column. 
 
I.   Preparation of Samples  
 
Urine samples were thawed as previously stated and then pooled.  To 2 ml of each 
pooled sample, distilled water (1.0 ml) was added.  The mixture was then passed 
through an Amberlite MB-1 (Sigma-Aldrich, Germany) column.  The column was 
washed with distilled water (20 ml) and to the eluted solution (5 ml), distilled water 
(1 ml), 0.475 mol NaOH (1 ml) and 0.293 mol ZnSO4 (1 ml) were added to make a 
total volume of 8 ml.  The mixture was vortexed and then centrifuged at 3000 rpm 
for 2 min.  
 
II.   Assay Procedure 
 
To the supernatant (2 ml), obtained above, 0.33 M Tris buffer (0.5 ml; pH 8.6), 250 
mg/dl NAD (1 ml), 0.1 M EDTA (0.1 ml) and 40 U/ml SDH (0.05 ml) were added.  
The mixture was incubated at 37 °C for 30 min followed by measurement of Sor 
using a flourimeter (Olis Inc., USA) at excitation wavelength, λex = 366 nm and 
emission wavelength, λem = 452 nm.   
Crystallization Experiments 
The same crystallization experiments as those described in Chapter Two (page 52) 
were performed on the urines from the Sor study only. 
Scanning Electron Microscopy 
 
At the end of the 120 min incubation period (following induction of crystallization 
with Na2Ox), 2 ml urine aliquots were filtered through a 0.22μm Millipore filter.  
Subsequent to drying, the filters were glued on aluminium stubs and were then 
splutter-coated with 3 – 5 nm of Au/Pd for 10 minutes (Bio-Rad, SEM Coating 
System).  A scanning electron microscope (Leica S440 Scanning Electron 
Microscope, Leica Cambridge, England) was used to view the stubs.  The 
microscope was operated at an accelerating voltage of 15 kV at a working distance 
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Aldolase Study 
 
It has been reported that the activity of aldolase in cleaving fructose-1-phosphate is 
highest in the liver and kidney (Tsunematsu and Shiraishi 1969).  It is also believed 
that most of the serum aldolase comes from the liver, where the metabolism of the 
sugar alcohols (Sor and Xyl) and other sugars occurs (Tsunematsu and Shiraishi 
1969, Bais et  al. 1985).  Two methods commonly used for the determination of 
serum aldolase activity, that is, a colorimetric method (Sibley and Lehninger 1949, 
Pinto et al. 1969a) and a spectrophotometric method (Feissli 1966), were employed 
in this chapter.   
 
Colorimetric Determination of Aldolase Activity 
 
A kit was used to measure aldolase activity by a colorimetric method (Caldon 
Biotech Inc., USA).  The initial step is the catalysis of the cleavage of fructose-1,6-
diphosphate (F-1,6-DP) to D-glyceraldehyde-3-phosphate (GAP) and 
dihydroxyacetone phosphate (DAP).  This is followed by the conversion of GAP to 
DAP with the addition of triosephosphate isomerase (TIM).  DAP is then reduced to 
L-α-glycerol phosphate (GP) by α-glycerophosphate dehydrogenase and NADH is 
oxidised to NAD, simultaneously.  These successive steps are depicted below.  
The absorbance is read at 340 nm and the rate of decrease is proportional to the 
aldolase activity. 
 
    
   F-1,6-DP                           DAP + GAP 
    
   GAP          DAP 
  
   2 DAP + 2 NADH            2 GP + 2 NAD      
 
 
I.   Preparation of Solutions 
 
A bottle of the reagent consisting of F-1,6-DP (0.2 mol/l), animal GDH (≥600 U/l), 
animal TIM (≥3000 U/l), NADH (0.32 mmol/l) and buffer; pH 7.0 was supplied with 
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II.   Assay Procedure 
 
To the reagent (3.0 ml) which was pipetted into a test tube and warmed to 37°C, a 
serum sample (200 μl) was added and the solution was mixed and incubated at 
37°C.  About 2 min subsequent to addition of the sample, the initial absorbance 
(A0) was measured.  The mixture was left to stand at 37°C and the final 
absorbance (A10) was measured exactly 10 min after the initial reading.  The rate of 
the reagent blank (ΔAb) was determined similarly using distilled water (200 μl) 
instead of serum and the aldolase activity (U/l) was determined by the following 
equation (Pinto et al. 1969a): 
                        
                                           (ΔAs - ΔAb) x total volume x 1000 
                                       
                                            6.22 x sample volume x 10 x 2    
 
                      [2=factor to compensate for oxidation of 2 μmole of NADH] 
 
 
Spectrophotometric Determination of Aldolase Activity 
 
As with the above procedure, a commercially available kit was purchased for the 
determination of aldolase activity spectrophotometrically (Randox, UK). The 
principle of the spectrophotometric procedure is similar to that of the colorimetric 
procedure described above.   
 
I.   Preparation of Solutions 
 
Three bottles of reagents were supplied with the kit.  Reagent bottle 1 consisted of 
a buffer/substrate [collidine buffer (51 mmol/l, pH 7.4), mono-iodoacetate (0.27 
mmol/l, F-1,6-DP (2.7 mmol/l)] which was reconstituted with redistilled water (20 
ml).  NADH (0.23 mmol/l), reagent bottle 2, was reconstituted with 1 ml of 
redistilled water while reagent bottle 3 containing GDH/TIM/LDH [GDH (≥326 
mU/ml), TIM (≥4.35 U/ml), LDH (≥616 mU/ml), ammonium sulphate (>35%)] was 
ready for use.  An aldolase calibrator (not provided with the kit but also purchased 
from Randox) was reconstituted with 1 ml of redistilled water.  Lastly, 0.9% NaCl 
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II.   Assay Procedure 
 
A serum sample (0.2 ml) was pipetted into a test tube followed by the successive 
addition of the buffer/substrate (2.50 ml), NADH (0.05 ml) and GDH/TIM/LDH (0.01 
ml).  The calibrator mixture was prepared in a similar manner except that the 
calibrator solution (0.2 ml) was used instead of a serum sample.  The sample blank 
was prepared by adding 0.9% NaCl solution to a serum sample (0.2 ml).  The three 
individual test tubes were each mixed followed by incubation at 37°C for 5 min.  At 
the end of this period the initial absorbance (A1) was read at 340 nm against the 
sample blank.  The mixture was left to stand at 37°C for exactly 20 min after the 
initial reading and the final absorbance (A2) was measured against the blank.  The 
following equation was used to calculate the aldolase activity (Feissli et al. 1966): 
 
                                              (A1 – A2) Sample 
                                                                                                                x   Conc. of calibrator 
                                             (A1 – A2) Calibrator 
 
        [Conc. of calibrator=16.7 U/l] 
 
 
Independent Analysis of Aldolase 
 
Both methods described above (colorimetric and spectrophotometric) were applied 
by the present author.  In addition, all samples were sent to an external laboratory 





Data from both studies were analysed by one-way ANOVA and regarded 




























Baseline 24 h urinary parameters are given in Table 3.3.  The lower values in 
blacks for citrate (significant) and oxalate (approaching significance) were not 
observed in the previous study described in Table 2.4, Chapter Two.  Conversely, 
several differences reported in this table were not observed in the present study. 
 
In the 24 h samples following Sor ingestion, only one significant change occurred 
in the black group, namely an increase in RS of uric acid.  Similarly, only the CaOx 
MSL significantly increased in the white group (Table 3.4).  This differs markedly 
with the changes which occurred in the previous study (Table 2.12).  Reasons for 
these differences will de explored in the Discussion section of this chapter. 
 
Fractional Collections (Non-Normalized Excretion) 
 
Prior to ingestion of Sor (corresponding to 0 h), no differences were observed in 
any of the urinary parameters in either group, as shown in Table 3.5.  Similarly, at 
1 h (Table 3.6), there were no changes within the two groups after Sor intake 
except for the decrease in phosphate in white subjects.  The increase in urinary 
citrate and the decrease in urinary phosphate at 2 h (Table 3.7) were also 
observed in the previous study.  However, the changes observed at 3 h (Table 3.8) 
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Blacks Whites p 
 
pH 6.53 ± 0.09 6.56 ± 0.06 0.3178 
Voume (ml/24h) 1836 ± 238 2206 ± 183 0.0916 
Citrate (mmol/24h) 3.21 ± 0.46 4.63 ± 0.35 *0.0041 
Oxalate (mmol/24h) 0.20 ± 0.02 0.27 ± 0.02 †0.0520 
Calcium (mmol/24h) 2.65 ± 0.37 3.18 ± 0.62 0.8352 
Magnesium (mmol/24h) 2.33 ± 0.34 2.52 ± 0.22 0.6172 
Sodium (mmol/24h) 228 ± 39.2 187 ± 30.5 0.7712 
Potassium (mmol/24h) 82.8 ± 16.4 54.1 ± 7.94 0.2403 
Urate (mmol/24h) 3.36 ± 0.59 3.24 ± 0.48 0.8006 
Creatinine (mmol/24h) 12.7 ± 1.07 14.0 ± 1.39 0.2294 
Phosphate (mmol/24h) 20.1 ± 2.05 27.2 ± 3.06 0.0726 
Tiselius risk index 198 ± 24.0 265 ± 53.0 0.2506 
RS Brushite 0.48 ± 0.15 0.62 ± 0.28 0.7765 
RS CaOx 1.99 ± 0.54 1.74 ± 0.51 0.7914 
RS Uric Acid 0.53 ± 0.16 0.33 ± 0.19 *0.0369 
MSL (mol/dm3) 0.17 ±0.01 0.10 ± 0.01 *0.0066 
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Table 3.4:  Mean 24 h urinary variables ± SE in black and white subjects after 
























pH 6.53±0.09 6.45±0.10 1.0000 6.56±0.06 6.70±0.06 0.4082 0.1115 
Volume (ml/24h) 1836±238 2084±128 1.1177 2206±183 2175±94.9 0.9402 0.6389 
Citrate (mmol/24h) 3.21±0.046 4.16±0.32 0.0740 4.63±0.35 5.03±0.48 0.9558 0.2066 
Oxalate (mmol/24h) 0.20±0.02 0.28±0.02 0.1280 0.27±0.02 0.29±0.02 0.7722 0.7831 
Calcium (mmol/24h) 2.65±0.37 2.82±0.37 0.7176 3.18±0.62 3.13±0.42 0.4880 0.3334 
Magnesium (mmol/24h) 2.23±0.34 2.65±0.26 0.1650 2.52±0.22 2.95±0.27 0.3701 0.5355 
Sodium (mmol/24h) 228±39.2 238±29.4 0.7201 187±30.5 183±15.3 0.6649 0.1743 
Potassium (mmol/24h) 82.9±16.4 80.3±12.7 0.7205 54.1±7.94 53.0±11.5 0.8956 0.1890 
Urate (mmol/24h) 3.36±0.59 3.51±0.42 0.2684 3.24±0.48 3.27±0.13 0.5012 0.6696 
Creatinine (mmol/24h) 12.7±1.07 16.8±1.30 0.0974 14.0±1.39 16.6±0.82 0.3852 0.9090 
Phosphate (mmol/24h) 20.1±2.05 26.0±2.72 0.2790 27.2±3.06 30.5±1.67 0.4242 0.2354 
Tiselius risk index 198±24.0 171±20.5 0.4116 265±53.0 146±25.5 0.0867 0.4432 
RS Brushite 0.48±0.15 0.41±0.16 0.7757 0.62±0.28 0.33±0.06 0.3341 0.6640 
RS CaOx 1.99±0.54 1.24±0.36 0.2508 1.74±0.51 1.18±0.29 0.2536 0.8926 
RS Uric Acid 0.53±0.16 1.83±1.08 *0.0351 0.28±0.19 0.31±0.05 0.2566 *0.0292 
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Blacks Whites p 
 
pH 6.21 ± 0.19  6.30 ± 0.17 0.7108 
Volume (ml/h) 77.0 ± 8.12 94.7 ± 21.5 0.4524 
Citrate (mmol/h) 0.15 ± 0.02 0.17 ± 0.05 0.6244 
Oxalate (mmol/h) 0.03 ± 0.01 0.03 ± 0.01 0.5162 
Calcium (mmol/h) 0.07 ± 0.01 0.05 ± 0.02 0.2948 
Magnesium (mmol/h) 0.10 ± 0.01 0.09 ± 0.02 0.9598 
Sodium (mmol/h) 17.4 ± 7.07 9.73 ± 2.28 0.3142 
Potassium (mmol/h) 3.92 ± 2.46 1.45 ± 1.32 0.3329 
Urate (mmol/h) 0.14 ± 0.01 0.22 ± 0.04 0.1732 
Creatinine (mmol/h) 0.90 ± 0.14 1.10 ± 0.22 0.4587 
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Table 3.6:  Mean 1 h urinary variables ± SE in black and white subjects after 





























pH 6.21±0.19 6.51±0.17 0.2469 6.30±0.17 6.35±0.18 0.5413 0.5334 
Volume (ml/h) 77.0±8.12 173±56.0 0.1075 94.7±21.5 90.4±23.3 0.3986 0.1909 
Citrate (mmol/h) 0.15±0.02 0.27±0.06 0.0788 0.17±0.05 0.21±0.06 0.5310 0.4791 
Oxalate (mmol/h) 0.03±0.01 0.04±0.01 0.2507 0.03±0.01 0.03±0.01 0.2846 0.4331 
Calcium (mmol/h) 0.07±0.01 0.15±0.06 0.2131 0.05±0.02 0.05±0.02 0.6098 0.1387 
Magnesium (mmol/h) 0.10±0.01 0.16±0.05 0.1846 0.09±0.02 0.11±0.02 0.4721 0.3104 
Sodium (mmol/h) 17.4±7.07 10.5±2.89 0.3785 9.73±2.28 5.69±1.55 0.6413 0.1586 
Potassium (mmol/h) 3.92±2.46 1.84±0.52 0.4189 1.45±1.32 1.85±0.73 0.0967 0.9903 
Urate (mmol/h) 0.14±0.01 0.13±0.04 0.7189 0.22±0.04 0.15±0.02 0.6506 0.8276 
Creatinine (mmol/h) 0.90±0.14 1.12±0.20 0.3970 1.10±0.22 0.97±0.09 0.6218 0.5144 
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Table 3.7:  Mean 2 h urinary variables ± SE in black and white subjects after 





























pH 6.21±0.19 6.71±0.18 0.0680 6.30±0.17 6.69±0.20 0.1488 0.9299 
Volume (ml/h) 77.0±8.12 241±52.7 *0.0064 94.7±21.5 173±46.3 0.1441 0.3404 
Citrate (mmol/h) 0.15±0.02 0.42±0.13 *0.0480 0.17±0.05 0.41±0.14 0.1403 0.9465 
Oxalate (mmol/h) 0.03±0.01 0.03±0.01 0.5759 0.03±0.01 0.04±0.01 0.5818 0.6111 
Calcium (mmol/h) 0.07±0.01 0.08±0.02 0.6786 0.05±0.02 0.05±0.01 0.8265 0.2106 
Magnesium (mmol/h) 0.10±0.01 0.13±0.02 0.2224 0.09±0.02 0.11±0.02 0.4466 0.6718 
Sodium (mmol/h) 17.4±7.07 5.10±1.98 0.1107 9.73±2.28 5.34±1.07 0.0983 0.9179 
Potassium (mmol/h) 3.92±2.46 1.27±0.59 0.3080 1.45±1.32 1.64±0.50 0.7589 0.6377 
Urate (mmol/h) 0.14±0.01 0.10±0.01 0.1674 0.22±0.04 0.19±0.03 0.5112 0.1304 
Creatinine (mmol/h) 0.90±0.14 0.68±0.10 0.2064 1.10±0.22 0.98±0.10 0.5498 0.0716 
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Table 3.8:  Mean 3 h urinary variables ± SE in black and white subjects after 
ingestion of 20 g Sor  
*statistically significant; †approaching statistical significance 
 
Fractional Collections (Excretion normalized to Creatinine) 
 
Figures 3.1-3.3 depict the urinary Ca, Ox and P excretion in the two groups before 
and after 20 g Sor intake.  Similarly to Chapter Two, these are expressed as the 
ratio of each parameter to creatinine. No significant changes were observed in 
urinary calcium and oxalate excretion in either of the two groups post Sor ingestion 
(Figure 3.1 and 3.2).  However, decreases in urinary phosphate at 1 h and 2 h in 
blacks (p=0.0055 and p=0.0001, respectively) at 1 h, 2 h and 3 h (p=0.0389, 
p=0.0016 and p=0.0291, respectively) in the white group were observed (Figure 
3.3).  Decreases in urinary phosphate were observed in the previous study but 



















pH 6.21±0.19 6.89±0.13 *0.0085 6.30±0.17 6.74±0.14 †0.0534 0.4690 
Volume (ml/h) 77.0±8.12 260±27.9 *0.0001 94.7±21.5 268±30.4 *0.0002 0.8483 
Citrate (mmol/h) 0.15±0.02 0.55±0.19 †0.0516 0.17±0.05 0.45±0.07 *0.0045 0.6224 
Oxalate (mmol/h) 0.03±0.01 0.03±0.01 0.7364 0.03±0.01 0.04±0.01 0.6284 0.5258 
Calcium (mmol/h) 0.07±0.01 0.15±0.04 *0.0489 0.05±0.02 0.07±0.01 0.2576 †0.0512 
Magnesium (mmol/h) 0.10±0.01 0.13±0.01 *0.0486 0.09±0.02 0.13±0.03 0.2381 0.8276 
Sodium (mmol/h) 17.4±7.07 6.89±1.98 0.1687 9.73±2.28 5.08±1.31 0.0940 0.4555 
Potassium (mmol/h) 3.92±2.46 1.78±0.44 0.4036 1.45±1.32 2.01±0.55 0.3883 0.7463 
Urate (mmol/h) 0.14±0.01 0.23±0.06 0.2622 0.22±0.04 0.17±0.03 0.5048 0.5148 
Creatinine (mmol/h) 0.90±0.14 0.74±0.11 0.3767 1.10±0.22 0.90±0.11 0.4239 0.3314 


















































































































                                                                                       Histograms labelled with the same symbol are significantly different (p<0.05) 
Figure 3.1: Mean hourly 
values for urinary 
calcium excretion [(mmol 
Ca per mmol Creatinine) 
x 102] for black and white 
subjects following 20 g 
Sor challenge 
Figure 3.2: Mean hourly 
values for urinary 
oxalate excretion [(mmol 
Ox per mmol Creatinine) 
x 102] for black and white 
subjects following 20 g 
Sor challenge 
 
Figure 3.3: Mean hourly 
values for urinary 
phosphate excretion 
[(mmol P per mmol 
Creatinine) x 102] for 
black and white subjects 
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Particle Formation Kinetics 
 
Particle Volume-Size Distribution 
 
The mean particle size is given in Table 3.9 before and after 20 g Sor load.  Sor did 
not induce any change in the mean particle size in whites relative to baseline. 
However, in blacks, the mean particle size decreased after a Sor load.  The mean 
particle volume-size distribution curves of urines from black and white subjects are 
shown in Figure 3.4.   
 
Table 3.9: Mean particle size (μm) in urines of black and white subjects before and 
after ingestion of 20 g Sor 
 
 Blacks Whites 
Before 4.01 3.28 







































Figure 3.4: Particle volume-size distribution pre- and post-20 g Sor 

















The plots for particle number versus time are shown in Figure 3.5.  At 120 min the 
particle number decreased in blacks post Sor load.  A similar trend was noted in 








































Figure 3.5: Particle number in urines of blacks and whites before and after 

























Scanning Electron Microscopy 
 
The scanning electron micrographs obtained before and after a 20 g Sor load are 
shown in Figure 3.6 for black (a and b) and white (c and d) subjects.  In all 
micrographs, the dominating crystals are the coffin-shaped calcium oxalate 
monohydrate crystals (COM).  No changes in the number of crystals were 
observed in black subjects.  However, in white subjects the number of crystals after 
the intake of Sor was lesser.  
 
 a c 
b d 
Figure 3.6: Scanning electron micrographs of CaOx crystals pre- 
and post-ingestion of 20 g Sor in blacks (a: pre; b: post) and 










Whites : pre-sorbitol 
















14C-Oxalate Crystal Deposition 
 
The rate of CaOx deposition is indicated by the gradient of each curve (top right-
hand corner) for black and white subjects pre- and post-intake of 20 g Sor (Figure 





y = 0.1997x + 6.2637
y = 0.1782x + 0.6081
y = 0.2177x - 2.0723



































 Figure 3.7: Percentage precipitated 14C-oxalate pre- and post-20 g Sor 




































The mean percentages for the inhibition of CaOx crystal aggregation in black and 
white subjects are given in Table 3.10, corresponding to the plots shown in Figure 
3.8.  Within each group no significant changes were noted after 20 g Sor load.  
Inter-group comparisons also revealed no changes both before and after Sor 
ingestion.   
 
Table 3.10: Mean percentage inhibition of aggregation in black and white subjects 
before and after a 20 g Sor load 
 
Variables Blacks Whites Blacks 
 vs  
Whites 
% Ia (SE)  p % Ia (SE) p p 
Before  54.1 (4.25)  67.4 (6.75)  0.1021 





































Figure 3.8: Plot of absorbance versus time pre- and post-20 g Sor load in 
urines of black and white subjects. The time at which stirring was stopped is 
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Summary of Urine Chemistry and Crystalluria Properties After 20 g Dose 
 
 
 Blacks Whites 
 






Fractional (non-normalized)      pH,            Cit,           Ca, 
  
    Mg,             P 
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Table 3.11 shows the excretions of 24 h urinary variables before a 30 g Sor load in 
the two race groups.  The urinary citrate was significantly different between the two 
groups, with blacks a having lower mean excretion than whites. In addition, the 
former group had a higher CaOx MSL compared to the latter group.  It is also 
noteworthy that urinary phosphate was approaching a significant difference, with 
the excretion lower in the black group.  Sor did not change any of the 24 h 
parameters after its ingestion in blacks but it increased the CaOx MSL in whites 
(Table 3.12).   
 
Fractional Collections (Non-normalized Excretion) 
 
At 0 h before a 30 g Sor load the urinary pH was approaching significance, with 
whites having a higher mean, as shown in Table 3.13. Sor provoked a decrease in 
the excretion of urinary phosphate in both groups at 1 h (Table 3.14).  In blacks, at 
2 h (Table 3.15) the urinary potassium and phosphate levels decreased and the 
latter was also noted in the white group.  A number of statistically significant 
changes were observed at 3 h (Table 3.16), in the black group the urinary pH, 
urine volume and urinary citrate increased, while urinary sodium and potassium 
decreased.  On the other hand, in the white group the urine volume also increased 
but urinary sodium and creatinine decreased.  No additional changes were 
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Blacks Whites p 
 
pH 6.64 ± 0.15 6.66 ± 0.08 0.8161 
Volume (ml/24h) 1859 ± 226 2179 ± 148 0.2793 
Citrate (mmol/24h) 3.04 ± 0.36 4.57 ± 0.55 *0.1023 
Oxalate (mmol/24h) 0.23 ± 0.03 0.26 ± 0.02 0.6795 
Calcium (mmol/24h) 2.58 ± 0.61 2.59 ± 0.58 0.8761 
Magnesium (mmol/24h) 1.60 ± 0.22 2.35 ± 0.28 0.1090 
Sodium (mmol/24h) 287 ± 53.9 217 ± 42.6 0.1266 
Potassium (mmol/24h) 88.9 ± 16.7 57.2 ± 12.8 0.0642 
Urate (mmol/24h) 2.72 ± 0.23 3.28 ± 0.29 0.1500 
Creatinine (mmol/24h) 13.6 ± 1.29 15.6 ± 1.37 0.4247 
Phosphate (mmol/24h) 17.8 ± 1.73 28.8 ± 2.96 †0.0513 
Tiselius risk index 194 ± 33.0 168 ±34.4 0.4016 
RS Brushite 0.87 ± 0.08 0.66 ± 0.10 0.9226 
RS CaOx 2.19 ± 1.20 1.41 ± 0.90 0.5313 
RS Uric Acid 0.39 ±0.05 0.32 ± 0.07 0.8792 
MSL (mol/dm3) 0.16 ± 0.01 0.11 ± 0.01 *0.0363 
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Table 3.12:  Mean 24 h urinary variables ± SE in black and white subjects after 
























pH 6.64±0.15 6.60±0.15 0.6609 6.66±0.08 6.68±0.07 0.9709 0.6884 
Volume (ml/24h) 1859±226 1977±133 0.8829 2179±1.48 1979±151 0.2299 0.9929 
Citrate (mmol/24h) 3.04±0.36 4.84±0.70 0.1150 4.57±0.55 3.53±0.55 0.2059 0.2337 
Oxalate (mmol/24h) 0.23±0.03 0.27±0.02 0.3872 0.26±0.02 0.23±0.02 0.4361 0.1846 
Calcium (mmol/24h) 2.58±0.61 2.35±0.41 0.8817 2.59±0.58 1.74±0.25 0.1642 0.3075 
Magnesium (mmol/24h) 1.60±0.22 1.73±0.29 0.8083 2.35±0.28 2.38±0.26 0.7809 0.1524 
Sodium (mmol/24h) 287±53.9 224±28.1 0.3282 217±42.6 164±19.8 0.6457 0.1614 
Potassium (mmol/24h) 88.9±16.7 74.4±12.1 0.4998 57.2±12.8 50.1±10.3 0.8354 0.2315 
Urate (mmol/24h) 2.72±0.23 3.10±0.20 0.3868 3.28±0.29 3.68±0.41 0.6420 0.4329 
Creatinine (mmol/24h) 13.6±1.29 16.1±1.03 0.3066 15.6±1.37 16.0±1.40 0.8543 0.9538 
Phosphate (mmol/24h) 17.8±1.73 24.6±2.62 0.1538 28.8±2.96 30.6±2.70 0.7412 0.2072 
Tiselius risk index 194±33.0 157±13.8 0.2777 168±34.4 99.9±12.4 0.1248 *0.0090 
RS Brushite 0.87±0.08 0.34±0.08 0.4902 0.66±0.10 0.57±0.25 0.6036 0.5148 
RS CaOx 2.19±1.20 1.46±0.33 0.6428 1.41±0.90 1.15±0.21 0.4529 0.4217 
RS Uric Acid 0.39±0.05 0.65±0.15 0.5006 0.32±0.07 0.38±0.12 0.8528 0.3081 
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Blacks Whites p 
 
pH 6.26 ± 0.13 6.69 ± 0.16 †0.0533 
Volume (ml/h) 123 ± 28.6 115 ± 31.2 0.8449 
Citrate (mmol/h) 0.17 ± 0.06 0.18 ± 0.04 0.9488 
Oxalate (mmol/h) 0.03 ± 0.01 0.02 ± 0.01 0.4778 
Calcium (mmol/h) 0.11 ± 0.04 0.08 ± 0.03 0.5505 
Magnesium (mmol/h) 0.07 ± 0.02 0.15 ± 0.03 0.0617 
Sodium (mmol/h) 12.5 ± 3.56 12.1 ± 4.11 0.9355 
Potassium (mmol/h) 2.97 ± 0.74 3.18 ± 1.70 0.9141 
Urate (mmol/h) 0.17 ± 0.04 0.16 ± 0.03 0.9310 
Creatinine (mmol/h) 1.08 ± 0.25 1.02 ± 0.14 0.8498 
Phosphate (mmol/h) 1.45 ± 0.37 1.31 ± 0.21 0.7396 
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Table 3.14:  Mean 1 h urinary variables ± SE in black and white subjects after 




























pH 6.26±0.13 6.39±0.18 0.5413 6.69±0.16 6.65±0.18 0.8793 0.3129 
Volume (ml/h) 123±28.6 94.1±17.5 0.3986 115±31.2 90.4±27.2 0.5640 0.9101 
Citrate (mmol/h) 0.17±0.06 0.13±0.03 0.5310 0.18±0.04 0.12±0.03 0.2829 0.7793 
Oxalate (mmol/h) 0.03±0.01 0.02±0.00 0.2846 0.02±0.01 0.03±0.00 0.5069 0.3306 
Calcium (mmol/h) 0.11±0.04 0.08±0.04 0.6098 0.08±0.03 0.06±0.01 0.3931 0.5105 
Magnesium (mmol/h) 0.07±0.02 0.06±0.01 0.4721 0.15±0.03 0.08±0.01 0.0800 0.2357 
Sodium (mmol/h) 12.5±3.56 10.4±2.81 0.6413 12.1±4.11 4.77±1.37 0.1099 0.0910 
Potassium (mmol/h) 2.97±0.74 1.45±0.44 0.0967 3.18±1.70 0.71±0.15 0.1658 0.1301 
Urate (mmol/h) 0.17±0.04 0.13±0.02 0.6506 0.16±0.03 0.14±0.03 0.6792 0.8908 
Creatinine (mmol/h) 1.08±0.25 0.95±0.05 0.6218 1.02±0.14 0.86±0.10 0.3821 0.4739 
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Table 3.15:  Mean 2 h urinary variables ± SE in black and white subjects after 




























pH 6.26±0.13 6.57±0.33 0.3708 6.69±0.16 6.62±0.11 0.7203 0.8876 
Volume (ml/h) 123±28.6 91.9±11.6 0.3460 115±31.2 140±21.1 0.5065 0.0684 
Citrate (mmol/h) 0.17±0.06 0.18±0.02 0.8961 0.18±0.04 0.19±0.04 0.8708 0.9106 
Oxalate (mmol/h) 0.03±0.01 0.04±0.01 0.0658 0.02±0.01 0.03±0.00 0.0710 0.3833 
Calcium (mmol/h) 0.11±0.04 0.07±0.01 0.3323 0.08±0.03 0.08±0.01 0.9189 0.5124 
Magnesium (mmol/h) 0.07±0.02 0.06±0.01 0.6261 0.15±0.03 0.12±0.01 0.5042 *0.0002 
Sodium (mmol/h) 12.5±3.56 7.65±2.51 0.2910 12.1±4.11 3.75±1.20 0.0682 0.1662 
Potassium (mmol/h) 2.97±0.74 1.00±0.27 *0.0289 3.18±1.70 0.98±0.22 0.2169 0.9605 
Urate (mmol/h) 0.17±0.04 0.10±0.00 0.3596 0.16±0.03 0.35±0.16 0.3700 0.4193 
Creatinine (mmol/h) 1.08±0.25 0.78±0.03 0.2816 1.02±0.14 0.89±0.08 0.4560 0.2266 
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Table 3.16:  Mean 3 h urinary variables ± SE in black and white subjects after 
ingestion of 30 g Sor  
*statistically significant 
 
Fractional Collections (Excretion normalized to Creatinine) 
 
Figures 3.9-3.11 show the urinary Ca, Ox and P excretion as creatinine ratios 
before and after 30 g Sor ingestion.  No statistically significant changes were 
observed in calcium excretion within the black group, whereas in the white group it 
increased significantly at 3 h relative to baseline (Figure 3.9).  With regard to 
oxalate excretion, there were no changes in blacks following a Sor load but in 
whites it increased at 2 h and 3 h as shown in Figure 3.10.  Similarly, phosphate 
excretion did not change in blacks but it decreased significantly in whites at 1 h and 





     
                  









pH 6.26±0.13 6.88±0.12 *0.0037 6.69±0.16 7.06±0.12 0.0875 0.3401 
Volume (ml/h) 123±28.6 314±32.3 *0.0005 115±31.2 254±37.7 *0.0109 0.2567 
Citrate (mmol/h) 0.17±0.06 0.52±0.12 *0.0251 0.18±0.04 0.39±0.11 0.0998 0.4554 
Oxalate (mmol/h) 0.03±0.01 0.04±0.01 0.1585 0.02±0.01 0.04±0.01 0.1138 0.8137 
Calcium (mmol/h) 0.11±0.04 0.11±0.03 0.9810 0.08±0.03 0.08±0.02 0.9248 0.3354 
Magnesium (mmol/h) 0.07±0.02 0.07±0.01 0.9956 0.15±0.03 0.10±0.02 0.1972 0.2889 
Sodium (mmol/h) 12.5±3.56 3.90±0.58 *0.0373 12.1±4.11 3.16±0.75 *0.0472 0.4631 
Potassium (mmol/h) 2.97±0.74 1.01±0.12 *0.0248 3.18±1.70 0.79±0.19 0.1805 0.3575 
Urate (mmol/h) 0.17±0.04 0.10±0.00 0.3385 0.16±0.03 0.13±0.02 0.4919 0.4224 
Creatinine (mmol/h) 1.08±0.25 0.73±0.07 0.2239 1.02±0.14 0.62±0.08 *0.0260 0.3273 






















































































































                                        Histograms labelled with the same symbol are significantly different (p<0.05) 
Figure 3.9: Mean hourly 
values for urinary 
calcium excretion [(mmol 
Ca per mmol Creatinine) 
x 102] for black and white 




Figure 3.10: Mean hourly 
values for urinary 
oxalate excretion [(mmol 
Ox per mmol Creatinine) 
x 102] for black and white 




Figure 3.11: Mean hourly 
values for urinary 
phosphate excretion 
[(mmol P per mmol 
Creatinine) x 102] for 
black and white subjects 




           * 

















Particle Formation Kinetics  
 
Particle Volume-Size Distribution 
 
No significant changes were observed in the mean particle size after the ingestion 
of 30 g of Sor in blacks (Table 3.17).  In whites, the mean particle size increased.  
The pattern of the curves in Figure 3.12 is of note.  The curves for white subjects 
are higher than the curves for black subjects, indicating a larger mean particle 
volume in the urine from the former group.   
 
 
Table 3.17: Mean particle size (μm) in urines of black and white subjects before 
and after ingestion of 30 g Sor 
   
 Blacks Whites 
Before 4.01 3.64 




































Figure 3.12: Particle volume-size distribution pre- and post-30 g Sor 

















Figure 3.13 shows the plots for particle number versus time before and after 
ingestion of 30 g Sor.  At 120 min the particle number decreased in blacks but 





































Figure 3.13: Particle number in urines of blacks and whites before and 

























Scanning Electron Microscopy 
 
The scanning electron micrographs obtained before and after a 30 g Sor load are 
shown in Figure 3.14 for black (a and b) and white (c and d) subjects.  In all 
micrographs, the dominating crystals are the coffin-shaped COM crystals.  Fewer 
crystals were observed after ingestion of Sor in the urines from black subjects and 
the opposite was noted in the urines from white subjects.  In both cases the size of 






Figure 3.14: Scanning electron micrographs of CaOx crystals    
pre- and post-ingestion of 30 g of Sor in blacks (a: pre; b: post) 





Blacks : pre-sorbitol Whites : pre-sorbitol 


















The rate of CaOx deposition is indicated by the gradient of each curve (top-right 
hand corner) for black and white subjects pre- and post 30 g Sor ingestion (Figure 
3.15).  A reduction in CaOx deposition rate was observed in blacks after the Sor 
load and conversely, the crystal deposition increased in whites.  The percentage of 
precipitated 14C-oxalate was higher in whites compared to blacks both before and 
after ingestion of Sor. 
 
 
y = 0.3878x + 1.9122
y = 0.3114x + 0.1216
y = 0.1938x + 2.6175




































Figure 3.15: Percentage precipitated 14C-oxalate pre- and post-30 g Sor 






















The mean percentages for the inhibition of CaOx crystal aggregation in black and 
white subjects are given in Table 3.18, corresponding to the plots shown in Figure 
3.16.  Within each group no significant changes were noted after 30 g Sor load.  
Inter-group comparisons also revealed no changes both before and after Sor 
ingestion.   
 
Table 3.18: Mean percentage inhibition of aggregation in black and white subjects 
before and after a 30 g Sor  load 
 
Variables Blacks Whites Blacks 
 vs  
Whites 
% Ia (SE)  p % Ia (SE) p p 
Before  55.9 (4.09)  57.7 (9.94)  0.8581 






































Figure 3.16: Plot of absorbance versus time pre- and post-30 g Sor load in 
urines of black and white subjects. The time at which stirring was stopped is 
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Summary of Urine Chemistry and Crystalluria Properties After 30 g Dose 
 
 Blacks Whites 
Fractional (non-normalized)      pH,             Cit,            Na, 
 
    K,                P 
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The typical chromatograms obtained from the HPAEC-PAD method for one of the 
standard solutions of Sor and for one of the urine samples are depicted in Figures 
3.17 and 3.18, respectively.   
 
The actual concentrations of Sor after the two doses in the urines of black and 
white subjects are given in Table 3.19.  In blacks, the levels of Sor peaked at 2 h 
subsequent to the 20 g dose, whereas in whites they peaked at 1 h, with the 
concentrations in the latter group being higher than in their black compatriots from 
0 to 24 h. 
 
After the 30 g dose, a similar effect was observed, with Sor concentrations again 




               Figure 3.17: Typical chromatogram for a Sor standard solution 
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                Figure 3.18: Typical chromatogram for a urine sample 
Table 3.19:  Concentration of Sor (μg/ml) in the urines of black and white subjects 
after the two doses using the HPAEC-PAD method 
 
 Blacks Whites 
Time (h) 20 g dose 30 g dose 20 g dose 30 g dose 
0 10.0 4.600 6.60 4.40 
1 45.6 118.4 61.4 326 
2 46.0 131.0 21.4 64.0 
3 2.00 11.40 6.80 9.40 
24 1.60 10.20 6.80 3.20 
 
Fluorescent Assay Method  
 
Table 3.20 shows the urinary concentrations of Sor measured fluorimetrically in the 
urines of the two groups.  The levels of Sor peaked at 2 h in both groups following 
a 20 g dose.  After the 30 g dose blacks had the highest concentration of urinary 
Sor at 3 h, whereas in whites it was at 1 h and 24 h.  The concentrations did not 
differ after the two doses in both groups, contrary to the observed differences in 
Table 3.19 when using the HPAEC-PAD method.  In addition, it is noted that the 
levels of Sor for each dose obtained from the two methods are not similar.  These 
results are surprising and will be dealt with in depth in the discussion section of this 
chapter. 
 
Table 3.20:  Concentration of Sor (μg/ml) in the urines of black and white subjects 
after the two doses using the Fluorescent Assay method 
 
 Blacks Whites 
Time (h) 20 g dose 30 g dose 20 g dose 30 g dose 
0 21.7 12.0 18.0 11.0 
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1 55.0 75.0 95.6 93.6 
2 93.0 87.3 105.7 85.7 
3 87.3 92.3 103.3 82.6 








The mean serum Ca and P values before and after ingestion of 20 g and 30 g Sor 
are given in Table 3.19.  Both Ca and P did not change significantly within the 
black group after 20 g or 30 g of Sor ingestion.  However, in whites Ca was 
approaching a significant increase after the 30 g load but no changes were 
observed in P.  Inter-group comparisons showed lower Ca levels in this group prior 
to 30 g Sor ingestion.  
 
Table 3.19: Mean ± SE serum calcium and phosphate excretion (mmol/l) at before 
and after intake of 20 g and 30 g of Sor in blacks and whites  
 





The relevant 24 h urinary variables for black and white subjects are shown in Table 
3.20.  Urinary oxalate and creatinine were similar in the two groups.  These results, 
most importantly with regard to urinary oxalate, are in agreement with those 
obtained in the previous study (Chapter Two) as well as in the present Sor study.  
Variable Blacks 
 
Whites Black vs Whites     




Ca (20 g) 2.21±0.02 2.23±0.02 0.446 2.21±0.01 2.22±0.02 0.651 0.903 0.816 
P (20 g) 1.25±0.03 1.20±0.04 0.258 1.24±0.05 1.17±0.04 0.238 0.807 0.606 
Ca (30 g) 2.25±0.02 2.24±0.02 0.680 2.19±0.01 2.23±0.01 †0.057 *0.004 0.477 
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Blacks vs Whites 
p 
 
Volume (ml) 1436 ± 132 1471 ± 164 0.8689 
Oxalate (mmol/24h) 0.24 ± 0.01 0.23 ± 0.02 0.8361 
Creatinine (mmol/24h) 13.9 ± 0.82 14.1 ± 1.29 0.8501 
 
 
The mean aldolase activities are shown in Figure 3.19.  It is noted that the 
difference in the activity between the black group and the white group was 
approaching statistical significance when determined by the spectrophotometric 
method carried out by the author at the Kidney Stone Research Laboratory (blacks: 
4.39 ± 0.53, whites: 3.25 ± 0.24; p=0.0553), with white subjects having a lower 
activity than black subjects.  However, neither the results from Lancet Laboratories 
(blacks: 6.26 ± 0.62, whites: 5.79 ± 0.45; p=0.5536) nor those obtained using the 
colorimetric method by the author (blacks: 5.34 ± 0.58, whites: 4.80 ± 0.52; 
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Figure 3.19: Mean aldolase activities in blacks and whites using 
Spectrophotometric and Colorimetric methods. Spectrophotometric method 1: 































































































































r = 0.8329 
p < 0.001 
r = 0.5682 
p < 0.001 
In order to test the correlation between the methods, scatter plots were created and 
a bivariate correlation test was performed as depicted in Figures 3.20 – 3.22. The 
spectrophotometric methods undertaken at the two laboratories correlated 
positively.  Similarly, a positive correlation was noted between the colorimetric 
method and the spectrophotometric method (from each laboratory). 
Figure 3.20: Evaluation of 
the correlation between the 
data obtained using the 
spectrophotometric method 
from two laboratories. 
 
Figure 3.21: Evaluation of 
the correlation between the 
data obtained using the 
colorimetric method and the 
spectrophotometric method 
(1) from Lancet Laboratories. 
 
Figure 3.22: Evaluation of 
the correlation between the 
data obtained using the 



































Subsequent to the ingestion of 20 g of sorbitol, the urinary excretion of calcium in 
the non-normalized fractions increased concomitantly with magnesium and citrate 
in black subjects but was, however, not maintained up to 24 h.  The role of 
magnesium and citrate as inhibitors of stone formation has been well established.  
The former forms a soluble complex with oxalate, resulting in decreased urinary 
excretion of this parameter.  The unchanged levels of oxalate in blacks could have 
been influenced by elevation of magnesium levels.  It is surprising, on the other 
hand, that the increase in calciuria was manifested in this group, in spite of the 
increased citrate excretion.  An opposite effect would have been anticipated, as 
citrate binds with calcium, leading to a lesser excretion of latter in the urine.  
However, citrate influenced the increased urinary pH, thereby hindering the 
supersaturation of uric acid.  This effect did not continue to 24 h, on the contrary, 
as a rise in RS of uric acid was observed during this period.  The rise in RS of uric 
acid is also surprising because it normally occurs at pH below 5.5 (Coe et al. 1980), 
as stated in Chapter One, and this was not the case in the present study.  
Increasing the dose to 30 g resulted in the rise in urinary pH, also accompanied by 
an increase in citrate in the black group and similarly this was not sustained in the 
24 h fraction.  In addition, the excretion of urinary phosphate and the proposed 
mechanism for the reduction in urinary phosphate levels was explained in Chapter 
Two.  The decreased urinary phosphate was observed in the previous study 
(Chapter Two) after the 20 g load but this was not the case in the present study. 
 
The non-normalized excretions in white subjects revealed a decrease in urinary 
phosphate after the administration of the 20 g dose.  This is in accordance with the 
results in Chapter Two except that the effect in that study was delayed until 24 h, 
r = 0.7695 
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whereas it occurred earlier in the present study.  In contrast, the decreased RS of 
brushite which accompanied the reduced phosphate levels in the previous study 
was not observed in this study in this group.  Additionally, decreased urinary 
calcium levels were noted previously in the white group at 24 h, presently, this 
effect was not reflected.  These inconsistencies may be ascribed to slight 
modifications in the standardized diets provided in the two studies and also the 
individual variation in the metabolism of Sor.  However, apart from the common 
decrease in urinary phosphate, the non-normalized excretion of oxalate did not 
change in the two studies in the white group as well as in the black group.  The 
30 g dose induced a decrease in urinary phosphate in white subjects, analogous to 
that observed after the 20 g dose.  Serum phosphate levels, however, did not 
change in both groups but Nguyen ad co-workers (1993) noted similar findings in 
their study with the 20 g dose. 
 
The normalized fractional excretions revealed that, post 20 g load, the oxalate 
excretion was not changed in either group but was significantly increased in the 
white group in the previous study (Chapter Two).  The discrepancy in the results of 
the two studies is surprising and one possible explanation for this inconsistency is 
probably the difference in the metabolism of sorbitol in the subjects recruited in the 
two studies, as the two groups were not the same.  Nevertheless, the current 
finding is in agreement with the results of Nguyen et al. (1993), as they also did not 
observe any effect after 20 g administration of sorbitol on the urinary excretion of 
oxalate.  However, contrary to these observations, the 30 g load in the present 
study increased the excretion of this parameter in the white group.  In the black 
group, both doses of sorbitol did not induce any significant changes in oxalate 
excretion.  This is consistent with the previous study (Chapter Two) in which no 
increase in oxalate excretion occurred in black subjects after the 20 g dose.   
 
The mechanisms by which sorbitol is converted to oxalate in the liver are described 
in Chapter Two.  Briefly, the first mechanism involves the dehydrogenation of 
sorbitol to fructose, which is in turn transformed to glucose (Adcock and Gray 
1957).  Alternatively, sorbitol undergoes a pathway whereby it is transformed to 
glyoxylate resulting in the production of oxalate (Conyers et  al. 1990).  The 
increased oxalate excretion in the white group and not in the black group suggests 
inactivity of one or more of the three enzymes involved in this pathway, that is, 
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the previous chapter (Chapter Two).  Since the increase in oxaluria in white 
subjects was observed only after the bigger dose, it can be suggested that the 
effect is dose dependent.  However, further studies involving a wider range of dose 
levels are required before a definite conclusion can be drawn. 
 
Following a 20 g sorbitol challenge, the urinary excretion of calcium did not change 
in both studies in the white group.  The results from the two studies are thus 
consistent and are in accordance with observations by Nguyen and co-workers 
(1993).  Increasing the dose to 30 g resulted in an increase in the excretion of this 
parameter in this group.  Seemingly, the 20 g load was not enough to provoke an 
increase in urinary calcium excretion, as it escalated following a 30 g load.  In black 
subjects, the excretion of calcium did not change in both studies after the 
administration of 20 g of sorbitol nor did it increase after the 30 g load in the 
present study.  It is apparent that increasing the dose from 20 g to 30 g affected 
the white subjects but not the black subjects.  A possible explanation for the 
increased calcium levels in the former group following the 30 g sorbitol load is that, 
non-absorbed polyols are usually passed through to the lower gut where they are 
fermented to short-chain volatile fatty acids.  These fatty acids then give rise to 
acid loading in the body and may consequently trigger the elevation of urinary 
calcium excretion (de Groot et al. 1995).  Serum calcium levels after the 30 g load 
also increased with increase in urinary excretions.  Generally, about 50 % of serum 
calcium is available for filtration in the kidney and excess calcium is absorbed and 
excreted in the urine (Sayer et al. 2004).  In principle, high concentrations of serum 
calcium contribute to elevated urinary levels, hence observed effect of the 30 g 
dose.  The concomitant increase in urinary calcium and oxalate in this group will 
dramatically increase the risk of CaOx crystallization in the fractional collections.  
The effect disappears in the 24 h collection, as can be seen in Table 3.12, in which 
no change in the RS values for CaOx are reflected.  This result suggests the 
findings of other studies which have shown that during a 24 h cycle, peak periods 
of crystalluria (and hence stone risk) occur.  Hence, ingestion of a 30 g dose of 
sorbitol is a risk factor for CaOx stone formation in white subjects but not in black 
subjects.   
 
The urinary phosphate excretion decreased in the white group after a 20 g load in 
both the present and the previous study.  Similarly, ingestion of 30 g induced a 
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was 156 % after the 20 g dose while after the 30 g dose it was 88 %, which implies 
that it is dose independent.  In black subjects, urinary phosphate decreased in both 
studies after the 20 g dose.  However, after the intake of 30 g, no statistically 
significant changes in phosphaturia were observed.  The explanation for the failure 
of the results for the 30 g dose to be statistically significant is the wide spread of 
the values which led to high standard errors as a consequence of the variation and 
thus lowered the precision.   The anomaly in these results suggests either an 
inconclusive effect of the 30 g load or dose independency in this group. 
 
The recovery of sorbitol in the urine after the ingestion of the two doses was 
measured.  Polyols are partially absorbed from the small intestine and it is believed 
about 80 % of sorbitol can be absorbed (Livesey 1992, Langkilde et al. 1994).  The 
unabsorbed portion undergoes bacterial fermentation in the colon to produce short-
chain fatty acids such as acetic and butyric acids as well hydrogen and methane 
gases. A small amount (10 to 20 %) of the absorbed portion is excreted in the urine 
(Livesey 1992).  The results from the two methods used for the determination of 
the concentration of the excreted urinary sorbitol were not consistent.  In the 
chromatographic method, after the 20 g dose, the white group had higher levels 
compared to the black group, implying a higher absorption in the former group.  A 
similar effect was observed after the 30 g dose.  Of important note is also the 
earlier transit time in white subjects compared to black subjects.  The fluorescent 
assay method, on the other hand, showed poor reproducibility and widely varied 
results.  It is possible that the resin column (with no indicator) that was used in this 
study failed to eliminate interference by the ionic and non-ionic factors.  The 
stability of the enzyme, SDH, is also of consideration.  It is apparent that the results 
obtained from the chromatographic method are more reliable as there were no 
interfering limitations. 
 
In the studies on the crystalluria properties, the results were generally varied and 
inconsistent.  However, particle numbers decreased consistently in black subjects 
in response to both doses (20g: 18 %, 30 g: 28 %).  Moreover, the observation 
after the 30 g dose was confirmed semi-quantitatively by SEM measurement. 
 
As hypothesised in this discussion and in the previous chapter, the increase in 
oxalate production following a sorbitol load in white subjects and not in their black 
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enzymes that are involved in the metabolic pathway of sorbitol (and xylitol) in one 
group and not the other.  It was therefore deemed necessary to test this hypothesis 
by determining the serum activity of aldolase, one of the enzymes common to both 
pathways and also associated with CaOx kidney stone disease.  As shown in 
Scheme 1 below, aldolase catalyses the equilibrium conversion of fructose-1,6-
phosphate (F-1,6-P) to glyceraldehyde-3-phosphate (G-3-P) and dihydroxyacetone 
phosphate (DHAP).  Hautmann and Lutzeyer (1976) discovered that, when 
compared to healthy kidneys, those from oxalate stone formers had a significantly 
lower aldolase activity.  The authors attributed this deficiency to a decrease in 
glyconeogenesis because in the kidney, unlike in other organs, glucose synthesis 
is favoured thereby resulting in oxaloacetate accumulation (OAA) which may lead 
to oxalate synthesis.  However, as mentioned in the introduction of this chapter, it 
has been suggested that most of the serum aldolase comes from the liver, where 
the activity of this enzyme is greatest.  The sorbitol and xylitol pathways proposed 
in Chapter Two for the production of oxalate possibly occur in the liver as well as in 
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Scheme 1:  Metabolic pathway for glucose in the cytoplasm of the kidney 
(Hautmann and Lutzeyer 1976) 
 
In the present study, the serum aldolase activity in white subjects was generally 
lower when compared to that of black subjects and was approaching statistical 
significance when measured spectrophotometrically by the present author at the 
Kidney Stone Research Laboratory.  In light of the lower activity of aldolase 
observed in the former group, the increased urinary excretion of oxalate following 
sorbitol ingestion can be explained in terms of the above metabolic pathway for 
glucose (Scheme 1).  Hautmann and Lutzeyer (1976) demonstrated that in the 
kidney the metabolism of glucose favours the direction of glucose synthesis and a 
reduced activity of aldolase results in the ultimate production of oxalate.  The 
metabolic conversion of sorbitol into glucose via the following pathway (Scheme 2) 
was proposed in Chapter Two.  It is therefore suggested that in the white group, 
due to the low baseline activity of aldolase, the metabolism of sorbitol results in 
glucose synthesis thereby increasing urinary oxalate excretion and is likely to occur 
in the kidneys.  In other words, this implies that the aldolase activity is inversely 





Scheme 2:  Metabolic pathway of sorbitol leading to the production of glucose 

















           ____________________________________________________________________________________ 154
 
The increase in oxalate excretion in black subjects after xylitol ingestion (Chapter 
Two) and the observation of a relatively lower baseline activity of aldolase (present 
chapter) suggests that in this group the liver is the main site for the metabolism of 
xylitol and that aldolase activity is directly proportional to urinary oxalate excretion. 
 
The inconsistency in the values obtained for the aldolase activity using the 
spectrophotometric method from the two laboratories can be attributed to the wider 
spread in the individual results noted in the data provided by Lancet Laboratories.  
It was therefore necessary for outliers to be eliminated.  Pinto et al. (1969b), when 
comparing serum aldolase activities obtained by a spectrophotometric method from 
two laboratories, noted differences in the results even though they also observed a 
positive correlation, as is the case in the present study.  The colorimetric correlated 
positively as well with the spectrophotometric method performed in both 
laboratories. 
 
Thus, summarizing the two studies described in this chapter, it is clear that 
different renal handling mechanisms of sorbitol are present in the two ethnic 
groups and indeed dose dependency effects are operative.  It has also been 
established that the baseline activity of aldolase differs in the two groups.   
 
Finally, it is apparent that further research is required to explore the effects of 
sorbitol and xylitol in CaOx urolithiasis.  For now, caution in the consumption of 
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4.1   Introduction 
 
As stated in the General Introduction, an increased urinary excretion of oxalate has 
been identified as one of the major risk factors for CaOx stone formation (Finlayson 
1974, Robertson et  al. 1978, Ito et  al. 1992).    Oxalate can be produced mainly 
endogenously, through sources like ascorbic acid, protein and precursors such as 
glycolate or to a lesser extent exogenously, through dietary sources.  It is believed 
that oxalate that is produced endogenously and that which is absorbed from dietary 
sources are excreted largely in the urine (Holmes et  al. 2005).  The role of dietary 
oxalate in CaOx stone formation has been reviewed quite extensively by various 
researchers (Finch et al. 1981, Massey et al. 1993, Holmes 2001).  It has been known 
for some time that some foods are particularly high in oxalate conte t and these 
include rhubarb, spinach, beetroot, parsley, soya products, wheat bran, nuts, peanut 
butter, chocolate, tea, etc.  Of particular interest is the high ratio of oxalate to calcium 
possessed by spinach and rhubarb which contributes to the elevated urinary 
excretion of oxalate as a result of the diminished availability of calcium to bind 
oxalate (Noonan and Savage 1999).  Brogren and Savage (2003) examined the 
changes in urinary oxalate after a spinach load under a controlled diet.  Their results 
showed an increase in the urinary excretion of oxalate after the ingestion of spinach. 
 
The absorption of oxalate is thought to occur along the intestinal tract but this 
process is not well understood.  There are few factors which have been implicated 
and are believed to influence oxalate absorption, namely, oxalate-degrading bacteria, 
bile acid malabsorption and co-ingestion of calcium and magnesium (Holmes and 
Assimos 2004).  The percentage of oxalate absorbed may vary widely depending 
also on the intake of oxalate and the composition of the remainder of the diet (Jaeger 
and Robertson 2004).  An important consideration is the bioavailability of oxalate in 
foods for intestinal absorption.  Brinkley et al. (1981) tested the oxalate bioavailability 
in normal subjects of 7 different oxalate-rich foods including spinach, instant tea, 
vegetable cocktail juice, cranberry juice, orange juice, pecans and chocolate, and in 
addition, three standard solutions of Na2Ox.   Out of the 7 food items, spinach had 
the highest oxalate content; however, the most concentrated Na2Ox standard 
solution (20 mmol) had even higher oxalate content than spinach.  With regard to 
oxalate bioavailability, spinach had a lower percentage compared to the standard 
oxalate solutions.  In comparison to other food items, the bioavailability of oxalate in 
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vegetable cocktail juice (moderate oxalate content).  However, pecans and orange 
juice (lower oxalate content) had a much higher bioavailability with respect to oxalate 
compared to spinach.  In other studies, the bioavailability of oxalate in rhubarb was 
lower compared to that of the sodium oxalate standard solutions reported in the 
aforementioned study by Brinkley (Prenen et al. 1984, Honow and Hesse 2002).   
 
There has been remarkable evidence which suggests that tubular injury prevails in 
idiopathic CaOx stone formers (Baggio et al. 1983).  It is posited that hyperoxaluria in 
stone-forming patients may lead to calcium oxalate crystallization in the kidney and 
ultimately tubular injury, which arises from crystal-cell interactions (Hackett et  al. 
1990, Scheid et  al. 1995, Lieske et  al. 1992, Sarica et  al. 2001).  Subsequent to 
hyperoxaluria, renal tubular damage can be manifested by an increase in the urinary 
excretion of marker enzymes such as N-acetyl-β-glucosaminidase (NAG) (Baggio et 
al. 1983, Jaeger et  al. 1986, Khan et  al. 1989, Scheid et  al. 1996, Tungsanga et  al. 
2005) and β-galactosidase (GAL) (Huang et al. 2003).  NAG is found mainly in the 
proximal tubular cells of the kidney and due to its sensitivity in detecting 
nephrotoxicity and stability in a urinary environment, it is considered as one of most 
important markers of tubular damage (Sikora et al. 2003). 
 
In a previous study, a positive correlati n between NAG and oxalate excretion was 
observed in children with urolithiasis (Balla et al. 1998).  Similarly, a study conducted 
in CaOx stone patients and healthy control subjects showed an elevated NAG 
excretion in patients with inc eased oxalate, among other urinary parameters (Winter 
et al. 1996).  Cell injury occurs as a result of binding of oxalate or CaOx crystals and 
their entry into the proximal tubular cells thereby provoking inflammation and 
consequently cell damage (Khan and Thamilselvan 2000).  Subsequently, NAG is 
excreted in the urine (Balla et al. 1998).  Evidence from animal (Baggio et al. 1983, 
Khan et al. 1979, Selvam et al. 1992) and cell culture (Hackett et al. 1994, Scheid et al. 
1995) studies suggests that oxygen free radical generation as a result of high oxalate 
concentrations causes damage to the renal tubular cells.  It is also suggested that 
lipid peroxidation, a process whereby free radicals are generated via the degradation 
of polyunsaturated fatty acids plays a role in cell injury (Tungsanga et al. 2005).   
 
There have been contradicting observations in other studies with regard to the 
association of NAG and urinary oxalate excretion in both healthy subjects and stone 
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observed changes in urinary and plasma oxalate after administering different 
increasing doses of sodium oxalate (0-8 mmol) to healthy subjects.  However, no 
changes were observed in NAG levels.   
 
An association of renal stone disease with renal tubular damage and oxidative stress 
has been also been reviewed. Hyperoxaluria-induced oxidative stress has been 
shown in various studies (Khan 1991, Selvam 2002).  Oxidative damage of DNA has 
been reported to be triggered by reactive oxygen species.  A biomarker of oxidative 
DNA damage known as 8-hydroxydeoxyguanosine (8-OHdG), which is excreted in 
the urine upon DNA repair, has been used as an important tool to assess the level of 
cellular oxidative stress (Chiou et al. 2003, Shimoi et al. 2002).  Boonla et al. (2007) 
undertook a study on healthy controls and nephrolithiasis patients i  which they 
measured the urinary NAG activity along with urinary 8-OHdG.  They found a higher 
excretion of both markers in patients than in controls.  Moreover, they observed a 
positive correlation between urinary NAG activity and urinary 8-OHdG.   
 
Since the aforementioned studies on the association between urinary NAG and 
urinary oxalate are inconclusive, further investigation of the effects of high oxalate 
dietary challenges is warranted.  In addition, the different renal handling responses 
which have been reported in previous studies for South African black and white 
subjects provides a further motivation for undertaking a study of this nature. 
 
 
The main objectives of this study are: 
 
 to investigate the effect of oral oxalate loading in the form of rhubarb, spinach 
and Na2Ox on the renal handling of oxalate in healthy black and white male 
South African subjects 
 
 to examine whether oxalate-induced renal injury occurs in the two ethnic 
groups by measuring the activity of urinary NAG, the marker enzyme for 
tubular injury and to assess the physiological mechanisms involved, after 
ingestion of rhubarb, spinach and Na2Ox challenges 
 
 to examine whether any evidence of cellular oxidative stress is apparent 
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urinary oxidative DNA biomarker, 8-OHdG, after ingestion of the Na2Ox 
challenge 
 
 to examine whether a correlation exists between urinary NAG and urinary      
8-OHdG in the two groups after ingestion of the Na2Ox challenge 
 
 to investigate the consequences of the rhubarb challenge on the CaOx 
crystallization properties in the urine of the two groups 
 
 to use the results of the above investigations to test the hypothesis that the 
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Three groups comprising ten black and ten white healthy males aged between 18 
and 30 years were recruited from the student cohort of the University of Cape Town.  
None of the subjects had any history of kidney stones or any metabolic disorder 
which could influence the absorption or excretion of oxalate.  Moreover, supplements 




The three groups of subjects were studied at different periods of time for three 
different protocols comprising rhubarb, spinach and sodium oxalate, respectively.  
The Ethics Committee of the University of Cape Town granted approval for the 
protocols.  Three days prior to the commencement of each protocol, subjects were 
instructed to avoid calcium- and oxalate-rich foods (Appendix CD: Chapter 2).     
 
Protocol 1: Rhurbarb juice 
 
On day 4, that is, three days after the subjects had been on the aforementioned 
calcium and oxalate restricted diets,  subjects consumed a strict standardized diet 
(Table 4.1) controlled in content for calories, fat, protein, carbohydrate, calcium, 
magnesium, sodium, phosphorus and oxalate.  The amounts of the nutrients are 
given in Table 4.2.  Urine fractions were collected during the first 6 h period and 
during the following 18 h period and were pooled to reconstitute the full 24 h 
collection.  During day 5, subjects continued with the standardized diet but coffee 
was replaced with 130 ml of rhubarb juice at breakfast.  Urine fractions were again 
collected over the 6 h period and a further 18 h period.  These were then pooled.   
 
Protocol 2: Spinach   
 
In order to stabilize the baseline urinary oxalate levels, a strict standardized diet, also 
controlled in content for calories, was consumed by the subjects for two days (day 4 
and day 5) prior to ingestion of spinach (day 6).  This is different to protocol 1 in 
which the standardized diet was consumed one day before (day 4) the intake of 
rhubarb juice (day 5).  The composition of the standardized meals is shown in Table 
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day 5 during the first 6 h period and during the following 18 h period.  On day 6, 
subjects continued consumption of the standardized diet but were given 160 g of 
spinach at breakfast and they collected urine fractions (6 h and 18 h). 
 
Protocol 3: Sodium Oxalate 
  
In week 1, a strict standardized diet controlled in content of calories, was provided to 
the subjects for daily consumption for a period of three days (days 4 to 6) (Table 4.1).  
The nutrient content of the standardized diet is shown in Table 4.2.  Analogous to 
protocol 2, the extension of the days for the consumption of the standardized diet 
was done in order to stabilize the baseline urinary oxalate levels.  On day 6, baseline 
urine fractions were collected from each subject over a period of 1 h (discarded), 5 h 
and a further period of 18 h.  During days 7 to 10, subjects consumed calcium and 
oxalate restricted diets as they did initially three days prior to the study. 
 
On days 11, 12 and 13, the standardized diet was continued but in addition the 
subjects each ingested a solution of Na2Ox (10 mmol) (Sigma-Aldrich, Germany, 
99% purity) (Holmes et  al. 2005), in 200 ml water during these days at breakfast.  
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Table 4.1:  Constituents of the strict standardized diet for the three protocols  
 




100 g bread rolls 
10 g margarine 
25 g strawberry jam 
30 g salami pressed beef 
130 ml coffee 
100 g bread rolls 
10 g margarine 
25 g strawberry jam 
30 g salami pressed beef 
130 ml rhubarb juice/ 160 g spinach/
10 mmol sodium oxalate 
Snack:  
11h00  
27 g muesli bar 
150 g banana 
27 g muesli bar 
150 g banana 
Lunch:  
13h00  
60 g turkey ragout 
140 g creamy sauce 
120 g mixed vegetables 
120 g pasta 
60 g turkey ragout 
140 g creamy sauce 
120 g mixed vegetables 
120 g pasta 
Snack:  
17h00 
150 g apple 
175 g low fat fruit yoghurt 
150 g apple 
175 g low fat fruit yoghurt 
Supper:  
19h00  
3 slices of whole wheat bread 
10 g margarine 
30 g cheddar cheese 
17 g cream cheese 
50 g tomato 
150 g apple 
3 slices of whole wheat bread 
10 g margarine 
30 g cheddar cheese 
17 g cream cheese 
50 g tomato 
150 g apple 
Snack:  
22h00  
1 slice of whole wheat bread 
5 g margarine 
17 g cream cheese 
50 g tomato 
1 slice of whole wheat bread 
5 g margarine 
17 g cream cheese 
50 g tomato 
Beverages: (2 l/day): 
700 ml caledon water until 13h00 
600 ml caledon water until 19h00 
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Table 4.2:  Nutrient content of the standardized diet for the three protocols 
  
VARIABLE AMOUNT 
Energy (kJ) 7700 
Total protein (g) 60.4 
Total fat (g) 56.8 
Carbohydrate (g) 193 
Calcium (mg) 827 
Magnesium (mg) 432 
Phosphorus (mg) 1320 
Citric acid (mg) 876 





Fractional urine samples were analyzed as previously described in Chapter Two 
(page 51).  However, in protocol 1, the reconstituted 24 h samples were also 
analyzed. 
 
Urinary NAG and 8-OHdG 
 
In all three protocols, the NAG activity was measured immediately in the baseline 
and urine fractions.  Urinary 8-OHdG was measured only in the urine samples (5 h 
fraction) from protocol 3.  Samples were stored at -80°C before analysis.  Both 
markers (NAG and 8-OHdG) were measured only in those samples where a 
significant increase in urinary oxalate excretion was observed.   
 
Determination of Urinary NAG  
 
A commercially available NAG test kit was used to determine the urinary NAG 
excretion (Roche, Germany).  The method involved hydrolysis of a substrate,            
3-cresolsulfonphthaleinyl-N-acetyl-β-D-glucosaminide by NAG, with the release of     
3-cresolsulfonphthalein, which was measured photometrically at 580 nm.  Three 
bottles were provided with the kit.  Bottle 1 was a buffer consisting of citric acid and 
potassium citrate, bottle 2 contained a lyophilized substrate consisting of sodium      
3-cresolsulfonphthaleinyl--N-acetyl-β-D-glucosaminide and borax and bottle 3 
consisted of a stop reagent, sodium carbonate.  The first step of the assay required 
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I. Preparation of Solutions  
 
The contents of bottle 1 were dissolved in 55 ml of redistilled water to make up a 
buffer solution. The substrate solution was prepared by dissolving the contents of 
bottle 2 in 55 ml of the buffer solution.  The contents of bottle 3 were dissolved in 110 
ml of redistilled water to make up a stop reagent solution. 
 
II. Assay Procedure 
 
The substrate solution (1 ml) was pipetted into test tubes and incubated at 37°C for 5 
minutes.  Urine samples (0.05 ml) were then added and the mixture was vortexed 
and incubated for 1 h at 37°C, followed by the addition of a stop reagent (2 ml).  The 
mixture was vortexed and then allowed to stand for 10 minutes.  The reagent blank 
was prepared in the same way with the elimination of a urine sample.  The 
absorbance of the each sample solution was measured at 580 nm against the blank 
and the NAG activity (U/l) was calculated using the following equation (Yakata et al. 
1983):  
 
                                                          1000 x 3.05            
                                                   40.67 x 1 x 0.05 x 60 
 




Determination of Urinary 8-OHdG 
 
Urinary 8-OHdG was determined by an enzyme-linked immunosorbent assay 
(ELISA) kit (New 8-OHdG Check, JaICA, Japan).  The kit consisted of a microtiter 
plate with wells which were precoated with 8-OHdG, a primary antibody                 
(anti 8-OHdG, a primary antibody solution (phosphate buffered saline), a secondary 
antibody (HRP-conjugated anti mouse antibody) and a secondary antibody solution 
(phosphate buffered saline).  In addition, the kit included a chromatic solution 
(3,3’,5,5’-tetramethylbenzidine, a diluting solution (hydrogen peroxide/citrate-
phosphate buffered saline), a washing solution (5x concentrated phosphate buffered 
saline), a reaction terminating solution (1M phosphoric acid) and standard 8-OHdG 
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I. Principles of the Procedure 
 
 Subsequent to addition of the primary antibody into the microtiter plate, the antibody 
reacts competitively with the 8-OHdG bound on the plate and the 8-OHdG in urine 
sample.  The bound antibodies in 8-OHdG in the sample are washed away from the 
antibodies that have bound to the 8-OHdG coated on the plate.  Addition of the 
secondary antibody to the plate leads to the binding of the antibody to the 
monoclonal antibody which is bound to the 8-OHdG coated on the plate.  Washing of 
the plate removes the unbound HRP-conjugated secondary antibody.  The substrate 
solution is then added which results in colour development in proportion to the 
amount of the bound anti 8-OHdG antibody in the plate.  Finally, phosphoric acid is 
added to terminate the reaction followed by measurement of the absorbance at 450 
nm. 
 
II. Assay Procedure 
 
To each 50 μl of urine sample per well, 50 μl of a reconstituted primary antibody was 
added and incubated at 37°C for 1 h.  Subsequent to discarding the mixture, the 
wells were washed with 250 μl of the washing solution.  100 μl of the secondary 
antibody was then added to the wells and incubated at 37°C for another hour.  Wells 
were washed again as previously described at the end of the incubation period.  After 
washing, 100 μl of the substrate solution was added to each well and incubated in 
the dark at room temperature for 15 minutes and then finally 100 μl of the reaction 
terminating solution was added and the absorbance was measured at 450 nm using 




Crystallization experiments were performed in urines obtained from protocol 1 only 
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The results for the baseline 24 h urinary excretion of various parameters for protocol 
1 before the ingestion of rhubarb juice are presented in Table 4.3.  Urinary citrate 
excretion was significantly higher in black subjects compared to white subjects while, 
on the other hand, higher urinary calcium, creatinine and phosphate levels were 
observed in the latter group relative to the former.  Furthermore, white subjects had 
higher RS of both brushite and CaOx and lower MSL.  These baseline results are 
consistent with those obtained in the other studies described in the previous 
chapters, with the exception of creatinine which was not previously significantly 
different in the two groups.  No additional significantly different urinary variables were 
observed between the two race groups. 
 
After the ingestion of rhubarb juice, no statistically significant changes were observed 
in black subjects (Table 4.4).  However, in white subjects rhubarb juice provoked an 
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Blacks Whites p 
 
pH 6.11 ± 0.13 6.06 ± 0.10 0.7650 
Volume (ml/24h) 2018 ± 135 1861 ± 211 0.5408 
Citrate (mmol/24h) 3.28 ± 0.23 1.84 ± 0.26 *0.0007 
Oxalate (mmol/24h) 0.48 ± 0.03 0.45 ± 0.02 0.5521 
Calcium (mmol/24h) 1.86 ± 0.55 4.11 ± 0.49 *0.0069 
Magnesium (mmol/24h) 2.23 ± 0.37 2.96 ± 0.29 0.1415 
Sodium (mmol/24h) 172 ± 51.1 132 ± 37.8 0.5427 
Potassium (mmol/24h) 42.5 ± 9.10 53.4 ± 8.43 0.4159 
Urate (mmol/24h) 2.87 ± 0.36 3.63 ± 0.27 0.1115 
Creatinine (mmol/24h) 12.8 ± 1.09 16.4 ± 0.81 *0.0167 
Phosphate (mmol/24h) 18.2 ± 1.98 27.8 ± 1.97 *0.0029 
Chloride (mmol/24h) 189 ± 27.6 185 ± 18.6 0.9058 
Tiselius risk index 327 ± 53.8 418 ± 57.6 0.2632 
RS Brushite 0.23 ± 0.10 0.88 ± 0.14 *0.0011 
RS CaOx 2.30 ± 0.47 8.60 ± 1.35 *0.0003 
RS Uric Acid 1.04 ± 0.24 1.59 ± 0.32 0.1848 
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Table 4.4:  Mean 24 h urine variables ± SE in black and white subjects after ingestion 
of rhubarb juice 

























pH 6.11±0.13 6.29±0.10 0.2943 6.06±0.10 6.62±0.11 *0.0016 *0.0440 
Volume (ml/24h) 2018±135 2167±154 0.3047 1862±211 2285±196 0.1585 0.6421 
Citrate (mmol/24h) 3.28±0.23 2.83±0.42 0.3188 1.84±0.26 2.00±0.34 0.7163 0.1401 
Oxalate (mmol/24h) 0.48±0.03 0.50±0.06 0.7303 0.45±0.02 0.51±0.05 0.3414 0.8997 
Calcium (mmol/24h) 1.86±0.55 1.26±0.24 0.3292 4.11±0.49 3.71±0.58 0.5995 *0.0011 
Magnesium (mmol/24h) 2.23±0.37 2.30±0.26 0.9965 2.96±0.29 3.11±0.44 0.7666 0.1242 
Sodium (mmol/24h) 172±51.1 116±20.7 0.2525 132±37.8 164±35.4 0.5517 0.2569 
Potassium (mmol/24h) 42.5±9.10 35.3±7.66 0.6720 53.4±8.43 59.5±9.02 0.6290 †0.0564 
Urate (mmol/24h) 2.87±0.36 3.39±0.23 0.2829 3.63±0.27 4.35±0.31 0.0983 *0.0221 
Creatinine (mmol/24h) 12.8±1.09 13.4±0.90 0.6451 16.4±0.81 20.7±3.93 0.3005 0.0855 
Phosphate (mmol/24h) 18.2±1.98 17.0±2.02 0.8222 27.8±1.97 28.9±3.32 0.7655 *0.0066 
Chloride (mmol/24h) 189±27.6 173±14.1 0.5710 185±18.6 226±27.7 0.2417 0.1056 
Tiselius risk index 327±53.8 261±36.1 0.3231 418±57.6 304±47.0 0.1475 0.4783 
RS Brushite 0.23±0.10 0.17±0.07 0.6097 0.88±0.14 1.24±0.24 0.2124 *0.0005 
RS CaOx 2.30±0.47 1.91±0.46 0.5575 8.60±1.35 5.50±1.50 0.1411 *0.0346 
RS Uric Acid 1.04±0.24 0.86±0.28 0.6136 1.59±0.32 0.49±0.10 *0.0043 0.2328 
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Urinary NAG 
 
The values for the mean urinary NAG activity ± SE for the two groups are shown in 
Table 4.5.  It is noted that, in general, values in white subjects were greater, albeit 
that these were not statistically significant.  The NAG activity did not change within 
each group.  
 
Table 4.5:  Mean urinary NAG activity (SE) [U/l] in black and white subjects before 








 NAG  (SE) p NAG  (SE) p p 
Before 0.25 (0.04)  0.53 (0.18)  0.1433 
After (6 h) 0.25 (0.05) 1.0000 0.58 (0.15) 0.9138 †0.0548 
After (18 h) 0.25 (0.07) 1.0000 0.33 (0.07) 0.2868 0.4478 


































14C-Oxalate Crystal Deposition 
 
Figure 4.1 shows the rate of CaOx deposition obtained from the urines of black and 
white subjects before and after the ingestion of rhubarb juice.  The gradients for each 
curve (top right-hand corner) reveal an increase in CaOx deposition in both groups, 
with whites having a higher percentage of precipitated 14C-oxalate compared to 
blacks following a rhubarb juice load. 
 
 
y = 0.1x + 4.308
y = 0.1892x + 1.445
y = 0.0653x + 4

































     
 Figure 4.1: Percentage precipitated 14C-oxalate pre- and post-rhubarb juice 
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Crystal Aggregation 
 
Table 4.6 shows the mean percentages for the inhibition of crystal aggregation in the 
two groups and the corresponding plot of absorbance versus time before and after 
the ingestion of rhubarb juice (Figure 4.2).  No statistically significant changes were 
observed in either group.   
 
Table 4.6: Mean percentage inhibition of aggregation (%Ia) in black and white 
subjects before and after a rhubarb juice load 
 
Variables Blacks Whites Blacks 
 vs  
Whites 
% Ia (SE)  p % Ia (SE) p p 
Before  81.3 (6.32)  74.5 (6.94)  0.8002 








































Figure 4.2: Plot of absorbance versus time pre- and post-rhubarb juice load in 
urines of black and white subjects. The time at which stirring was stopped is 
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Summary of Urine Chemistry and Crystalluria Properties After Rhubarb Juice Load 
 
 Blacks Whites 
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PROTOCOL 2 
 
6 h Fraction 
 
Table 4.7 shows the 6 h urinary excretion of various variables for protocol 2 in black 
and white subjects before the ingestion of spinach. The urinary oxalate and 
magnesium excretion were higher in black subjects than in white subjects.  None of 
the other variables were significantly different. 
 
Spinach provoked an increase in urinary pH in blacks 6 h after ingestion as shown in 
Table 4.8.  In addition, citrate excretion was decreased in this group.  In whites, 
spinach augmented the excretion of urinary urate only.   
 





Blacks Whites p 
 
pH 6.30 ± 0.12 6.22 ± 0.13 0.6873 
Volume (ml/6h) 802 ± 76.9 848 ± 55.6 0.7008 
Citrate (mmol/6h) 1.45 ± 0.16 0.97 ± 0.20  0.0924 
Oxalate (mmol/6h) 0.13 ± 0.01 0.08 ± 0.01 *0.0226 
Calcium (mmol/6h) 0.78 ± 0.12 0.94 ± 0.35 0.6007 
Magnesium (mmol/6h) 0.69 ± 0.12 0.24 ± 0.06      *0.0263 
Sodium (mmol/6h) 25.1 ± 12.4 19.9 ± 6.95 0.7836 
Potassium (mmol/6h) 5.61 ± 2.17 4.38 ± 1.53 0.7152 
Urate (mmol/6h) 0.97 ± 0.07 0.82 ± 0.07 0.2207 
Creatinine (mmol/6h) 4.56 ± 0.32 4.36 ± 0.25 0.6865 
Phosphate (mmol/6h) 4.38 ± 0.52 2.88 ± 0.36 0.0802 
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Table 4.8: Mean 6 h urinary variables ± SE in black and white subjects after ingestion 
of spinach 
*statistically significant; †approaching statistical significance 
 
18 h Fraction 
 
There was a significant difference in the mean 18 h baseline urine volume between 
the two groups, with blacks having lower levels compared to whites (Table 4.9).  No 
other differences were observed between the two groups. 
 
After the ingestion of spinach, there was a rise in citrate and oxalate excretion in 
black subjects (Table 4.10).  However, no significant changes were noted in the 












Baseline Post-Ox p Baseline Post-Ox p p 
Post-Ox 
pH 6.30±0.12 6.84±0.18 *0.0237 6.22±0.13 6.75±0.22 0.0727 0.7676 
Volume (ml/6h) 802±76.9 705±101 0.4538 848±55.6 856±22.7 0.8974 0.3195 
Citrate (mmol/6h) 1.45±0.16 0.72±0.18 *0.0077 0.97±0.20 1.08±0.25 0.7250 0.2677 
Oxalate (mmol/6h) 0.13±0.01 0.10±0.01 0.0875 0.08±0.01 0.14±0.04 0.2411 0.3042 
Calcium (mmol/6h) 0.78±0.12 0.58±0.10 0.2310 0.94±0.35 0.67±0.22 0.5395 0.6725 
Magnesium (mmol/6h) 0.69±0.12 0.58±0.12 0.5366 0.24±0.06 0.20±0.03 0.6056 †0.0552 
Sodium (mmol/6h) 25.1±12.4 32.9±6.78 0.5884 19.9±6.95 60.7±20.9 0.1014 0.1314 
Potassium (mmol/6h) 5.61±2.17 6.98±2.54 0.6875 4.38±1.53 10.1±4.12 0.2284 0.5080 
Urate (mmol/6h) 0.97±0.07 1.13±0.11 0.2373 0.82±0.07 1.66±0.29 *0.0243 †0.0571 
Creatinine (mmol/6h) 4.56±0.32 4.73±0.31 0.7043 4.36±0.25 4.38±0.60 0.9761 0.5707 
Phosphate (mmol/6h) 4.38±0.52 4.51±0.52 0.8624 2.88±0.36 4.84±0.99 0.1007 0.7496 
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Table 4.9: Mean baseline 18 h urinary variables ± SE in black and white subjects 





Blacks Whites p 
 
pH 6.06 ± 0.10 6.11 ± 0.10 0.8071 
Volume (ml/18h) 990 ± 125 1710 ± 253 *0.0069 
Citrate (mmol/18h) 1.23 ± 0.30 1.99 ± 0.36 0.5056 
Oxalate (mmol/18h) 0.13 ± 0.02 0.19 ± 0.05 0.2342 
Calcium (mmol/18h) 1.30 ± 0.35 1.87 ± 0.51 0.3438 
Magnesium (mmol/18h) 1.18 ± 0.29 0.81 ± 0.42 0.4421 
Sodium (mmol/18h) 63.7 ± 17.0 32.9 ± 7.26 0.3827 
Potassium (mmol/18h) 16.1 ± 4.81 11.3 ± 2.82 0.4908 
Urate (mmol/18h) 1.62 ± 0.22 1.53 ± 0.52 0.9298 
Creatinine (mmol/18h) 8.98 ± 0.97 11.8 ± 2.96 0.2285 
Phosphate (mmol/18h) 17.3 ± 2.46 21.0 ± 3.15 0.3059 
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Table 4.10: Mean 18 h urinary variables ± SE in black and white subjects after 





At 6 h, following spinach load, the urinary excretion of oxalate did not change in both 
groups.  NAG was therefore not measured on those samples as shown in Table 4.11. 
However, at 18 h oxalate excretion increased in the majority of black subjects and in 
few white subjects but NAG did not change significantly in either group.  Unlike in the 
rhubarb study, the mean NAG levels in white subjects were lower.  
 
Table 4.11:  Mean urinary NAG activity (SE) [U/l] in black and white subjects before 
and after ingestion of spinach 
 
 Blacks (n=9) Whites (n=3) Blacks vs Whites 
 NAG  (SE) p NAG  (SE) p p 
Before 1.40 (0.46)  0.61 (0.28)  0.3445 
After (6 h) - - - - - 
After (18 h) 0.71 (0.16) 0.1604 0.33 (0.15) 0.4261 0.2295 
 














pH 6.06±0.10 6.16±0.11 0.5371 6.11±0.10 6.30±0.11 0.2102 0.4690 
Volume (ml/18h) 990±125 1165±138 0.3584 1710±253 1444±267 0.4177 0.3180 
Citrate (mmol/18h) 1.23±0.30 2.06±0.21 *0.0358 1.99±0.36 2.21±0.57 0.4422 0.7595 
Oxalate (mmol/18h) 0.13±0.02 0.24±0.02 *0.0005 0.19±0.05 0.27±0.04 0.1043 0.4264 
Calcium (mmol/18h) 1.30±0.35 1.43±0.31 0.7761 1.87±0.51 1.78±0.32 0.8777 0.4888 
Magnesium (mmol/18h) 1.18±0.29 0.97±0.20 0.5645 0.81±0.42 0.46±0.10 0.4172 0.1070 
Sodium (mmol/18h) 63.7±17.0 30.0±6.23 0.0792 32.9±7.26 71.0±27.5 0.3314 0.0695 
Potassium (mmol/18h) 16.1±4.81 12.0±2.93 0.4745 11.3±2.82 18.0±5.35 0.2733 0.3025 
Urate (mmol/18h) 1.62±0.22 1.37±0.12 0.3575 1.53±0.52 1.58±0.23 1.0000 0.3983 
Creatinine (mmol/18h) 8.98±0.97 8.51±0.96 0.7418 11.8±2.96 9.02±1.59 0.3837 0.7814 
Phosphate (mmol/18h) 17.3±2.46 14.4±1.53 0.3472 21.0±3.15 16.1±2.63 0.1919 0.5621 
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Summary of Urine Chemistry After Spinach Load 
 
 Blacks Whites 
 
Fractional (6 h) 
      




        Ur 
 
Fractional (18 h)  
      
               Cit,            Ox 
 
                   
                                
 
NAG (18 h) 
 
                   
 
    




































5 h Fraction 
 
The mean baseline excretions of the various urinary variables at 5 h before the 
administration of Na2Ox are presented in Table 4.12. Urinary pH and citrate were 
higher in blacks as well as the urine volume.   
 
In Table 4.13, urinary concentrations measured at baseline and 5 h after 
administration of Na2Ox are compared.  It is seen that urinary pH, citrate and 
potassium decreased significantly in blacks.  Of note is the increase in oxalate 
excretion in this group which approached statistical significance.  No significant 
changes were observed in whites.   
 





Blacks Whites p 
 
pH 7.06 ± 0.13 6.68 ± 0.11 *0.0400 
Volume (ml/5h) 840 ± 68.3 616 ± 68.0 *0.0319 
Citrate (mmol/5h) 1.80 ± 0.12 0.94 ± 0.15 *0.0004 
Oxalate (mmol/5h) 0.08 ± 0.01 0.06 ± 0.01 0.0954 
Calcium (mmol/5h) 0.73 ± 0.12 0.84 ± 0.09 0.4478 
Magnesium (mmol/5h) 0.57 ± 0.07 0.60 ± 0.05 0.6707 
Sodium (mmol/5h) 9.43 ± 0.81 13.4 ± 3.85 0.3238 
Potassium (mmol/5h) 4.54 ± 0.48 5.55 ± 1.81 0.5948 
Urate (mmol/5h) 0.84 ± 0.08 0.96 ± 0.11 0.5403 
Creatinine (mmol/5h) 4.54 ± 0.62 4.40 ± 0.69 0.8818 
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Table 4.13: Mean 5 h urinary variables ± SE in black and white subjects after 
ingestion of sodium oxalate  
 *statistically significant; †approaching statistical significance 
 
18 h Fraction 
 
Table 4.14 shows the urinary excretions of the parameters 18 h before the ingestion 
of Na2Ox.  The white subjects had a significantly higher urinary excretion of sodium 
compared to their black counterparts.  No further observations were made. 
 
In Table 4.15, uri ary concentrations measured 18 h after administration of Na2Ox 
are compared with the control values.  Urinary oxalate increased significantly in 


















pH 7.06±0.13 6.41±0.13 *0.0024 6.68±0.11 6.50±0.44 0.6916 0.6585 
Volume (ml/5h) 840±68.3 645±85.7 0.0913 616±68.0 742±95.1 0.2952 0.8655 
Citrate (mmol/5h) 1.80±0.12 1.07±0.21 *0.0088 0.94±0.15 1.39±0.26 0.1596 0.8065 
Oxalate (mmol/5h) 0.08±0.01 0.17±0.05 †0.0528 0.06±0.01 0.08±0.01 0.1039 0.1475 
Calcium (mmol/5h) 0.73±0.12 0.63±0.09 0.5180 0.84±0.09 0.68±0.08 0.2082 0.4560 
Magnesium (mmol/5h) 0.57±0.07 0.45±0.07 0.2597 0.60±0.05 0.50±0.05 0.1755 0.2333 
Sodium (mmol/5h) 9.43±0.81 7.63±0.84 0.1430 13.4±3.85 22.5±6.87 0.2641 0.5985 
Potassium (mmol/5h) 4.54±0.48 2.35±0.41 *0.0027 5.55±1.81 6.08±1.75 0.8371 0.9467 
Urate (mmol/5h) 0.84±0.08 1.27±0.29 0.3367 0.96±0.11 0.77±0.07 0.2775 0.0832 
Creatinine (mmol/5h) 4.54±0.62 4.62±0.91 0.9425 4.40±0.69 2.79±0.33 0.0605 *0.0100 
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Blacks Whites p 
 
pH 6.21 ± 0.08 6.29 ± 0.14 0.8418 
Volume (ml/18h) 1576± 214 1628 ± 214 0.4565 
Citrate (mmol/18h) 2.93 ± 0.49 2.78 ± 0.35 0.3660 
Oxalate (mmol/18h) 0.14 ± 0.01 0.20 ± 0.04 0.0667 
Calcium (mmol/18h) 1.79 ± 0.29 2.70 ± 0.30 0.6770 
Magnesium (mmol/18h) 1.82 ± 0.32 2.34 ± 0.27 0.6066 
Sodium (mmol/18h) 39.1 ± 12.9 48.9 ± 12.2 *0.0456 
Potassium (mmol/18h) 17.0 ± 5.92 17.5 ± 3.68  0.9522 
Urate (mmol/18h) 1.38 ± 0.24 2.40 ± 0.24 0.1852 
Creatinine (mmol/18h) 7.12 ± 0.96 12.1 ± 1.36 0.0926 
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Table 4.15: Mean 18 h urinary variables in black and white subjects after ingestion of 
sodium oxalate  
*statistically significant; †approaching statistical significance 
 
Urinary NAG  
 
The mean urinary NAG levels before and after (5 h and 18 h) the ingestion of Na2Ox 
are given in Table 4.16. The NAG activity did not change within each group at 5 h or 
18 h relative to baseline.  However, whites had a significantly higher activity than 
blacks when making an inter-group comparison. 
 
Table 4.16:  Mean urinary NAG activity (SE) [U/l] in black and white subjects before 
and after ingestion of sodium oxalate 
 
 Blacks (n=5) Whites (n=4) Blacks vs Whites 
 NAG  (SE) p NAG  (SE) p p 
Before 0.42 (0.19)  0.61 (0.10)  0.0987 
After (5 h) 0.31 (0.18) 0.8003 0.78 (0.22) 0.6508 *0.0403 










Baseline Post-Ox p Baseline Post-Ox p p 
Post-Ox 
pH 6.21±0.08 5.90±0.15 0.0826 6.29±0.14 6.18±0.28 0.7438 0.3720 
Volume (ml/18h) 1576±214 1267±198 0.3033 1628±214 1676±242 0.8833 0.2065 
Citrate (mmol/18h) 2.93±0.49 3.45±0.50 0.4638 2.78±0.35 2.67±0.44 0.8531 0.2603 
Oxalate (mmol/18h) 0.14±0.01 0.35±0.04 *0.0001 0.20±0.04 0.24±0.03 0.3533 †0.0565 
Calcium (mmol/18h) 1.79±0.29 1.45±0.30 0.4322 2.70±0.30 2.85±0.43 0.7791 *0.0156 
Magnesium (mmol/18h) 1.82±0.32 1.40±0.14 0.2444 2.34±0.27 2.31±0.40 0.9606 *0.0446 
Sodium (mmol/18h) 39.1±12.9 28.8±7.28 0.4958 48.9±12.2 95.8±27.3 0.1539 *0.0295 
Potassium (mmol/18h) 17.0±5.92 14.1±4.71 0.7067 17.5±3.68 36.6±12.1 0.1492 0.1014 
Urate (mmol/18h) 1.33±0.24 1.15±0.11 0.1716 2.40±0.24 2.55±0.26 0.7844 0.0913 
Creatinine (mmol/18h) 7.12±0.96 8.45±1.22 0.4197 12.1±1.36 14.9±0.97 0.1305 *0.0009 















Table 4.17 shows of the mean urinary 8-OHdG levels before and 5 h after the 
ingestion of Na2Ox.  No statistical differences were observed in the black group or in 
the white group.  However, it is noted that the value after 5 h in the black group is 




Table 4.17:  Mean urinary 8-OHdG levels (SE) [ng/ml] in black and white subjects 
before and after ingestion of sodium oxalate 
 
 Blacks (n=5) Whites (n=4) Blacks vs Whites 
 8-OHdG  (SE) p 8-OHdG  (SE) p p 
Before 7.42 (2.11)  6.98 (2.33)  0.9122 
After (5 h) 9.18 (3.03) 0.7434 5.60 (1.09) 0.8989 0.0605 
 
Correlation between NAG and 8-OHdG 
 
A bivariate correlation test was performed as shown in Figure 4.3 to test whether 
there is a correlation between urinary NAG and urinary 8-OHdG levels after the 
ingestion of Na2Ox.  This test was performed using the urinary data obtained from 
both groups.  There was no correlation between the two markers as indicated by the 



















           Figure 4.3: Correlation analysis of NAG and 8-OHdG 
 













r = 0.0469 
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Summary of Urine Chemistry After Sodium Oxalate Load 
 
 Blacks Whites 
 
Fractional (5 h) 
     pH,            Cit,            Ox,       
 
    K 
 
         
 
Fractional (18 h)  
      
                     Ox 
 
                   
                                
 










    





































As stated in the introduction, the main objective for the three studies presented in this 
chapter was to measure the response to dietary oxalate challenges in black and 
white South African subjects and to assess the association, if any, of the biomarkers 
for renal tubular damage (NAG) and cellular oxidative stress (8-OHdG) with urinary 
oxalate.  Since previous studies have identified a link between increased urinary 
oxalate and NAG excretions after an oral oxalate load and others did not, the present 
study was imperative, especially in the context of the perceived differences in the 
renal handling of oxalate in South Africa’s black and white population groups.   
 
In protocol 1, rhubarb juice did not have any significant effect on oxalate excretion 
within either group.  However, urinary pH increased and RS of uric acid decreased in 
white subjects.  The rise in urinary pH is consistent with the observed decrease in RS 
of uric acid as a low pH poses a risk of uric acid supersaturation.  Of interest is the 
higher urinary excretion of calcium in the white group compared to the black group 
following ingestion of rhubarb juice.  The unchanged levels of urinary oxalate 
observed in the former group can be ascribed to the complexation of oxalate with 
calcium thereby limiting the oxalate available for absorption in the intestine (Sutton et 
al. 1994, Messa et al. 1997, Seiner et al. 2003).   However, neither urinary oxalate nor 
calcium excretion changed in black subjects was observed following a rhubarb juice 
load, this result is inconsistent with Lewandowski et al.’s findings (2001) whereby 
they noted an increase in oxalate excretion after an oxalate load this group.  The 
oxalate content of rhubarb juice used in the present study was therefore later 
analysed routinely by a high-performance liquid chromatography (HPLC) method with 
a view to elucidate the unchanged urinary oxalate levels.  The results indicated that 
the rhubarb juice contained a total of 374.4 mg of oxalate /100 ml of rhubarb juice, of 
which 150.4 mg/100ml is soluble, which was indeed not sufficient to cause any 
significant increase in the urinary oxalate excretion.   
 
Rhubarb juice did not change the urinary NAG excretion in either group.  This can be 
attributed to the unchanged urinary oxalate concentrations in both groups.  However, 
the higher baseline levels in whites, which were approaching statistical significance is 
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The crystalluria properties of the urines from the two groups revealed lower levels of 
CaOx deposition in black subjects in conjunction with lower urinary NAG activities as 
well as the RS of CaOx.  The white subjects, on the other hand, had a higher 
deposition rate which was supported by the higher urinary NAG levels in this group.   
However, the increased MSL in the white group subsequent to rhubarb juice load 
implies increased hindrance of CaOx crystallization, which is inconsistent with the 
higher RS of CaOx and its deposition observed in this group.  Regardless of this 
discrepancy, it seems plausible to conclude that the oxalate load had an adverse 
effect in white subjects, with regard to all the aforementioned risk factors except for 
the MSL.   
 
Subsequent to the ingestion of spinach in protocol 2, the urinary citrate excretion in 
black subjects decreased at 6 h but this did not influence any rise in urinary oxalate 
excretion.  This finding is not in agreement with the reported results of oxalate 
excretion peaking between 4-6 hours after ingestion of an oxalate-rich meal (Tiselius 
and Almgard 1977).  One possible explanation for this anomaly is the presence of 
calcium in the standardized meals which the subjects consumed, even though it was 
present in negligible amount.  Moreover, the calcium in spinach could not have had 
an effect due to its lack of bioavailability (Brinkley et al. 1981). Similar to rhubarb juice 
in protocol 1, the oxalate content was measured routinely at a later stage using a 
HPLC method.  The results revealed that the spinach used in the present study 
contained a total of 818.4 mg of oxalate/100 g of spinach of which 175.3 mg /100g is 
soluble.  It is therefore surp ising that the urinary oxalate did not increase in either 
group as the oxalate content in spinach was sufficient to trigger a rise. 
 
At 18 h, the urinary oxalate excretion was augmented in the black group.  The 
delayed response in the excretion of urinary oxalate is interesting and it could mean 
that oxalate absorption occurred in the large intestine rather than in the small 
intestine in this group. Lewandowski et  al. (2001) observed higher urinary oxalate 
levels in black South African subjects compared to their white compatriots at 24 h 
after an oxalate-rich snack which included spinach.  In the present study, spinach did 
not have any significant effect on the urinary oxalate excretion in white subjects.  The 
metabolic pathway for oxalate production in the liver leading to CaOx stone formation 
and the enzymes involved is depicted in Scheme 1.  The conversion of glycolate to 
glyoxylate is catalyzed by glycolate oxidase (GO), also known as glycolic acid 
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dehydrogenase (LDH).  It seems therefore logical to suggest that, apart from the 
increased absorption of oxalate obtained from spinach, which resulted in the elevated 
excretion in the urine in black subjects and not in white subjects, there is also a 
possibility of a higher activity of the aforementioned enzymes in the former group 
which could have promoted the endogenous synthesis of oxalate. 
 
The concomitant increase in citrate levels with oxalate subsequent to ingestion of 
spinach in black subjects is surprising.  Since high levels of citrate normally affect 
oxalate excretion by reducing its absorption and thus its excretion, the contradictory 
effect observed in the black group is not understood.  The NAG activity was not 
significantly different in both groups, in spite of the increased oxalate concentrations 





Scheme 1: The metabolic pathway of glycolate and enzymes involved leading 
to oxalate in the human liver (Behnam et al. 2006) 
 
Sodium oxalate, administered in protocol 3 provoked an increase in urinary oxalate in 
black subjects.  This finding indicates a higher risk of CaOx crystallization in this 
group.  The white subjects did not respond to the sodium oxalate load as opposed to 
what was expected, which is also contrary to what was hypothesized earlier.  In fact, 
at 18 h, lower oxalate levels were observed in this group compared to their black 
counterparts.  On the other hand, statistically significant changes in urinary NAG 
within each group were not apparent subsequent to sodium oxalate ingestion.  
glycolate 
    O2               H2O2 
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 GR 
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However, the white group had a higher mean activity in comparison with the black 
group, which is contradictory to the lower oxalate levels noted in the former group.  
The failure of sodium oxalate to raise NAG excretion, though, is consistent with the 
observations from other studies, where no differences were found in NAG levels after 
sodium oxalate intake (Holmes et al. 2005, Knight et al. 2007).  In addition, sodium 
oxalate had no significant effect on the urinary excretion of 8-OHdG in the two 
groups.  Moreover, there was no correlation between these two markers, contrary to 
the observations by Boonla et al. (2007).  This can be attributed to the sample size in 
which the correlation test was performed.  A larger size could provide a conclusive 
estimation. 
 
In retrospect, the two oxalate-rich foods, rhubarb juice and spinach did not induce 
any changes to the urinary NAG excretion within the black and the white groups.  
Similarly, sodium oxalate triggered no response in both groups.  It was hypothesized 
earlier that exposure to high concentrations of oxalate would induce cell injury in 
white subjects and this would trigger the release of NAG.  The reason for this 
expectation was that, aggravated dietary oxalate levels would provoke an increase in 
the urinary excretion oxalate since, as mentioned before, studies have demonstrated 
that this group is more prone to CaOx kidney stone formation than the black group.  It 
is intriguing that in all three protocols the white subjects did not respond as expected 
to the oxalate challenges, as no statistically significant changes were observed in the 
urinary excretion of oxalate, either.  Khan and Thamilselvan (2000) posited that the 
mechanism by which NAG is excreted is that, cell injury, as a result of binding of 
oxalate and/or calcium oxalate crystals into the renal tubular cells and their entry 
thereof, induces the excretion of NAG in the urine via the tubular lumen, which 
manifests damage to the cells.  The failure for the two groups to present elevated 
NAG levels implies that cell injury did not occur. 
 
Oxidative damage to DNA due to attack by reactive oxygen species has been 
implicated in high urinary levels of 8-OHdG observed in stone formers (Boonla et al. 
2007).  Hyperoxaluria may induce oxidative stress and elevate 8-OHdG.  In the 
present study neither group showed a correlation between 8-OHdG and urinary 
oxalate after an acute sodium oxalate load, possibly implying absence of oxidative 
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In view of the results presented in this chapter, it can be concluded that even though 
the two South African race groups were subjected to high oxalate loads and elicited 
different handling responses, the hypothesis put forward initially that the white 
subjects will adversely demonstrate cell injury and oxidative stress remains 
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5.1   Introduction 
 
Oxalate can be synthesized in animal models from endogenous metabolism of 
various precursors including glycolate, glyoxylate and hydroxypyruvate (Ogawa et al. 
2000a).  In plants, glycolate is generated from phosphoglycolate.  The diffusion of 
glycolate across the chloroplast envelope as it moves into the peroxisomes, 
facilitates its metabolism by glycolate oxidase (GO) to glyoxylate (Ogawa et  al. 
2000b).  The metabolic origin of glycolate in the body is not clearly understood but it 
is believed that a larger portion of it is endogeneously synthesized.  It is suggested 
that the metabolism of glyoxylate from glycolate to urinary oxalate occurs in the 
hepatocytes in the presence of enzymes (Ogawa 2000b).  The ingested or 
synthesized glycolate is either metabolized to glyoxylate by GO in the liver or 
excreted in the urine (Nakai and Ichiyama 2000).    
 
Taurine, a β-amino acid is one of the most abundant amino acids present in tissues.  
It is synthesized from dietary cysteine and methionine and is present in certain 
foodstuffs such as dairy, meat, eggs and poultry (Kerai et al. 2001).  Red Bull, a well 
known energy drink is also a rich source of taurine (Kim 2003).  It has been shown 
that taurine has a beneficial effect as an antioxidant in biological systems due to its 
ability to scavenge reactive oxygen species, and to reduce the peroxidation of 
unsaturated membrane lipids (Nandhini et al. 2005).  The kidney is one of the most 
important organs involved in taurine regulation and there is considerable evidence to 
demonstrate that the kidney egulates the whole body homeostasis of taurine (Rozen 
et al. 1979).  In the kidney, there is a high affinity, low capacity, Na+-dependent, β-
amino acid specific transport system, which is responsible for the re-absorption of 
taurine across the renal tubular brush border membrane (Rozen et  al. 1979).  The 
effect of taurine on urinary oxalate excretion after intravenous loading with glycolic 
acid in rats has been investigated (Ogawa et al. 1999).  The results from this study 
showed a significant decrease of oxalate synthesis from glycolate after loading with 
glycolate to taurine-treated rats. Other studies have also shown that an oral 
administration of taurine reduces urinary excretion of glycolate (Talwar et al. 1985).  
Bile acids which are not absorbed in the body may react with intestinal calcium which 
may lead to the formation of soaps.  These limit oxalate binding with free calcium and 
the consequence of this is the absorption of oxalate in the intestine and its increased 
urinary excretion (Earnest et  al. 1974).  In a study of hyperoxaluric patients with 
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decreasing the production of glyoxylate and oxalate (Dowling et al. 1971, Admirand et 
al. 1971).  However, this therapeutic effect of taurine was not confirmed in a later 
study (Smith et  al. 1972a). Since then, no other human studies have been 
undertaken, particularly with a view to investigate the role of taurine in stone 
inhibition similar to that demonstrated in animal studies. 
 
Having noted in the previous chapters the different renal handling of various dietary 
agents in the South African black and white subjects, the present study was 
undertaken to investigate whether the two groups will have a different response to an 
oral taurine load.   
 
 
The main objectives of this study are: 
 
 to determine the urinary concentrations of glycolate in healthy black and white 
male South African subjects after a taurine load and to explore any evidence 
of its inhibitory effect on the excretion of glycolate and oxalate. 
 
 to determine the crystallization properties in the urine of the two ethnic groups 
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Ten black and ten white healthy South African males (aged 18-30) recruited from the 
student cohort of the University of Cape Town participated in the study.  Approval for 




All subjects avoided calcium- and oxalate-rich foods for 3 days prior to the 
commencement of the study, as instructed.  On day 4, subjects consumed a strict 
standardized diet.  The actual composition of the standardized meals and the nutrient 
content are shown in Table 5.1 and Table 5.2, respectively.  A 24 h urine sample was 
collected on day 5 while subjects continued with the standardized diet. On day 6,  
250 ml Red Bull (Red Bull GmbH, Austria) containing carbonated water, sucrose, 
glucose, sodium citrate, taurine (1000 mg), glucuronolactone (600 mg), caffeine                     
(80 mg), inositol, niacin, D-pantothenol, vitamin B12, artificial flavours and colours 
was ingested with the snack at 11h00.  During the following 24 h, a urine sample was 
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Table 5.1:  Constituents of the strict standardized diet  
 
MEAL DAY 4 AND 5 DAY 6 
Breakfast:  
8h30  
100 g bread rolls 
10 g margarine 
30 g salami pressed beef 
50 g tomato 
250 ml coffee 
100 g bread rolls 
10 g margarine 
30 g salami pressed beef 
50 g tomato 
250 ml coffee 
Snack:  
11h00  
27 g muesli bar 27 g muesli bar 
250 ml Red Bull 
Lunch:  
13h00  
90 g steamed chicken breast 
100 g tomato 
20 g lettuce 
50 g hamburger roll 
20 g sauce 
30 g lightly salted potato crisps 
150 g banana 
90 g steamed chicken breast 
100 g tomato 
20 g lettuce 
50 g hamburger roll 
20 g sauce 
30 g lightly salted potato crisps 




1 slice of whole wheat bread 
20 g cream cheese 
50 g tomato 
1 slice of whole wheat bread 
20 g cream cheese 




120 g mince  
120 g carrots 
100 g tomato 
50 g green pepper 
240 g pasta 
30 g cheese 
120 g mince  
120 g carrots 
100 g tomato 
50 g green pepper 
240 g pasta 
30 g cheese 
Snack:  
22h00 pm 
175 g low fat strawberry yoghurt 
150 g apple 
175 g low fat strawberry yoghurt 
150 g apple 
 
Beverages: (2.25 l/day): 
250 ml coffee (4 g coffee powder, 4 g creamer, 10 g sugar in 250 ml water) 
700 ml caledon water until 13h00 
600 ml caledon water until 19h00 
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Table 5.2:  Nutrient content of the standardized diet  
  
VARIABLE AMOUNT 
Energy (kJ) 12063 
Total protein (g) 110.3 
Total fat (g) 85.0 
Carbohydrate (g) 383.5 
Calcium (mg) 785 
Magnesium (mg) 364 
Phosphorus (mg) 1385 
Citric acid (mg) 1385 





Urine parameters were routinely measured in each of the 24 h urine samples 
obtained on day 5 and day 6 during the protocol as described in Chapter Two    
(page 51).  Urine aliquots from each subject were kept at -80°C for the determination 
of urinary glycolate until analysis. 
 
Determination of Urinary Glycolate 
 
The method described by Van hee et al. (2004) was followed.   Urine samples were 
prepared prior to analysis (described below) and the concentration of glycolate in 
each sample was then measured using gas chromatography tandem mass 
spectrometry (GC/MS).  The pre-treatment of the samples involved a derivatization 
step.  The objective for this step was to chemically modify the active hydroxyl sites in 
the glycolate molecule in urine samples by adding an excess of the derivatizing agent 
bis-N,O-trimethylsilyl trifluoroacetamide (BSTFA) in order to enhance 
chromatographic detectability of glycolate.  Derivatization is crucial as it aids in 
increasing not only the detectability of compounds but also their volatility and 
stability.  Moreover, differences in the sample compounds are accentuated through 
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I.   Preparation of Standards 
 
A 100 mg/l glycolic acid (Sigma-Aldrich, Germany) stock solution prepared in 
redistilled water was used to make up six dilute standard solutions of varying 
concentrations (0.5, 10, 15, 30, 40 and 50 mg/l).  The internal standard was prepared 
by adding 1,3-propylene (7 mg) (Aldrich, Bornem, Belgium)  to acetonitrile (10 ml) 
(Merck, Darmstad, Germany) and the solution was stored at 4°C until use. 
 
II.     Derivatization Assay 
 
20 μl of the urine sample was transferred by a micropipette into a screw-cap vial and 
to it 20 μl of the internal standard solution 1,3-propylene glycol in acetonitrile (7mg/10 
ml), 20 μl of dimethylformamide (DMF) (Merck, Darmstad, Germany) and 750 μl of 
BSTFA (Sigma-Aldrich, Germany) were added.  The standard solutions (20 μl) were 
pre-treated in the same manner.  The vial was vortexed immediately followed by 
incubation at 70°C for 15 min and then cooled.   
 
III. Chromatographic Procedure  
 
1 μl of the solution was injected into the GC system (Agilent Technologies, USA), at a 
set temperature of 280°C, on an HP-5MS (Agilent part no: 19091S-433) fused silica 
capillary column (30 m x 0.25 mm I.D, 0.25 μm film thickness) with helium as carrier 
gas at linear velocity of 36 cm/min, with a 1/60 split ratio.  The samples were 




Crystallization experiments were performed as described in Chapter Two (page 52) 
and all data were statistically analyzed by one-way ANOVA at statistical significance 
of p≤0.05. 
 
Scanning Electron Microscopy 
 
Urine samples were prepared, filtered and mounted on stubs and the stubs were 
viewed under a scanning electron microscope as described in Chapter Three      
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5.3   Results 
 
Prior to the administration of taurine, there were no statistically significant differences 
in the urinary excretion of any of the urinary variables in either the black or the white 
group as shown in Table 5.3.  These results are not in agreement with the baseline 
differences observed in the earlier studies in the previous chapters between the two 
groups.  This anomaly will be discussed in Chapter Six.  
 
The intake of a taurine load did not have a significant effect within either of the two 
race groups except for the increase in BRI in whites after a taurine load (Table 5.4).  
However, inter-group comparisons demonstrated that whites had higher urinary 
oxalate and creatinine levels as well as the RS of brushite compared to their black 
compatriots after taurine ingestion.   
 






Blacks Whites p 
 
pH 6.61 ± 0.11 6.47 ± 0.07 0.3999 
Volume (ml/24h) 1980 ± 197 2204 ± 169 0.3209 
Citrate (mmol/24h) 3.96 ± 0.67 4.75 ± 0.39 0.3847 
Oxalate (mmol/24h) 0.28 ± 0.03 0.32 ± 0.03 0.5286 
Calcium (mmol/24h) 2.60 ± 0.38 3.75 ± 0.77 0.2723 
Magnesium (mmol/24h) 2.63 ± 0.39 2.83 ± 0.26 0.8897 
Sodium (mmol/24h) 185 ± 32.0 132 ± 25.3 0.3503 
Potassium (mmol/24h) 51.0 ± 10.2 64.8 ± 13.4 0.3029 
Urate (mmol/24h) 3.33 ± 0.25 3.68 ± 0.29 0.9759 
Creatinine (mmol/24h) 12.9 ± 1.72 16.6 ± 0.99 0.1418 
Phosphate (mmol/24h) 20.0 ± 1.15 25.6 ± 2.05 0.2720 
Glycolate (mg/l) 12.0 ± 2.25 12.6 ± 6.11 0.8472 
Tiselius risk index 319 ± 58.9 247 ± 32.5 0.3001 
RS Brushite 0.14 ± 0.08 0.43 ± 0.11 0.0808 
RS CaOx 3.43 ± 0.56 2.36 ± 0.30 0.1725 
RS Uric Acid 0.30 ± 0.23 0.39 ± 0.12 0.7804 
BRI (/l) 1.16 ± 0.88 0.49 ± 0.33 0.4969 
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Table 5.4:   Mean 24 h urinary variables ± SE in black and white subjects after 
ingestion of taurine  
 
 













pH 6.61±0.11 6.27±0.21 0.2346 6.47±0.07 6.35±0.19  0.5507 0.7934 
Volume (ml/24h) 1980±197 2094±204 0.6669 2204±169 2393±108  0.3606 0.2034 
Citrate (mmol/24h) 3.96±0.67 4.41±0.70 0.8095 4.75±0.39 4.09±0.72 0.4284 0.8710 
Oxalate (mmol/24h) 0.28 ±0.03 0.26±0.02 0.1908 0.32±0.03 0.31±0.02 0.6904 *0.0194 
Calcium (mmol/24h) 2.60±0.38 2.44±0.27 0.5832 3.75±0.77 3.97±0.62 0.8287 †0.0520 
Magnesium (mmol/24h) 2.63 ±0.39 2.29±0.41 0.3843 2.83±0.26 2.86±0.40 0.9446 0.2943 
Sodium (mmol/24h) 185 ±32.0 146±30.8  0.1878 132±25.3 142±38.6 0.2312 0.6139 
Potassium (mmol/24h) 51.0±10.2 41.8±4.65 0.5263 64.8±13.4 41.8±13.2 0.2366 0.8746 
Urate (mmol/24h) 3.33±0.25 3.25±0.33 0.4462 3.68±0.29 3.89±0.34 0.7070 0.2550 
Creatinine (mmol/24h) 12.9±1.72 11.2±1.78 0.3322 16.6±0.99 17.4±1.42 0.6512 *0.0124 
Phosphate (mmol/24h) 20.0± 1.15 19.5±2.84 0.6988 25.6±2.05 27.2±1.94 0.6868 0.0923 
Glycolate (mg/l) 12.0±2.25 11.9±2.02 0.5023 12.6±6.11 12.3±1.90 0.8355 0.8283 
Tiselius risk index 319±58.9 410±92.2 0.4162 247±32.5 253±38.6 0.9046 0.1355 
RS Brushite 0.14±0.08 0.17±0.08 0.7990 0.43±0.11 0.58±0.17 0.5248 *0.0163 
RS CaOx 3.43±0.56 2.37±0.34 0.1452 2.36±0.30 3.04±0.48 0.3285 0.3094 
RS Uric Acid 0.30±0.23 0.57±0.34 0.5369 0.39±0.12 0.50±0.15 0.6050 0.8720 
BRI (/l) 1.16±0.88 3.21±0.92 0.1458 0.49±0.33 2.97±0.78 *0.0194 0.8495 
MSL (mol/dm3) 0.11±0.02 0.09±0.04 0.4484 0.08±0.02 0.09±0.03 0.6606 0.9030 
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Particle Formation Kinetics 
 
Particle Volume-Size Distribution 
 
Taurine did not induce any change in the mean particle size in blacks relative to 
baseline (Table 5.5). However, in whites, the mean particle size increased after a 
taurine load.  The mean particle volume-size distributions in urines from black and 
white subjects before and after taurine loading are shown in Figure 5.1.   
 
Table 5.5: Mean particle size (μm) in urines of black and white subjects before and 
after ingestion of taurine 
 
 Blacks Whites 
Before 4.01 3.64 




































Figure 5.1: Particle volume-size distribution after a taurine load in urines of 


















The curves for particle number versus time are shown in Figure 5.2.  At 120 min the 
particle number increased in blacks post a taurine load.  In whites taurine did not 





































Figure 5.2: Particle number in urines of blacks and whites before and after 
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Scanning Electron Microscopy 
 
The scanning electron micrographs obtained before and after a taurine load are 
shown in Figure 5.3 for urines from black and white subjects.  In all micrographs, the 
dominating crystals are the coffin-shaped COM crystals.  The number of crystals 
increased in the black group but remained unchanged in the white group.  An 
increase in particle size was noted in the white group. 
 
 
 a   c 
 b   d 
 
Figure 5.3: Scanning electron micrographs of CaOx crystals pre and 
post ingestion of taurine in blacks (a: pre; b: post) and whites (c: pre; 







Blacks : pre-taurine Whites : pre-taurine 















14C-Oxalate Crystal Deposition 
 
The rate of CaOx deposition is indicated by the gradient of each curve (top right-hand 
corner) for black and white subjects pre- and post-intake of taurine (Figure 5.4).  A 
reduction in CaOx deposition rate was observed in both groups after a taurine load. 
 
 
y = 0.3072x + 6.6193
y = 0.2892x + 6.5084
y = 0.1708x + 4.2647







































Figure 5.4: Percentage precipitated 14C-oxalate pre- and post-taurine ingestion in 
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Crystal Aggregation 
 
The mean percentages for the inhibition of CaOx crystal aggregation in black and 
white subjects are given in Table 5.6, corresponding to the plots shown in Figure 5.4.  
Within each group no significant changes were noted after a taurine load in either of 
the two groups.  Inter-group comparisons also revealed no changes both before and 
after taurine ingestion.   
 
Table 5.6: Mean percentage inhibition of aggregation in black and white subjects 
before and after a taurine load 
 
 Blacks Whites Blacks vs Whites 
% Ia (SE)  p % Ia (SE) p p 
Before  62.0 (8.92)  58.4 (7.01)  0.7502 



































Figure 5.4: Plot of absorbance versus time pre- and post-taurine load in urines 
of black and white subjects. The time at which stirring was stopped is indicated 
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Summary of Urine Chemistry and Crystalluria Properties After Taurine Load 
 
   Blacks Whites 
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5.4 Discussion 
 
The inhibitory effect of taurine on urinary glycolate and thus oxalate excretion was 
investigated in this chapter.  The two groups did not show any statistically significant 
changes in the two urinary parameters following a taurine load.  However, inter-group 
comparisons showed significantly higher levels of oxalate in white subjects.   As 
stated earlier, glycolate is a well-known precursor of oxalate which is matabolized 
mainly in the liver to produce glyoxylate and is in turn converted to oxalate.  Even 
though some of the glycolate in the body is derived from the diet, a large portion is 
synthesized endogenously (Harris and Richardson 1980).  Studies on rats have 
reported a high excretion of oxalate in the urine after the administration of glycolate 
and other precursors of oxalate such as, glyoxylate, hydroxypyruvate and 
hydroxyproline (Ogawa et al. 1999, Ogawa et  al. 2000).  The ingestion of the latter 
has been shown both in animal (Bushinsky et  al. 2002, Takayama et  al. 2003, 
Bushinsky et al. 2005, Ogawa et al. 2007) and human (Knight et al. 2006) studies to 
induce an increase in urinary glycolate and oxalate.  
 
Several potential inhibitors of oxalate synthesis have been studied both in vitro and in 
vivo (Smith et  al. 1972b, O’Keeffe et  al. 1973).  The NAD-dependent oxidation of 
glyoxylate to oxalate which is catalyzed by lactate dehydrogenase (LDH) (Scheme 1, 
Chapter Four) has been identified as the most important pathway for the synthesis of 
oxalate (Smith et  al. 1972b).  In the in vitro study undertaken by Smith and co-
workers (1972b) in search of finding the most potent inhibitor(s) of oxalate synthesis, 
fourteen oxalate or glycolate analogues were examined and 
hydroxymethanesulfonate (sulfonic acid analogue of glycolate) was the most 
effective inhibitor of the two enzymes, glycolic acid oxidase (GAO) and LDH in the 
erythrocytes of rats.  Earlier human studies have also supported this finding (Gibbs 
and Watts 1967).  In addition, oxalatehydrazide (oxalate analogue) was 
demonstrated to be also the most potent inhibitor of LDH (Smith et  al. 1972b).  
Scheme 1, below, is a depiction of the possible sites of oxalate synthesis inhibition.   
 
Elevated excretion of urinary oxalate and its precursors has been reported in vitamin 
B6 deficiency due to taurine depletion (Gershoff 1964, Swan et al. 1964, Miller et al. 
1978, Nishijima et al. 2003).  The potency of pyridoxine in reducing the synthesis of 
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demonstrated that administration of taurine together with glycolate in rats lowered 





Scheme 1:  Possible sites of oxalate synthesis inhibition (broken arrow from 
ascorbate to oxalate indicates pathway not defined and may go via glyoxylate) 
(Smith et al. 1972b) 
 
In spite of the findings described above, taurine displayed no effect towards the 
aforementioned urinary risk factors in both groups.  Since taurine neither promoted 
nor inhibited the excretion of oxalate or glycolate significantly in the two groups, it 
appears that it did not alter the activity of the enzymes glycolate oxidase (GO) and 
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sufficient to induce significant changes within the two groups.  However, inter-group 
comparisons revealed that a subtle change may indeed have occurred.  This would 
need further investigation. 
 
Talwar and co-workers (1985) performed an in vitro experiment with 0.5 mmol/l of 
taurine and they observed no effect of this substance on COM crystal growth.  
However, the data was not published.  The increased number of precipitated 
particles in the black group (substantiated by Coulter Counter and SEM studies), 
indicates that taurine failed to inhibit crystal growth.  On the other hand, taurine 
induced a decrease in the rate of crystal deposition in both groups.  This implies a 
protective role exhibited by taurine.  However, this is inconsistent with the urine 
chemistry results and its relevance is not clear.   
 
In summary, the role of taurine in reducing urinary glycolate and oxalate, which has 
been reported in other human and animal studies, was not demonstrated in the 
present study.  Furthermore, the two South African population groups did not differ 
with respect to other urinary parameters in the handling of the taurine challenge.  
There is one possible explanation for the apparent inconsistency with the other 
studies.  The source of taurine which was used in the present study, Red Bull Energy 
Drink, contains many other ingredients, any one of which may have induced 
confounding effects.  Future studies involving humans are indeed warranted, but 
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6.1   General Discussion  
 
The studies described in this thesis addressed the effects of various lithogenic and 
antilithogenic dietary supplements on the urinary risk factors for calcium oxalate 
kidney stone formation and whether these effects were different in subjects from 
South Africa’s black and white population groups.  It is appropriate now to interrogate 
the results which have been obtained in these studies and to assess the effects of 
each of the different supplements. 
 
Refined Carbohydrate: Significance in Urolithiasis Risk Factors 
 
The impact of refined carbohydrates on the key risk factors for kidney stone 
formation has been established and firmly understood.   Consumption of refined 
carbohydrates has risen over the years with the evolution of affluent lifestyles, so has 
the incidence of urolithiasis.  Low digestible carbohydrates such as sorbitol and xylitol 
which belong to the class of polyols/sugar alcohols have also been studied and their 
influence on the urinary constituents is intriguing.  The summarized effects of 
ingestion of some sugars on urinary calcium, oxal te and phosphate excretion which 
have been investigated by various researchers are given in Table 6.1. 
 
 
In Chapter Two of this thesis, the effects of oral glucose, sorbitol and xylitol loads on 
the excretion of the aforementioned urinary parameters were examined in black and 
white South African male subjects.  The highlights which emerged from the study 
were, firstly, the reduction of phosphate in the black group after glucose intake.  
Sugar           Ca            Ox               P                             References 
 
Glucose                                                               Gluszek 1988, Nguyen et al. 1989  
 
Sucrose                                                               Lemann et al. 1969, Nguyen et al. 1994 
 
Fructose                                                              Nguyen et al. 1995 
 
Sorbitol                                                               Nguyen et al. 1993 
 
Xylitol                                                                 Bar 1985, Nguyen et al. 1993 
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Additionally, ingestion of 75 or 100 g of glucose has been shown in previous studies 
to increase the urinary excretion of oxalate, whereas no significant change has been 
observed after a 20 g load.  Similar findings were observed in the present study after 
the latter load in both race groups.  Secondly, an analogous decrease in phosphate 
subsequent to the ingestion of sorbitol occurred in each group, with an additional 
increase in oxalate in the white group.  Thirdly, xylitol overtly increased oxalate in the 
black group and even though the white group responded in a similar manner, the 
increase was not statistically significant.  Plausible proposed mechanisms for the 
occurrence of these influences in one group and not the other or in a greater or 
lesser extent were provided.  An apparent conflict arose when attempting to correlate 
the results from the series of crystallization experiments to the urine chemistry 
results, but it was recognized that subtle changes in the latter can influence the 
crystallization capacity of the urine. 
 
The second aforesaid highlight stipulated that sorbitol caused significant changes in 
urinary phosphate (both groups) and oxalate (white group) and this was intriguing 
since a previous study reported no changes in the two parameters including calcium.  
It was therefore critical to explore this further by increasing the dose with a view to 
establishing whether the excretion of oxalate, in particular, would be aggravated in 
the white group (Chapter Three).  The 30 g sorbitol load did indeed intensify the 
urinary excretion of oxalate in the white group and it also induced a remarkable 
increase in urinary calcium which correlated with the almost significant increase in 
serum concentrations.  The SEM photographs confirmed the increase in the size and 
number of deposited CaOx crystals, implying enhanced CaOx crystallization in this 
group.  Yet again no changes were observed in the black group in either urinary 
parameter.  On the other hand, urinary phosphate did not change in this group 
following a 30 g load but a similar decrease previously observed after the 20 g load 
was sustained in the white group despite the unchanged serum levels in either group. 
Interestingly, Nguyen co-workers (1993) did not note any changes as well in serum 
phosphate levels.  Nevertheless, the results of the present study have demonstrated 
that sorbitol does affect the urinary phosphate excretion. 
 
Thus, the significance of sorbitol influencing the risk factors of urolithiasis has been 
demonstrated by the two studies for the first time.  The unfavourable effect of this 
sugar in the stone-prone white group but not in the black group suggests a superior 
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In addition, the assessment of the baseline activity of serum aldolase, an enzyme 
implicated in the metabolic conversion of sorbitol and xylitol to oxalate, revealed a 
difference in the two groups.  The implication of this is that the renal handling of the 
two polyols is possibly controlled by this enzyme.  The higher activity demonstrated 
by black subjects relative to their white compatriots supports the hypothesis that the 
baseline activity of aldolase is different in the two ethnic groups.  
 
Oxalate: Significance in Cellular and Oxidative Injury  
 
Elevated urinary levels of markers of tubular damage such as NAG, GAL,       
gamma-glutamyl transpeptidase (GGT) and angiotensin I converting enzyme have 
been noted in stone-forming patients compared to healthy individuals (Baggio et al. 
1983).  However, in some loading studies, oral administration of acute loads of 
oxalate had no adverse effects on cellular injury, as indicated by the unchanged 
excretion of NAG, despite increased urinary oxalate concentrations (Holmes et  al. 
2005, Knight et al. 2007).  In both studies, the administered loads of oxalate ranged 
from 2-8 mmole.  It is therefore possible that extreme concentrations of oxalate are 
required to trigger the desired response. 
 
In Chapter Four, three different oxalate challenges in the form of rhubarb, spinach 
and sodium oxalate were investigated in order to examine whether they would have 
an effect on the urinary excretion of oxalate and NAG in the two South African race 
groups.  Significant increases in oxalate excretion were observed in the black group 
after ingestion of spinach and sodium oxalate whereas rhubarb did not affect the 
excretion of this parameter in any of the groups.  It is rather surprising that increases 
in urinary oxalate were observed in the black group but not in the white group, since 
it was indicated in Chapter One that Lewandowski and co-workers (2005) reported 
lower levels in this group despite excessive consumption of dietary oxalate.  The 
concentrations, however, were not high enough to cause an increase in the relative 
supersaturation of CaOx.  With respect to urinary NAG excretion, all three challenges 
did not have a significant impact on this variable even though the white group 
demonstrated higher levels after rhubarb and sodium oxalate ingestion compared to 
their black compatriots.  The latter did not provoke any changes in the biomarker for 
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It can be speculated that the dietary oxalate loads administered in these studies were 
possibly not sufficient to trigger either cellular injury or oxidative stress in the two 
groups. 
 
Taurine: Significance in Stone Inhibition 
 
Animal studies have repeatedly demonstrated that taurine plays a significant role in 
the reduction of urinary oxalate and its precursors and thus inhibits CaOx 
crystallization as discussed in the previous chapter.  The present study was the first 
to administer taurine and to examine the urine chemistry in the two South Africa’s 
race groups in response to this challenge.  The results showed that taurine did not 
provoke any changes in urinary oxalate or its precursor, glycolate in either group.  
Thus, it can be concluded that in the metabolic pathway for the production of oxalate 
from glycolate, taurine neither suppressed nor activated the hepatic enzymes LDH 
and GAO, thereby culminating in unaltered urinary composition.  The ability of taurine 
to retard the CaOx deposition in both groups was of note as it demonstrated a 
possible inhibitory role even though this was not reflected by the urine chemistry.  
Evidently, further investigations are warranted to clarify the potency of taurine in 
inhibition of urolithiasis in humans. 
 
Baseline 24 h Urinary Variable Comparisons 
 
The urinary excretion of calcium and phosphate were commonly lower in black 
subjects compared to white subjects prior to the ingestion of the dietary challenges 
(Chapters Two to Four).  The lower calcium excretion in the former is in accordance 
with previous studies which have reported similar observations, as stated in Chapter 
One.  In addition, the metastable limit was higher in black subjects (Chapters Two to 
Four) and the relative supersaturation  of CaOx was lower (Chapter Four) in this 
group than in white subjects.  The higher metastable limit observed in the former 
group signifies that black subjects’ urine can withstand elevated concentrations of 
supersaturation exclusive of CaOx crystallization.  These observations support the 
lower incidence of kidney stone formation in this group than in their white 
compatriots.  In Chapter Five none of the urinary parameters were significantly 
different.  This and other inconsistencies can be ascribed to the fact that the 
controlled standardized diets administered in all the studies were different and were 
designed for the specific protocols in each study.  The 24 h baseline urinary data in 
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independently, due to the small numbers of subjects who participated in each of 
them. 
 
6.2   Conclusions 
 
The pathogenesis of urolithiasis is governed by a wide spectrum of factors which are 
crucial in the understanding of this condition.  As stated earlier, diet plays a 
fundamental role in the excretion of the key stone risk factors.  This thesis was 
conducted with the aim of gaining more insight to the renal response to several 
lithogenic and antilithogenic dietary agents in South Africa’s white “stone-prone” and 
black “stone-resistant” population groups.  A significant attempt was also made to 
clarify some contradictions in research literature.   
 
The results from the different studies in this thesis have not only demonstrated 
different renal handling mechanisms of the dietary challenges in the two groups but 
they have also provided some insight into the complexity associated with the rarity of 
stone formation in the black group.  This was highlighted, for instance, by the 
increased oxaluria in this group subsequent to the administration of the spinach and 
sodium oxalate protocols, which did not cause cell injury, as seen by the unaltered 
excretion of the markers for cellular and xidative damage.  Thus, the conceptualized 
idea in the research literature that even a slight elevation of urinary oxalate excretion 
poses a risk of injury to renal epithelial cells thereby facilitating stone formation was 
invalidated.    
 
Lastly, the dual role demonstrated by sorbitol in increasing urinary oxalate excretion 
and concomitantly decreasing phosphate excretion in white subjects is intriguing as 
the former promotes calcium oxalate kidney stone formation, while the latter inhibits 
calcium phosphate kidney stone formation.  Previous studies have reported that 
sorbitol has no effect on the excretion of these urinary parameters.  However, the 
present study has for the first time revealed that it does indeed have an effect.  
 
It is recognised that in the studies a small number of subjects participated, hence 
these studies are limited in their statistical power. Nevertheless, differences which 
have been identified are worthy of noting.  Thus the studies described in this thesis 
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kidney stone disease in general, and have provided insights into unravelling the 
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